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ABSTRACT 
The phytopathogenic fungus Alternaria brassicicola (Schwein.) Wiltshire together with A. 
brassicae cause Alternaria black spot (also called dark leaf spot) in Brassica species. During 
infection, A. brassicicola produces various secondary metabolites to facilitate its colonization 
and invasion. A systematic investigation of the secondary metabolites produced by A. 
brassicicola was carried out.  
In addition to previously reported metabolites, four metabolites, α-acetylorcinol (210), 
tyrosol (219), depudecin (151) and dihydrobrassicicolin A (220) were isolated and characterized 
from culture extracts of A. brassicicola for the first time. Chemical synthesis of α-acetylorcinol 
(210) was accomplished for the first time with an overall yield of 36%. Neither α-acetylorcinol 
(210) nor tyrosol (219) caused necrotic lesions on the leaves of or displayed elicitor activity in 
Brassica juncea, B. napus, or Sinapis alba. 
A. brassicicola was incubated under different sets of culture conditions, and the culture 
filtrates were extracted and analyzed by HPLC-DAD. The production of brassicicolin A (1), 
depudecin (151) and α-acetylorcinol (210) was increased in low concentrations of KNO3 or 
NaNO3, or in the absence of nitrates. These results suggest that nitrate inhibits the biosynthesis 
of brassicicolin A (1), depudecin (151), and α-acetylorcinol (210). In the iron deficient 
conditions, A. brassicicola produced larger amounts of siderophores than in control cultures 
(ferric citrate 2 µM) or in high concentration of ferric citrate (200 µM). Moreover, spore 
germination fluids (SGFs) collected from detached leaves of B. juncea, B. napus, and S. alba 
contained fungal metabolites (i.e., siderophores and phomapyrone A (25)). These results suggest 
that siderophores may play a role in fungal colonization by obtaining iron from host plants. In 
addition, HPLC analyses of extracts of the detached leaves of B. juncea, B. napus, and S. alba 
infected with A. brassicicola revealed that phomapyrone A (25), a fungal metabolite and non-
phytotoxin, was detected and quantified for the first time.  
Brassicicolin A (1) is a host-selective phytotoxin produced by A. brassicicola. The 
biosynthetic precursors of brassicicolin A (1) were investigated using the following isotopically 
labeled compounds: D-[U-13C6]glucose, L-[15N]valine, and L-[2H8]valine. The labeled 
brassicicolin A (1e, 1j or 1m) was obtained from the extracts of culture filtrates of A. 
brassicicola obtained from incubation of cultures with labeled precursors. The 13C NMR and 
	 iii 
INADEQUATE spectra of 13C-enriched brassicicolin A (1e) obtained showed 13C-13C coupling 
resulting from adjacent 13C carbons. Enhancement of the isocyanide carbon resonances of the 
13C-enriched brassicicolin A (1e) suggested that the isocyanide carbons are labeled. Furthermore, 
spectroscopic data including 1H NMR, 15N NMR and HR-ESI-MS of 2H-enriched (1j) or 15N-
enriched brassicicolin A (1m) indicated that both 2-hydroxy-3-methylbutanoyl and 
isocyanoisovaleryl units are derived from valine. 
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1 Introduction 
1.1 General objectives 
The plant pathogenic fungus Alternaria brassicicola (Schwein.) Wiltshire together with 
A. brassicae (Berk.) Sacc. cause Alternaria black spot disease in crucifers. A. brassicicola 
produces various secondary metabolites including phytotoxin(s). This thesis describes a 
systematic investigation of the metabolites of A. brassicicola produced in aseptic cultures and in 
planta. In addition, the biosynthetic study of brassicicolin A, a host-selective phytotoxin is 
presented. The overall goal of this project is to understand the chemical interactions between A. 
brassicicola and its host plants. This knowledge could lead to the development of novel 
strategies to control A. brassicicola. The specific objectives of my Ph. D. research work are 
summarized below. 
A. Investigation of the components of culture media and conditions that influence the 
production of secondary metabolites by A. brassicicola, including: 
a. Carbon and nitrogen sources, organic and inorganic components, and 
temperature; 
b. Inhibitors of histone deacetylases and DNA methyltransferases; 
c. Co-cultivation with A. brassicae. 
B. Investigation of metabolites produced on leaf tissues of plants (susceptible and resistant) 
infected with A. brassicicola, including:  
a. Comparative chemical analyses of metabolites produced in infected and control 
leaves of Brassica juncea cv. Cutlass (susceptible), B. napus cv. Westar 
(susceptible) and Sinapis alba cv. Ochre (resistant); 
b. Comparative chemical analyses of metabolites produced in infected and control 
leaves of Arabidopsis thaliana Columbia (Col-0) and mutants (pad3-1 and pen2-
1). 
C. Investigation of the biosynthetic pathway of brassicicolin A (1) using isotopically labeled 
precursors.  
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1.2 Secondary metabolites produced by phytopathogenic fungi 
Secondary metabolites (SMs) are defined as metabolites that “are found in only specific 
organisms, or groups of organism, and are an expression of the individuality of species” 
(Dewick, 2002). To be specific, secondary metabolites are “low-molecular-weight natural 
products with restricted taxonomic distribution, often synthesized after active growth has ceased, 
which do not have an obvious function in producer species” (Keller, Turner et al., 2005). 
Moreover, natural products are “organic compounds of natural origin that are unique to one 
organism, or common to a small number of closely related organisms” (Mann, 1987). Although 
SMs are one of the subclasses of natural products (Hanson, 2003), the terms “natural product” 
and “secondary metabolite” are interchangeable (Mann, 1987). 
SMs have chemical-ecological roles in adaptation, fitness, and survival of living 
organisms (O’Brien and Wright, 2011) rather than having basic cellular functions like primary 
metabolites. Among various SMs, it has been demonstrated that toxic metabolites produced by 
phytopathogenic fungi facilitate the development of plant diseases that may lead to serious yield 
losses of economically important crops (Muria-Gonzalez, Chooi et al., 2015; Pusztahelyi, Holb 
et al., 2015). Toxic metabolites that cause damage to plants are known as phytotoxins. Although 
many efforts to establish the role(s) of phytotoxins in plant disease have been made during the 
last decades, a better understanding of the chemical-ecological roles of phytotoxins is essential to 
control plant pathogens in effective ways.  
 
1.2.1 Phytotoxins produced in culture and in planta 
The definition of phytotoxins has evolved substantially (Graniti, 1991), since it was first 
used (Wheeler and Luke, 1963). In a more recent review on phytotoxins, Strange suggested that 
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phytotoxins are “compounds synthesized by plant pathogens, which adversely affect their hosts” 
(Strange, 2007). Phytopathogenic fungi and bacteria biosynthesize and secrete phytotoxins 
during infection. Phytotoxins can be classified into host-selective (or host-specific) toxins 
(HSTs) and non-host-selective (or non-host-specific) toxins (NHSTs). HSTs have a specific 
range of host plants that are susceptible to the pathogens, whereas NHSTs have a wide spectrum 
of host plants irrespective of host specificity (Scheffer and Livingston, 1984). 
Phytotoxins have mostly been isolated from culture extracts of phytopathogens. In certain 
cases, chemical syntheses and derivatization of phytotoxins, and/or genetic manipulation of 
phytopathogens are required to establish the importance of phytotoxins (Strange, 2007). A 
review article published in 2007 covered about 126 phytotoxins produced by microbial 
phytopathogens (up to end of 2005) (Strange, 2007). In this section, a few examples of 
phytotoxins produced by microbial phytopathogens that cause disease symptoms are described 
below.  
HC-Toxin (2), a cyclic tetrapetide, is produced by Cochliobolus carbonum, one of the 
most virulent pathogens on maize.  HC-toxin (2) is a cyclic compound containing D-Pro-L-Ala-D-
Ala-L-Aeo, where Aeo represents 2-amino-9,10- epoxi-8-oxodecanoic acid (Kawai, Rich et al., 
1983). The absolute configurations of HC-toxin (2) were confirmed by total synthesis (Kawai 
and Rich, 1983).  
 
 
 
Interestingly, resistant maize having HC-toxin reductase can transform HC-toxin (2) by 
reducing the carbonyl group in the Aeo residue (Johal and Briggs, 1992; Meeley and Walton, 
1991). The host specificity of HC-toxin (2) was confirmed by observing HC-toxin reductase 
activity in cereal crops (e.g. barley, sorghum, oats) that are resistant to C. carbonum (Walton, 
2006). Meeley and Walton reported that resistant maize reduced HC-toxin (2) to less toxic 8-
hydroxy HC-toxin (3), where a NAD(P)H-dependent HC-reductase catalyzed this detoxification 
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(Meeley and Walton, 1991). Further investigation on detoxification of HC-toxin (2) and host 
susceptibility revealed that plants expressing HC-toxin reductase activity (Scheme 1.1) were 
resistant to C. carbonum (Meeley, Johal et al., 1992). This is an example of detoxification of 
phytotoxins in which host plants acquire resistance to virulent isolates by transforming 
phytotoxins to less toxic metabolites.   
 
 
 
Scheme 1.1 Detoxification of HC-toxin (2) by resistant maize. 
 
Albicidin (4) was first reported as a phytotoxin produced by Xanthomonas albilineans 
causing leaf scald disease of sugarcane (Birch and Patil, 1985). Strains that do not produce 
albicidin (4) fail to cause disease, whereas albicidin-producing strains cause disease in 
susceptible sugarcane. Albicidin (4) also showed antibacterial activity by inhibiting DNA 
replication in Escherichia coli at nanomolar concentrations (Birch and Patil, 1985). The 
complete structure of albicidin (4), however, remained unknown for more than 30 years because 
the strain produced albicidin (4) in low amount. Cociancich et al., finally, elucidated the 
structure of albicidin (4) on the basis of HR-MS and NMR spectroscopic data; 1 mg of albicidin 
(4) was purified from 100 L cultures (Cociancich, Pesic et al., 2015). Kretz et al. carried out the 
total synthesis of albicidin (4) and confirmed the structure (Kretz, Kerwat et al., 2015).  
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Zhang and Birch first reported that Pantoea dispersa (syn. Erwinia herbicola) detoxified 
albicidin (4) almost completely (Zhang and Birch, 1997a), and later on cloned and sequenced a 
gene (albD) responsible for enzymatic detoxification of albicidin (Zhang and Birch, 1997b). 
Zhang and Birch suggested that the gene (albD, albicidin hydrolase) could be transferred into 
sugarcane to confer disease resistance to susceptible sugarcanes (Zhang and Birch, 1997b). 
Zhang et al. reported that transgenic sugarcane harboring the albD gene showed no damage on 
infected leaves, whereas non-transgenic sugarcane showed severe disease symptoms (Zhang, Xu 
et al., 1999).  
It is worth noting that HC-toxin (2) and albicidin (4) are detoxified differently. That is, 
HC-toxin is detoxified by naturally resistant plants, whereas albicidin is detoxified by transgenic 
plants having a detoxification gene cloned from a bacterium. In both cases, one single gene is 
involved in detoxification of phytotoxins. Those two detoxification strategies are important to 
further develop crops resistant to devastating microbial pathogens.  
Fusicoccin (5) is another example of a phytotoxin. Fusicoccin (5) is produced by 
Fusicoccum amygdali Del., the causal agent of drupe canker of almond trees (Prunus amygdalus 
St.) and peaches (Ballio, Chain et al., 1964). The structure of fusicoccin (5), elucidated by Ballio 
et al., is a diterpenoid containing a 5-8-5 ring structure (called fusicoccane) (Ballio, Brufani et 
al., 1968). Unlike HSTs, fusicoccin (5) has been known as a non-host-selective toxin (NHST) 
and has been shown to display various biological activities such as opening leaf stomata, 
awaking seed dormancy, stimulating seed germination, inducing root formation and promoting 
cell enlargement (Ballio, 1991; Marre, 1979; Muromtsev, Voblikova et al., 1994). Interestingly, 
fusicoccin (5) was isolated from peach pulp (ca. 5 mg/kg) and almond shoots (ca. 10 mg/kg) 
after infection with F. amygdali Del. (Ballio, D'Alessio et al., 1976).  
 
 
 
H
HO O
O
HHO
O
OH
O
OCH3
OH
H
O O
H
O
5
	 6 
Phomalide (6) was first isolated from Leptosphaeria maculans [asexual stage of Phoma 
lingam (Tode ex Fr.) Desm.] and its chemical structure was elucidated by Pedras et al. (Pedras, 
Taylor et al., 1993). Phomalide (6) is a depsipeptide, which contains both ester and amide bonds. 
Phomalide (6) exhibited phytotoxicity on B. napus cv. Westar (susceptible to L. maculans) but 
not on B. juncea cv. Cutlass (resistant to L. maculans) (Pedras and Biesenthal, 1998). Phomalide 
(6) was detected in leaf-extracts of B. napus after infection with L. maculans/P. lingam (Pedras 
and Biesenthal, 1998). Pedras et al. reported that phomalide (6) was detected in liquid cultures 
during the early stages of fungal growth (24–60h), and once sirodesmins (NHST) were produced 
in culture, the production of phomalide (6) was inhibited (Pedras, Taylor et al., 1993). Pedras 
and Biesenthal also reported that prodution of phomalide (6) was not detected in cultures 
incubated with sirodesmin PL (7)  (Pedras and Biesenthal, 1998). Elliott et al. reported that 
sirodesmin PL (7) was detected in extacts of stem and cotyledonary tissues of B. napus infected 
with L. maculans/P. lingam (Elliott, Gardiner et al., 2007). 
   
 
In general, phytotoxins are isolated from culture filtrates of phytopathogenic fungi. 
However, such phytotoxins are not always detected in planta after fungal infection. Detection of 
phytotoxins in infected plants can be strong evidence to establish the involvement of phytotoxins 
during infection. However, phytotoxins have not been detected in many cases, even though 
severe disease symptoms are observed in infected plant tissues. Since artificial conditions for 
fungal growth are different from natural environments, where fungi interact dynamically with 
plants, phytopathogenic fungi might not produce such phytotoxins in vitro. In addition, 
synergistic effects by multiple phytotoxins might cause plant disease symptoms. Detection of 
phytotoxins could be hindered by complex mixtures of plant metabolites produced in infected 
tissues. Furthermore, in some cases, metabolism of phytotoxins by plants or production in small 
quantities could prevent detection of phytotoxins in planta (Hohn, 1997).  
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1.2.2 Orphan pathways 
During the past decades, whole-genome sequence projects of many microorganisms have 
been completed. As a result, it has become evident that there are genes encoding numerous 
metabolites that are not produced (Gross, 2007). Such metabolites belong to orphan biosynthetic 
pathways that are “gene clusters for which the encoded natural product is unknown”; thus, 
numerous metabolites present in orphan biosynthetic pathways await to be discovered (Gross, 
2007). Many efforts to activate these cryptic or silent gene clusters particularly in 
microorganisms have been made; as a result, numerous metabolites have been reported 
(Brakhage, 2013; Brakhage and Schroeckh, 2011; Cichewicz, 2010; Gross, 2007; Höfs, Walker 
et al., 2000; Scherlach and Hertweck, 2009; Strauss and Reyes-Dominguez, 2011; Wiemann and 
Keller, 2014). The following sections cover various strategies to activate silent and/or cryptic 
gene clusters encoding secondary metabolites.  
 
1.2.2.1 Modification of culture conditions 
Bode et al. proposed OSMAC (One Strain MAny Compounds) approach to activate 
cryptic or silent biosynthetic gene clusters by changing cultivation parameters such as media 
components, temperature, pH, aeration, light etc. (Bode, Bethe et al., 2002). Simple 
modifications of cultivation parameters might induce a given organism to produce hidden 
metabolites. For example, Aspergillus ochraceus DSM7428 produced only one metabolite, 
named aspinonene (8); however, DSM7428 produced more metabolites (8–21) under different 
culture conditions (e.g., different culture vessels, fermenters, shaken or static cultures) (Figure 
1.1). Newly characterized orphan metabolites are polyketides (9–15), and nonribosomal peptides 
(16–18) (Bode, Bethe et al., 2002).   
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Figure 1.1 Secondary metabolites isolated from cultures of Aspergillus ochraceus grown under 
various culture conditions (Bode, Bethe et al., 2002).  
 
 
 
The phytopathogenic fungus L. maculans causes blackleg disease on crucifers. A 
systematic investigation of metabolites of L. maculans produced under various culture conditions 
was carried out (Pedras and Chumala, 2011; Pedras and Yu, 2008a, b, 2009b). Briefly, L. 
maculans/P. lingam produced phomalide (6), sirodesmin PL (7), deacetylsirodesmin PL (7a), 
sirodesmin H (7b), sirodesmin J (7c), sirodesmin, K (7d) and phomamide (22) in minimal 
medium (MM), components of which are chemically defined. L. maculans L2/M2 produced 
depsilairdin (23) a HST, polanrazine B (24), phomapyrone A (25), and phomalairdenone A (26) 
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in MM (Figure 1.2) (Pedras and Yu, 2009a). In potato dextrose broth (PDB) media, L. 
maculans/P. lingam produced maculansins A (27), B (28), and 2,4-dihydroxy-3,6-
dimethylbenzaldehyde (29) (Pedras and Yu, 2008b). None of the previously reported metabolites 
(6–7, 7a–7d, 22) produced in MM were detected in PDB. Interestingly, maculansin A (27) was 
more toxic to B. juncea cv. Cutlass (resistant to L. maculans, susceptible to A. brassicicola) than 
to B. napus cv. Westar (susceptible to L. maculans). 2,4-Dihydroxy-3,6-dimethylbenzaldehyde 
(29) showed a strong inhibitory activity of root growth in B. juncea and B. napus (Pedras and 
Yu, 2008b). Furthermore, high NaCl concentration in MM induced production of 8-
hydroxynaphthalene-1-sulfate (30) and bulgarein (31, 31a) in L. maculans/P. lingam cultures 
(Pedras and Yu, 2009b). Considering these metabolites associated with melanin biosynthesis, it 
was suggested that L. maculans/P. lingam produces those metabolites for self-protection in high 
salt. None of those metabolites (30–31b) exhibited phytotoxic activity or elicitor activity in 
crucifers (Pedras and Yu, 2009b). 
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Figure 1.2 Secondary metabolites produced by Leptosphaeria maculans/Phoma lingam (Pedras 
and Chumala, 2011; Pedras and Yu, 2008a, b, 2009b).  
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methylation have led to discovery of various secondary metabolites in several species. Small 
molecules responsible for epigenetic modifications (Figure 1.3) have shown that inhibition of 
histone deacetylases (HDAC) or DNA methyltransferases (DNMT) activates silent or cryptic 
secondary metabolite gene clusters (Cichewicz, 2010). As an example, a study showed that in 
Aspergillus niger, more than 70% of polyketide synthase (PKS), non-ribosomal peptide 
synthetase (NRPS), and hybrid PKS-NRPS gene clusters were not expressed under general 
growth conditions (e.g., shake and static culture conditions). However, treatment with SAHA 
(32) and 5-Aza (35) led to substantial induction of many biosynthetic gene clusters (Fisch, 
Gillaspy et al., 2009). As summarized in Table 1, epigenetic modifiers (32–35) have enabled the 
discovery of secondary metabolites in various species (Figure 1.4–Figure 1.12).  
 
 
 
 
 
Figure 1.3 Chemical structures of representative epigenetic modifiers. HDAC inhibitors, SAHA 
(32), SBHA (33), RG-108 (34); DNMT inhibitor, 5-Aza (35).  
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Figure 1.4 Metabolites of Cordyceps indigotica induced by SBHA (33) and 5-Aza (35) (Asai, 
Yamamoto et al., 2012a; Asai, Yamamoto et al., 2012b).  
 
 
Figure 1.5 Metabolites of Cordyceps annullata induced by SBHA (33) (Asai, Luo et al., 2012). 
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Figure 1.6 Metabolites of Chaetomium indicum induced by SBHA (33) (Asai, Yamamoto et al., 
2013). 
 
 
 
 
Figure 1.7 Metabolites induced by epigenetic modifiers; Daldinone E (53) (Du, King et al., 
2014), tenuipyrone (54) (Asai, Chung et al., 2012b), EGM-556 (55) (Vervoort, Drašković et al., 
2011), nygerone A (56) (Henrikson, Hoover et al., 2009). 
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Figure 1.8 Metabolites of Torrubiella luteorostrata induced by SBHA (33) (Asai, Yamamoto et 
al., 2011).  
 
Figure 1.9 Metabolites of Beauveria felina induced by SAHA (32) (Chung, El-Shazly et al., 
2013). 
 
Figure 1.10 Metabolites of Gibellula formosana induced by SBHA (33) and RG-108 (34) (Asai, 
Chung et al., 2012a).  
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Figure 1.11 Metabolites of Aspergillus sydowii induced by SAHA (32) (Chung, Wei et al., 
2013).  
 
 
 
Figure 1.12 Metabolites of Aspergillus sydowii induced by 5-Aza (35) (Wang, Sena Filho et al., 
2010). 
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cultivated in artificial media might not biosynthesize secondary metabolites that are exclusively 
produced due to interactions with other organisms. Thus, co-cultivation of a given 
microorganism with one or multiple antagonists could be a way to mimic complex natural 
environments. For example, co-cultivation of A. nidulans with soil bacteria (actinomycetes) led 
to activation of cryptic gene clusters encoding orsellinic acid (79), lecanoric acid (80), and two 
phenolic compounds (81 and 82) (Schroeckh, Scherlach et al., 2009). In addition, novel 
prenylated polyketides (83 and 84) were isolated from A. fumigatus culture filtrates after co-
culturing with Streptomyces rapamycinicus (König, Scherlach et al., 2013).  
 
 
Co-cultivation of Alternaria species with other species led to the discovery of 
metabolites. The endophytic fungus, A. tenuissima, was cultivated with Nigrospora sphaerica, 
another endophytic fungus, leading to induction of two polyketides (85 and 86) in co-culture 
extracts (Chagas, Dias et al., 2013). Neither A. tenuissima nor N. sphaerica produced 
stemphyperylenol (85). The production of alterperylenol (86) was increased when they are co-
cultured. Interestingly, stemphyperylenol (85) showed antifungal activity against N. sphaerica at 
0.2 mM, while a 10-fold higher concentration did not cause phytotoxicity in the host plant 
(Smallanthus sonchifolius). Stemphyperylenol (85) might play an important role in maintaining 
ecological relationships between endophyte-endophyte and endophyte-plant (Chagas, Dias et al., 
2013). A review addressing microbial interactions that increased the chemodiversity of  
metabolites produced in co-cultures has been published recently (Bertrand, Bohni et al., 2014).  
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1.2.3 Chemistry of phytopathogenic Alternaria species 
 In general, Alternaria species infect aerial parts of host plants, and produce metabolites 
including phytotoxins to facilitate infection processes. Alternaria species cause economically 
important diseases in various oilseed and horticultured crops, fruits, and cereals (Thomma, 
2003).  
1.2.3.1 Secondary metabolites produced by Alternaria species 
A comprehensive review was published in 2013 regarding metabolites (more than 268 
metabolites covered from 1965 to 2013) of Alternaria species and their biological activities. In 
this article, more than 268 metabolites (covered from 1965 to 2013) produced by Alternaria 
species were reviewed (Lou, Fu et al., 2013) (Table 2). More recently reported (2014–2015) 
secondary metabolites produced by Alternaria species are summarized in Table 3.  
 
Table 2 Structural types of secondary metabolites produced by Alternaria species (Lou, Fu et 
al., 2013). 
Class Number 
Alkaloids 61 
Cyclopeptides 22 
Steroids 7 
Terpenoids 49 
Pyranones 56 
Quinones 45 
Phenolics 38 
Miscellaneous 12 
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Figure 1.13 Metabolites isolated from Alternaria phragmospora (Metwaly, Fronczek et al., 
2014). 
 
 
 
 
 
Figure 1.14 Metabolites isolated from Alternaria alternata (Wang, Yang et al., 2014; Xu, Pu et 
al., 2015). 
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Figure 1.15 Metabolites isolated from Alternaria tenuissima (Anyanwu and Sorensen, 2015; 
Bashyal, Wellensiek et al., 2014; Wang, Luo et al., 2014). 
 
Figure 1.16 Metabolites isolated from Alternaria species (Chen, Shen et al., 2014; Idris, Tantry 
et al., 2015; Shi, Wei et al., 2015). 
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Figure 1.17 Metabolites isolated from Alternaria species (Cai, King et al., 2014). 
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1.2.3.2 Phytotoxins produced in culture and in planta 
1.2.3.2.1 Host-selective toxins 
Host-selective toxins (HST) are usually defined as low-molecular-weight metabolites 
produced by plant pathogens that damage (e.g. necrosis, chlorosis, wilting, water-soaking 
symptoms) susceptible plants. More recently, several studies have shown that protein toxins 
produced in spore germination fluids (SGFs) also cause disease symptoms in susceptible plants 
(Akimitsu, Tsuge et al., 2014). In general, the HST-producing isolates cause disease, whereas the 
non-producing isolates fail to cause disease. HSTs produced by Alternaria species have been 
reviewed (Akimitsu, Tsuge et al., 2014; Tsuge, Harimoto et al., 2013). To date, more than 20 
HSTs have been isolated and characterized. Several examples of Alternaria HSTs of fruits (e.g., 
strawberry, tangerine, or apple) and crops (e.g., crucifers) are described below.  
Structurally, AK toxins (119 and 119a) have a 9,10-epoxy-8-hydroxy-9-
methyldecatrienoic acid (EDA) moiety connected with an N-acetyl-β-methyl-phenylalanyl 
moiety through an ester linkage. AF- and ACT-toxins also contain EDA. AF toxins are produced 
by A. alternata strawberry pathotype. The AF toxin producer biosynthesizes three AF toxins 
(120, 120a, and 120b), where the AF toxin I (120) is a major component (Hayashi, 1990; 
Maekawa, Yamamoto et al., 1984). The structure of AF toxin II (120a) was first elucidated by 
Nakatsuka et al. (Nakatsuka, Ueda et al., 1986), while the structures of the other toxins were 
determined by 2’-O-acyl derivatization of AF toxin II (120a). Furthermore, 2’-O-acyl derivatives 
of AF toxin II (e.g., acetyl, propionyl, or isovaleryl) exhibited phytotoxicity in both strawberries 
and pears, whereas AF toxin II (120a) was toxic to strawberries (Tsuge, Harimoto et al., 2013).  
ACT toxins (named ACT I 121, and II 121a) were isolated from culture filtrates of A. 
alternata tangerine pathotype (Kohmoto, Itoh et al., 1993). ACT toxin I (121) is a major 
component of SGFs of A. alternata tangerine pathotype. ACT-toxin I (121) exhibited 
phytotoxicity on Citrus reticulata Blanco (Emperor mandarin) at 20 nM, whereas a 104-fold 
increase in ACT-toxin I (121) did not affect resistant citrus or Japanese pear (Kohmoto, Itoh et 
al., 1993).  
AM toxins (122, 122a, and 122b) are produced by the apple pathotype of A. alternata, 
the chemical structures of which were elucidated as a cyclic tetrapeptide consisting of L-α-
hydroxy-isovaleric acid, L-alanine, α-amino acrylic acid, and l-α-amino(methoxyphenyl)valeric 
acid (Ueno, Nakashima et al., 1975b). AM toxins I (122, 0.002 µg/mL) and III (122b, 0.010 
	 26 
µg/mL) caused necrosis on leaves of susceptible cultivars, whereas resistant cultivars did not 
show necrosis at 200 µg/mL of 122 and 10 µg/mL of 122b, respectively. The biological activity 
of AM toxin II (122a) is unknown (Ueno, Hayashi et al., 1975; Ueno, Nakashima et al., 1975a).  
 
 
 
Destruxin B (123) was first isolated from Oospora destructor (Metch.) Delac., (Kodaira, 
1962) and the chemical structure of destruxin B (123) was elucidated (Païs, Das et al., 1981). 
Destruxin B (123) was reported as a host-selective toxin produced by Alternaria brassicae 
(Berkeley) Saccardo (Ayer and Peña-Rodriguez, 1987).  
 
 
 
Destruxin B (123) was found to cause severe toxicity in B. campestris cv. Yellow Sarson, 
and Toria, whereas B. campestris cv. Candle showed mild symptom. Considering sensitivity to 
destruxin B (123) and susceptibility to A. brassicae, Bains and Tewari first proposed that 
destruxin B (123) is a host-selective toxin (Bains and Tewari, 1987). Furthermore, Buchwaldt 
and Green insisted that destruxin B (123) should be regarded as a host-selective toxin based upon 
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observations that Brassica species are most sensitive to the toxin 123, whereas the taxonomically 
far-distant plants from Brassica species are much less sensitive (Buchwaldt and Green, 1992).  
Evidence of detoxification of destruxin B (123) by susceptible or resistant plants supports 
that destruxin B (123) is a host-selective toxin. Biotransformation of destruxin B (123) occurred 
with hydroxylation followed by glycosylation; S. alba (resistant) metabolized destruxin B (123) 
to hydroxydestruxin B (124) substantially faster than susceptible Brassica species. On the other 
hand, B. napus (susceptible) transformed hydroxydestruxin B (124) to β-D-glucosyl 
hydroxydestruxin B (125) substantially faster than S. alba (resistant) (Scheme 1.2). Furthermore, 
hydroxydestruxin B (124) induced production of phytoalexins (e.g., sinalexin and sinalbin A) in 
S. alba, whereas no phytoalexins were detected in susceptible Brassica species. On the basis of 
these observations, Pedras et al. suggested that S. alba (resistant) can overcome fungal pathogen 
attack through detoxification of destruxin B (123) as well as production of phytoalexins (Pedras, 
Zaharia et al., 2001). Furthermore, Camelina sativa and Capsella bursa-pastoris also detoxified 
hydroxydestruxin B (124) to non-toxic hydroxydestruxin B glucoside  (125) and 6-O-
malonylhydroxydestruxin-β-D-glucopyranoside (126) (Pedras, Montaut et al., 2003). 
 
 
Scheme 1.2 Biotransformation of destruxin B (123) in crucifers (Pedras, Montaut et al., 2003; 
Pedras, Zaharia et al., 2001).  
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Pedras and Khallaf carried out studies on detoxification of destruxin B (123) using 
crucifers and cereal crops (Pedras and Khallaf, 2012). It was reported that A. thaliana, 
Thellungiella salsuginea, Erucastrum gallicum, B. rapa and B. napus transformed destruxin B 
(123) to hydroxydestruxin B (124), whereas cereals Avena sativa and Triticum aestivum 
transformed it to hydroxydestruxin B (124), dehydrodestruxin B (127/127a), and 
desmethyldestruxin B (128). Furthermore, phytoalexins were elicited by destruxin B (123) in A. 
thaliana, T. salsuginea, and E. gallicum, whereas no phytoalexins were detected in B. rapa, B. 
napus, A. sativa and T. aestivum. They suggested that in detoxifying destruxin B (123), the tested 
crucifers appear to have destruxin B hydrolase, while in cases of cereals, multiple enzymatic 
reactions are likely to be involved (Pedras and Khallaf, 2012).  
Four analogs of destruxin B—desmethyldestruxin B (128), homodestruxin B (129), 
hydroxyhomodestruxin B (129a), hydroxydestruxin B (124)—were investigated for a structure-
phytotoxic activity relationship. In leaves of S. alba cv. Ochre, destruxin B (123), and 
homodestruxin B (129) are converted to hydroxydestruxin B (124), and hydroxyhomodestruxin 
B (129a), respectively (Pedras, Zaharia et al., 1999). Cell suspension culture assays of S. alba cv. 
Ochre (resistant) revealed that homodestruxin B (129, EC50 = 3×10−4 M) showed the most 
toxicity followed by destruxin B (122) and desmethyldestruxin B (128), whereas the 
phytotoxicity of hydroxylated destruxins was significantly decreased compared to the parent 
compounds (Pedras, Biesenthal et al., 2000). A comprehensive review on destruxins was 
published (Pedras, Irina Zaharia et al., 2002). 
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1.2.3.2.2 Non-host-selective toxins 
Non-host-selective toxins exhibit phytotoxicity against a broad spectrum of plants. While 
many studies on host-selective toxins have been reported, relatively fewer studies on non-host-
selective toxins have been published (Ballio, 1991; Mitchell, 1984). Non-host-selective toxins 
produced by Alternaria species were briefly covered in the most recent review (Lou, Fu et al., 
2013).  
Tentoxin (130), a cyclic tetrapeptide, is produced by Alternaria tenuis. Initially, culture 
extracts of A. tenuis induced albinism—chlorophyll deficiency—in citrus seedlings (Ryan, 
Greenblatt et al., 1961). Fulton et al. reported the causal agent of albinism from A. tenuis culture 
filtrates to be tentoxin (Fulton, Bollenbacher et al., 1965). The chemical structure of tentoxin 
(130) was confirmed by total synthesis (Rich and Mathiaparanam, 1974).   
 
 
 
 
Zinniol (131) produced by A. tagetica was established as a non-host-selective toxin. 
Zinniol induced necrosis in unrelated plant species such as carrot, cucumber, barley, zinnia, and 
marigold (Cotty, 1983; Robeson and Strobel, 1984; White and Starratt, 1967). In addition to 
necrosis, zinniol (131) inhibited germination of seeds of zinnia, tomato, lettuce, watermelon, and 
carrot (White and Starratt, 1967). A structure activity relationship study was carried out using 
natural and synthetic zinniol derivatives against marigold (Tagetes erecta) (Gamboa-Angulo, 
Escalante-Erosa et al., 2002). They reported that zinniol (131) caused severe necrosis on T. 
eracta. Monosubstituted derivatives (131b, 131f) showed weak phytotoxicity, whereas 131a and 
131c did not cause damage. Furthermore, carboxylated methyl ether derivatives 131d and 131e 
showed strong phytotoxicity (Gamboa-Angulo, Escalante-Erosa et al., 2002).  
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1.2.3.2.3 Spore germination fluids  
Nishimura and Kohmoto initially used the term “released toxin” when a metabolite was 
detected and isolated from spore germination fluids (SGFs) of virulent isolates of Alternaria 
species (Nishimura and Kohmoto, 1983b). This concept was proposed by Nishimura and 
Scheffer (1965), when HV-toxin was released from SGFs of Helminthosporium victoriae on oat 
leaves. Many HSTs produced by Alternaria species were detected in SGFs (Hayashi, 1990; 
Nishimura and Kohmoto, 1983a). In general, spore germination fluids (SGFs) of a fungus are 
harvested from spore suspensions on leaves of susceptible plants after appropriate incubation 
time (ca. 24–48 h). Filtrates of SGFs are assayed to determine phytotoxicity in susceptible and 
resistant plants. SGFs could be collected from non-plant materials such as glass surface, or 
plastic plates. But, such SGFs generally do not show phytotoxicity (Oka, Akamatsu et al., 2005; 
Quayyum, Gijzen et al., 2003). 
Host recognition and HST production by phytopathogenic fungi take place on the sites of 
initial contact at the early stage of infection. Thus, investigation of SGFs containing HSTs would 
establish the roles of fungal metabolites in disease development. This section covers host-
selective protein toxins produced by the phytopathgenic fungi Alternaria species during the early 
germination of spores. 
Otani et al. reported the first protein toxin produced by A. brassicicola (Otani, Kohnobe 
et al., 1998). SGFs were obtained from spore suspension of A. brassicicola germinated on leaves 
of susceptible B. oleracea (cabbage). SGFs caused necrosis and/or chlorosis in susceptible 
Brassica species, but they did not show phytotoxicity to non-host plants. Furthermore, proteinase 
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K and heat led to loss of phytotoxicity, suggesting SGFs contained protein toxin(s). Purification 
of the SGF toxin resulted in isolation of a 35 kDa protein toxin, named AB-toxin.  
The fungus A. panax Whetzel causes Alternaria blight in American ginseng (Panax 
quinquefolius L.). SGFs of A. panax collected from ginseng leaves caused disease symptoms in 
P. quinquefolius, but not in non-host plants. SGFs did not display phytotoxic activity after 
heating or treating with proteinase A. After chromatography of SGFs produced by A. panax, a 35 
kDa host-selective protein toxin, named AP-toxin, was isolated (Quayyum, Gijzen et al., 2003). 
Despite having the same molecular weight as that of AB-toxin, AP-toxin did not cause damage 
on hosts of A. brassicicola; it was concluded that AP-toxin is different from AB-toxin 
(Quayyum, Gijzen et al., 2003).  
A host-selective protein toxin in SGFs from A. brassicae called ABR-toxin (27.5 kDa) 
was produced in host plants, but not in non-host plants, suggesting production of ABR-toxin 
might be affected by factors of host plants (Parada, Sakuno et al., 2008). SGFs of A. brassicae 
collected from B. oleracea (cabbage) caused chlorosis only in Brassica leaves (Parada, Sakuno 
et al., 2008).  
 
 
1.2.3.3 Metabolites produced by Alternaria brassicicola 
Pedras et al. reported a fungal metabolite (named brassicicolin A) produced by A. 
brassicicola, which exhibits phytotoxicity on leaves of B. juncea cv. Cutlass susceptible to A. 
brassicicola (Pedras, Chumala et al., 2009). Initially, brassicicolin A (1) was isolated from A. 
brassicicola and reported as an antibiotic complex against B. subtilis and S. aureus (Ciegler and 
Lindenfelser, 1969). The structure of brassicicolin A (1) was elucidated by Gloer et al. and 
confirmed by chemical degradation studies (Gloer, Poch et al., 1988). In addition to antibiotic 
activity, brassicicolin A (1) showed phytotoxicity only on B. juncea (susceptible) at 0.05 mM, 
whereas phytotoxicity was not observed on S. alba cv. Ochre (resistant) at 0.5 mM (Pedras, 
Chumala et al., 2009).  
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MacKinnon et al. reported six fusicoccane-like diterpenoids (named brassicicenes A to F) 
(Figure 1.18) isolated from the extracts of culture filtrates of A. brassicicola. MacKinnon et al. 
proposed that brassicicenes A to F (132–137) might have phytotoxicity, but phytotoxic bioassays 
were not carried out due to small quantities of those metabolites (MacKinnon, Keifer et al., 
1999). Pedras et al. reported brassicicenes G to I (138–140) isolated from the extracts of culture 
filtrates of A. brassicicola, but phytotoxicity assays were not carried out due to small amounts. 
Considering brassicicenes G to I (138–140) were isolated from fractions exhibiting low 
phytotoxicity, it is likely that they have no phytotoxicity (Pedras, Chumala et al., 2009). Most 
recently, Kenmoku et al. reported brassicicenes J (141) and K (142) (Kenmoku, Takeue et al., 
2014).   
 
Figure 1.18 Structures of brassicicenes produced by Alternaria brassicicola. 
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Pedras et al. reported that phomapyrones A (25), F (147) and G (148), and infectopyrone 
(149) were isolated from non-phytotoxic fractions of extracts of A. brassicicola culture filtrates 
(Pedras, Chumala et al., 2009). Initially, phomapyrones A (25) to G (148) and infectopyrone 
were isolated and characterized from the culture filtrates of L. maculans/P. lingam (Pedras and 
Chumala, 2005; Pedras, Morales et al., 1994) (Figure 1.19). Although crude extracts of the 
fungal cultures showed phytotoxic effects (Pedras, Morales et al., 1994), purified phomapyrones 
A (25) and D (145) did not exhibit phytotoxicity (Pedras and Chumala, 2005).  
 
 
 
Figure 1.19 Structures of phomapyrones. 
 
 
1.2.3.4 Biosynthesis of secondary metabolites of Alternaria species  
After structure elucidation of a metabolite of interest, biosynthetic building blocks can be 
proposed from a retrobiosynthetic analysis. To carry out biosynthetic studies of a metabolite of 
interest, isotopically labeled precursors (e.g., 13C, 2H, 15N, 18O) of primary building blocks are 
administered to cultures of the producing organism and the labeled intermediates or final 
products are isolated. The precursor/metabolite relationship can be confirmed by analyses of the 
labeled metabolites using nuclear magnetic resonance (NMR) spectroscopy and mass 
spectrometry (Schneider, 2007). 
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Depudecin and phomapyrone A 
Administration of [1-13C], [2-13C], [1,2-13C2], [2-2H3], or [2-2H,2-13C]acetate into Nimbya 
scuroucicola culture, a producer of depudecin (151), revealed that depudecin (151) is derived 
from an acetate-derived hexaketide (Scheme 1.3) (Tanaka, Fujimori et al., 2000). Wight et al. 
reported that the depudecin (151) gene cluster contains six genes, DEP1–DEP6, and A. 
brassicicola dep5 mutant showed reduced virulence on B. oleracea (Wight, Kim et al., 2009). 
 
 
 
Scheme 1.3 Labeling pattern of depudecin (151) (Tanaka, Fujimori et al., 2000). 
 
 
A biosynthetic study of phomapyrone A (25) produced by the fungus L. maculans/P. 
lingam demonstrated the polyketide origin; 25 is derived from a pentaketide containing four 
methyl groups derived from methionine (Scheme 1.4) (Pedras and Chumala, 2005).  
 
 
 
 
Scheme 1.4 Labeling pattern of phomapyrone A (25) (Pedras and Chumala, 2005). 
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Brassicicolin A and the origin of isocyanide carbon 
Brassicicolin A (C32H48N2O14) consists of one D-mannitol, two isocyanoisovaleryl, two 2-
hydroxy-3-methylbutanoyl, and two acetyl units. Since the structure of brassicicolin A (1) was 
elucidated in 1988 (Gloer, Poch et al., 1988), no biosynthetic studies have been published to 
date. Brassicicolin A (1) has an isocyanide group. While the biosynthetic origins of the nitrogen 
in isocyanide group are likely derived from (S)-valine, the origin of carbon remains elusive. 
Reviews on naturally occurring isocyanides and related metabolites were published in 1988 and 
2004 (Edenborough and Herbert, 1988; Garson and Simpson, 2004). 
An organic isocyanide (also called isonitrile) contains a functional group having nitrogen 
and carbon with an R group (alkyl or aryl) directly attached to nitrogen (Figure 1.20). The 
isocyanide group has both nucleophilic and electrophilic atoms. The presence of an isocyanide 
group in a given compound might be confirmed by spectroscopic data such as IR (ca. 2165–2110 
cm-1) and 13C NMR (ca. δC 154–170 ppm). Mild acidic conditions might promote hydrolysis of 
isocyanides to formamides (Edenborough and Herbert, 1988).  
 
 
Figure 1.20 Resonance structures of isocyanides. 
 
Xanthocillin (153) produced by Penicillium notatum Westling was isolated (Rothe, 
1950). A complex mixture of xanthocillins exhibited antibiotic activity against a wide spectrum 
of microorganisms. A biosynthetic study of xanthocillin (153) revealed that [2-14C]tyrosine was 
incorporated into xanthocillin (153), whereas neither 14C-formate nor [methyl-14C]methionine 
was incorporated into the isocyanide carbon (Edenborough and Herbert, 1988). Similarly, [2-
13C,14C]glycine was incorporated into O-methyl groups of xanthocillin X monomethyl ether 
(153a), whereas neither 14C-formate nor [3-14C]serine was incorporated into the isocyanide 
carbon (Herbert and Mann, 1984; Kitahara and Endo, 1981). It is likely that in terrestrial 
isocyanides, the nitrogen is derived from amino acids; however, the biosynthetic origin of the 
isocyanide carbon has not been established in many cases.  
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Brady and Clardy proposed the biosynthetic origins of nitrogen and carbon of isocyanide 
containing antibiotic metabolite (158) (Brady and Clardy, 2005a, b). A biosynthetic study was 
carried out using recombinant E. coli strains and labeled precursors (155, 157a, 159, 160) 
(Scheme 1.5). As a result of feeding experiments, 15N-enriched 158 was detected in cultures 
expressing the isocyanide/isonitrile genes (IsnA/IsnB) after administration of 15N-labled 
tryptophan (155); N-formyl tryptophan (159), and N-formyl tryptamine (160) were not 
incorporated into 158. If each gene is expressed separately, incorporation of 15N-labeled 
precursors does not occur. IsnA and IsnB are involved in the biosynthesis of the isocyanide 158. 
To establish the role of IsnB, the 15N-labeled methyl ester (157a) was administered due to 
instability of the synthetic 157. The 15N-enriched 158 was detected in the cultures, where IsnB 
was expressed in the presence of 15N-labeled methyl ester 157a, suggesting that IsnB is 
responsible for decarboxylation of isocyanide-containing intermediate 157. The role of IsnA is 
unclear (Brady and Clardy, 2005a) (Scheme 1.5).  
Next, to establish the biosynthetic origin of carbon of isocyanide 158, mutants deficient 
in key primary metabolic enzymes were used (Brady and Clardy, 2005b). In brief, the mutant 
deficient in glucose-6-phosphate-1-dehydrogenase (zwf) (Fraenkel and Banerjee, 1972) grown in 
either [U-13C6]glucose or [2-13C]glucose produced the 13C-enriched isocyanide 158, but when 
grown in [1-13C]glucose did not produce the 13C-enriched isocyanide 158. Furthermore, [2-
13C]ribose led to production of 13C-enriched isocyanide 158; whereas [1-13C]ribose did not. It 
was concluded that ribulose-5-phosphate (156) could be the final carbon donor of isocyanide 158 
because it is a tautomer of both arabinose-5-phosphate and ribose-5-phosphate (156a) (Brady 
and Clardy, 2005b). 
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NC
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Scheme 1.5 Biosynthesis of indole vinylisocyanide (158). zwf = glucose-6-phosphate-1-
dehydrogenase, Isn = isocyanide or isonitrile (Brady and Clardy, 2005a, b).  
 
 
Pedras and Yaya reported a plant-derived isocyanide (named isocyalexin A (166)) 
(Pedras and Yaya, 2012) as a phytoalexin isolated from UV-irradiated rutabaga. The structure of 
isocyalexin (166) was confirmed by chemical synthesis (Pedras and Yaya, 2012). Isocyalexin A 
(166) showed a strong antifungal activity against Rhizoctonia solani (complete inhibition at 0.50 
mM), whereas moderate or weak antifungal activity against A. brassicicola, L. maculans, and 
Sclerotinia sclerotiorum. Biosynthetic studies of isocyalexin A (166) were carried out using 
perdeuterated compounds and (S)-[13C11,15N2]-enriched 155 (Pedras and Yaya, 2013). Based on 
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the incorporation of labeled compounds into isocyalexin (166), a biosynthetic pathway to 
isocyalexin (166) was proposed (Scheme 1.6). Pedras and Yaya pointed out that transformation 
of 4’-methoxyindolyl-3’-glycine (163) from aziridine intermediate 162 is one of the key steps to 
biosynthesis of isocyalexin A (166). Interestingly, the carbon source of the isocyanide group in 
isocyalexin A (166) is derived from (S)-tryptophan (155) (Pedras and Yaya, 2013).  
 
 
 
Scheme 1.6 A proposed biosynthetic pathway of isocyalexin A (166): A, Neber-type 
rearrangement; B, sulfation; C, Beckmann-type rearrangement (Pedras and Yaya, 2013). 
 
 
Although terrestrial isocyanides are rarely found, marine organisms produce isocyanide 
compounds along with the corresponding formamide and/or isothiocyanate derivatives 
(Faulkner, 1984). Despite efforts to identify the origin of isocyanide carbons in marine 
organisms using N-formyl precursors, data have shown that the isocyanide carbon is not derived 
from the corresponding formamides or the C-1 of tetrahydrofolate pool (Garson and Simpson, 
N
H
O
O-
NH3+
155
N
H
NOSO3-K+
S β-D-Glc
OCH3
161
N
H
S β-D-Glc
OCH3
N
N
H
OCH3
COO-
NH3+
N
H
NOHOCH3
N
H
NOCH3
OSO3-K+
N
H
N+OCH3
162
163164165
166
C-
H2O
K2SO4
A
CO2
B
K2SO4C
β-D-S-Glc
N
H
NOCH3 C
N
H
OCH3S O
O
167 168
	 39 
2004). However, it is possible that marine organisms can utilize the cyanide produced by 
microbial symbionts that are using amino acids such as glycine, methionine, or serine to generate 
inorganic cyanides (Bornemann, Patterson et al., 1988). Karuso and Scheuer reported that 
[14C]cyanide was incorporated into 2-isocyanopupukeanane (169) and 9-isocyanopupukeanane 
(170) in Ciocalypta sp. and Acanthella sp., respectively (Karuso and Scheuer, 1989). Intact 
incorporation of [13C, 15N]cyanide into 9-isocyanopupukeanane (170b) was also observed in 
Acanthella sp. (Karuso and Scheuer, 1989) (Scheme 1.7).  
 
 
 
 
Scheme 1.7 Proposed biosynthetic pathways of 2-isocyanopupukeanane (169) and 9-
isocyanoneopupukeanane (170) (Karuso and Scheuer, 1989) 
 
Garson first established that sodium [14C]cyanide was incorporated (up to 1.8%) into the 
isocyanide carbon in diisocyanoadociane (171) using the Great Barrier Reef sponge 
Amphimedon terpenensis (Garson, 1986). Feeding experiments were carried out using more 
advanced precursors to establish biosynthetic relationships between cyanide and isocyanide and 
thiocyanate and isothiocyanate (Simpson and Garson, 2004). Administration of [14C]thiocyante 
to A. terpenensis led to detection of 14C-labeled diisocyanoadociane (171), 14C-labeled 9-
isothiocyanatopupukeanane (174), and 14C-labeled 2-thiocyanatoneopupukeanane (173), 
suggesting that thiocyanate could be a biosynthetic precursor of isocyanide, thiocyanate, and 
isothiocyanate compounds. Administration of [14C]cyanide to A. terpenensis led to detection of 
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14C-labeled 2-thiocyanatoneopupukeanane (173) and 14C-labeled -9-isocyanopupukeanane (175). 
Considering the incorporation of [14C]cyanide and [14C]thiocyante into 2-
thiocyanatoneopupukeanane (173), interconversion between cyanide and thiocyante might occur. 
Furthermore, administration of [14C]9-isothiocyanatopupukeanane (174) to Axinyssa n. sp. 
resulted in detection of 14C-labeled-9-isocyanopupukeanane (175), while feeding of 175 led to 
isolation of 174 in Axinyssa n. sp.. However, administration of [14C2]–bisisothiocyanatodociane 
(172) to A. terpenensis did not lead to detection of labeled diisocyanoadociane (171) (Scheme 
1.8). That is, isothiocyanate is not a precursor of isocyanide; instead, interconversion between 
isocyanide and isothiocyanate might take place as a strategy for homeostasis of   two compounds 
(Garson and Simpson, 2004).  
 
 
 
Scheme 1.8 Administration of 14C-labeled precursors to two marine sponges Amphimedon 
terpenensis and Axinyssa n.sp. (Simpson and Garson, 2004) 
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1.2.3.5 Siderophores 
To overcome low bioavailability of iron and to detoxify reactive oxygen species (ROS) 
produced by plants, certain plant pathogens produce siderophores, a family of low-molecular-
weight Fe3+ chelators. Siderophores as high-affinity iron (Fe3+) chelators not only enable fungal 
pathogens to utilize iron, but also act as antioxidants to detoxify (ROS) (Haas, Eisendle et al., 
2008). The roles of siderophores produced by phytopathogenic fungi have been studied and 
several comprehensive reviews have been published (Chen, Yang et al., 2014; Dixon and 
Stockwell, 2014; Expert, Enard et al., 1996; Expert, Franza et al., 2012; Haas, Eisendle et al., 
2008; Hider and Kong, 2010; Renshaw, Robson et al., 2002).  
Several siderophores produced by phytopathogenic Alternaria species were reported 
during the last decades. Jalal et al. reported that A. longipes ATCC 26293 produced coprogen 
(176), neocoprogen I (177), isoneocoprogen I (178), and Nα-dimethylcoprogen (179) based upon 
1H and 13C NMR spectroscopic data, and fast-atom-bombardment (FAB) mass spectrometric 
data (Jalal, Love et al., 1988). Hydroxycoprogen (180), hydroxyneocoprogen I (181), and 
hydroxyisoneocoprogen I (182) produced by A. longipes were reported (Jalal and van der Helm, 
1989). Ohra et al. tested the phytotoxicity of siderophores using ferricrocin (183) and coprogen 
(176) isolated from A. cassia, a phytopathogen in diseased seedlings of sicklepod (Cassia 
obtusifolia L.). Ferricrocin (183) caused necrosis in cowpea, whereas coprogen (176) caused 
weak necrosis in cowpea (Ohra, Morita et al., 1995).  
More recently, Oide et al. proposed that the siderophores produced by fungal pathogens 
might obtain iron from host plants (Oide, Moeder et al., 2006). The A. brassicicola non-
ribosomal peptide synthetase deficient mutant (nps6) caused smaller lesions in Arabidopsis 
thaliana, compared to lesions caused by the wild type isolate. Furthermore, increased sensitivity 
to oxidative stress was observed in A. brassicicola nps6 mutant. HPLC analysis of the culture 
filtrates of wild type and nps6 mutant revealed that only wild type produced siderophores; 
coprogen (176), Nα-dimethylcoprogen (179), and dimerumic acid (184). Furthermore, addition of 
iron either to spore suspensions or to A. thaliana enhanced the virulence of the nps6 mutant. 
These findings suggest that non-ribosomal peptide synthetase (NPS6) is involved in biosynthesis 
of siderophores and such siderophores play an important role in taking iron from host plants 
(Oide, Moeder et al., 2006). 
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1.3 Secondary metabolites produced by plants 
1.3.1 Phytoalexins and phytoanticipins  
Plants produce numerous secondary metabolites active against plant pathogens and 
having diverse chemical structures. The secondary metabolites that plants produce to defend 
themselves are largely classified into two groups: phytoanticipins and phytoalexins (Dixon, 
2001; VanEtten, Mansfield et al., 1994). Over the past decades, a great variety of chemical 
structures of phytoanticipins and phytoalexins have been elucidated. Phytoalexins are secondary 
metabolites having antimicrobial activity and are produced de novo under different abiotic and/or 
biotic stress (e.g. microbial infection, UV irradiation, and heavy metal salts). It is essential that 
these plant metabolites exhibit antifungal or antibacterial activities and that they are absent in 
healthy plants to belong to the phytoalexin group (Pedras, Yaya et al., 2011). More than 50 
phytoalexins have been characterized in crucifers (the Brassicaceae family) since Takasugi et al. 
first reported cruciferous phytoalexins (Takasugi, Katsui et al., 1986). The phytoalexins 
produced in B. juncea (brown mustard), B napus (rapeseed) and S. alba (white mustard) are 
summarized in Table 4. Comprehensive reviews on phytoalexins produced by crucifers are 
available (Pedras and Yaya, 2010; Pedras, Yaya et al., 2011).   
 
Table 4 Selected phytoalexins produced in Brassica juncea cv. Cutlass (brown mustard), 
Brassica napus cv. Westar (canola) and Sinapis alba cv. Ochre (Pedras, Yaya et al., 2011). 
Species Elicitation Phytoalexins  
Brassica juncea (brown 
mustard) 
CuCl2, AgNO3 
A. brassicae, L. maculans 
Brassilexin (185) 
Cyclobrassinin (186) 
Cyclobrassinin sulfoxide (187) 
Indolyl-3-acetonitrile (188) 
Spirobrassinin (189) 
Brassica napus 
(rapeseed) 
CuCl2 
L. maculans 
1-Methoxybrassinin (190) 
4-Methoxycyclobrassinin (191) 
Brassilexin (185) 
Cyclobrassinin (186) 
Cyclobrassinin sulfoxide (187) 
Dehydrocyclobrassinin (192) 
Spirobrassinin (189) 
Sinapis alba (white 
mustard) 
Destruxin B (123) 
A. brassicae, L. maculans   
Sinalbin A (193) 
Sinalbin B (194), 
Sinalexin (195) 
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Phytoanticipins are defined as “low molecular weight, antimicrobial compounds that are 
present in plants before challenge by microbial infection” (VanEtten, Mansfield et al., 1994). 
Although these plant metabolites are clearly defined, there has been confusion in certain cases. 
For example, three nitriles, indolyl-3-acetonitrile (188), arvelexin (188a) caulilexin C (188b) 
were considered phytoanticipins in Thellungiella halophile (Pedras, Zheng et al., 2009; Pedras 
and Zheng, 2010), although previously indole-3-acetonitrile (188) was reported as a phytoalexin 
in brown mustard (B. juncea) (Pedras, Nycholat et al., 2002). A recent review article covers 
issues of definition and ecological roles of phytoanticipins (Pedras and Yaya, 2015).  
 
 
 
 
 
More than 130 glucosinolates have been reported from the order Brassicales (Agerbirk 
and Olsen, 2012). Glucosinolates are constitutively present in crucifers, thus they are considered 
phytoanticipins (Morant, Jørgensen et al., 2008). The biologically active isothiocyanates and 
N
H
S
N
SCH3
186
N
H
S
N
185
N
H
S
N
SCH3
O
187
N
H
CN
188
N
H
NS
H3CS
O
189
N
H
N
S
SCH3
OMe
N
H
S
N
SCH3
191
OMe
190
N
S
N
SCH3
192
N
S
N
OCH3
195
N
S
N
R
OCH3
193 R = S(O)CH3
194 R = SCH3
N
R1
R2
CN
188 R1 = R2 = H
188a R1 = OMe R2, = H
188b R1 = H, R2 = OCH3
	 45 
nitriles are hydrolysis products of glucosinolates. Stable isothiocyanates formed by enzymatic 
reactions (i.e., myrosinase) have shown strong antimicrobial activity than the corresponding 
glucosinolates (Scheme 1.9) (Pedras and Yaya, 2015).  
 
 
 
 
Scheme 1.9 General scheme for hydrolysis of glucosinolates   
 
 
Indole glucosinolates (196, 197, and 161) are of interest in this work because they are 
biosynthetic precursors of almost all (S)-tryptophan-derived phytoalexins (Pedras, Yaya et al., 
2011). For example, once indolyl-3-methylisothiocyanates (199) are formed from indole 
glucosinolates via myrosinase-mediated reaction, brassinin and related phytoalexins (199–201) 
having scaffold A are biosynthesized (Takasugi, Katsui et al., 1986). Other phytoalexins (such as 
rapalexins 204) containing scaffold B are derived from indole glucosinolates but their 
biosynthetic pathway is independent from those of brassinin-type phytoalexins (Scheme 1.10) 
(Pedras, Montaut et al., 2004; Pedras and Yaya, 2013). 
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Scheme 1.10 Biosynthetic relationship of indole glucosinolates and phytoalexins containing two 
different scaffolds (Pedras and Yaya, 2013).  
 
Since the whole genome sequence of A. thaliana was completed 
(TheArabidopsisInitiative, 2000), numerous studies have been carried out using ecotypes and 
mutants. Camalexin was first reported as a phytoalexin from C. sativa (Browne, Conn et al., 
1991), and Tsuji et al. reported camalexin from A. thaliana induced upon infection with 
Pseudomonas syringae  (Tsuji, Jackson et al., 1992). The biosynthesis of camalexin, including 
the relevant enzymes and genes has been reviewed (Pedras, Yaya et al., 2011). In brief, 
camalexin is derived from (S)-tryptophan (155) and cysteine. The biosynthesis of indole-3-
acetaldoxime (205) is mediated by CYP79B2 and CYP79B3, and indolyl-3-acetonitrile (188) is 
presumably activated by conjugation with glutathione (GSH) (206) to yield (R)-S-(cyano-1H-
indolyl-3-methyl)cysteine (207). In the last step, CYP71B15 catalyzes the biosynthesis of 
camalexin (209) from (S)-dihydrocamalexic acid (208) (Scheme 1.11). Schuhegger et al. 
reported that a camalexin-deficient (pad3) mutant of A. thaliana accumulated dihydrocamalexic 
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acid (208) in leaves. Furthermore, the recombinant yeast expressing PAD3 converted 
dihydrocamalexic acid (208) to camalexin (209) (Schuhegger, Nafisi et al., 2006).  
The peroxisome-associated myrosinase (PEN2) is responsible for hydrolyzing the β-
thioglycosidic bond of indole glucosinolates (Bednarek, Pislewska-Bednarek et al., 2009). 
Unlike PAD3, this enzyme is not involved in the biosynthesis of camalexin.  
 
 
 
Scheme 1.11 Camalexin (209) biosynthesis (Pedras, Yaya et al., 2011).  
 
 
 
1.4 Summary  
Phytopathogenic fungi biosynthesize and secrete SMs known as phytotoxins that cause 
damage to plants during fungal invasion. The phytopathogenic fungus Alternaria brassicicola 
(Schwein.) Wiltshire causes Alternaria black spot (also called dark leaf spot) in Brassica species. 
Many SMs of A. brassicicola grown under standard fermentation conditions have been reported; 
however, with the exception of siderophores, no fungal SMs have been detected in plants 
infected with A. brassicicola. One of the major challenges for detection is due to plants 
biotransforming fungal metabolites produced during infection. Unknown phytotoxins of A. 
brassicicola that are not produced in standard growth conditions could participate in disease 
N
H
O OH
NH2
N
H
N OH
N
H
CN
188155
N
H
CNS
O
H
NGly
NGlc
205
206
N
H
208
N
S
COOH
N
H
209
N
S
CYP71B15
CYP79B2
CYP79B3 CYP71A13
GSH
N
H
CNS
O
+H3N
-O
PAD3
207
	 48 
development. Detection of phytotoxins could be hindered by complex plant metabolites 
produced in infected tissues. For those reasons, it is difficult to detect fungal metabolites in 
infected tissues.  
So far, brassicicolin A (1), a host-selective toxin produced by A. brassicicola, has not 
been detected in host plants infected with A. brassicicola. To clarify the involvement of SMs in 
disease development, a systematic investigation of SMs produced by A. brassicicola and its host 
plants is necessary. In this work, components of culture media and conditions that influence 
production of SMs by A. brassicicola will be investigated for a better understanding of the 
chemical interactions between A. brassicicola and its host plants. Then, the comparative 
chemical analysis of SMs produced in infected plants and control plants will be carried out. 
Finally, a biosynthetic study of brassicicolin A (1), a host-selective phytotoxin, will be 
conducted. Completion of my Ph. D. research work could lead to the development of novel 
strategies to control A. brassicicola.  
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2 Results and discussion 
2.1 Metabolites of A. brassicicola 
A comprehensive investigation of secondary metabolites produced by A. brassicicola 
grown under various conditions was carried out. Two standard media, minimal medium (MM) 
and potato dextrose broth (PDB) as well as modified MM were employed for growth of A. 
brassicicola (Pedras and Park, 2015). 
2.1.1 Isolation and structure elucidation of metabolites produced in standard media 
A. brassicicola was incubated in standard minimal medium (MM) and potato dextrose 
broth (PDB) at 23 °C and 30 °C under shaking. After seven days of incubation, cultures were 
filtered and the mycelia were separated from the broths. The resulting culture filtrates were 
extracted with EtOAc, the extracts were concentrated and analyzed by HPLC-DAD and HPLC-
ESI-MS.  
The amounts of crude extracts from cultures in PDB were significantly larger than those 
in MM, while the mycelial weights did not show significant differences. HPLC chromatograms 
of crude extracts showed more complex metabolite profiles in MM than in PDB (Figure 2.1). 
The reported metabolites were screened by comparison of UV spectra in Dr. Pedras’ HPLC 
libraries (Figure 2.2). Four known metabolites were confirmed by comparing spectroscopic data 
of the metabolites isolated in this work with previously reported data of each metabolite.  
Brassicicolin A (1) was produced with a larger amount in MM than in PDB. High 
temperature (30 °C) increased production of brassicicolin A (1) in either MM or PDB. Spectral 
data of brassicicolin A (1) were consistent with those previously reported (Pedras, Chumala et 
al., 2009). Although HPLC method A did not resolve phomapyrone A (25) from brassicicolin A 
(1) (Figure 2.1), phomapyrone A (25) displayed a unique UV absorption, which makes two 
metabolites distinguishable (Figure 2.2). Spectral data of phomapyrone A (25) isolated in this 
work were consistent with those previously reported (Pedras, Morales et al., 1994). UV spectra 
of phomapyrones E (146) and G (148) were fairly similar (Figure 2.2), but multiplicity in 1H 
NMR spectra of those metabolites allowed differentiation of two phomapyrones. Pedras and 
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Chumala reported that H-10 in phomapyrone G (148) shows quartet at δH 3.05 (1H, 6Hz), 
whereas phomapyrone E does not have H-10. H-12 in phomapyrone E (146) shows doublet at 
δH1.30 (3H, 6 Hz), whereas phomapyrone G (148) shows singlet δH1.50 (3H) (Pedras and 
Chumala, 2005). Based on comparison of spectral data of each metabolite, tR = 20.1 min, and tR 
= 24.1 min were assigned as phomapyrone E (146) and phomapyrone G (148), respectively. 
 
 
Figure 2.1 HPLC-DAD chromatograms of crude extracts of culture filtrates of Alternaria 
brassicicola grown in minimal medium (MM) and potato dextrose broth (PDB) at 23°C and 
30°C (Method A, detection 220 nm): Metabolites A, tR = 8.4 min; B, tR = 9.2 min; C, tR = 11.6 
min.   
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Figure 2.2 UV spectra of four reported metabolites of Alternaria brassicicola. A, Phomapyrone 
A (25); B, brassicicolin A (1); C, phomapyrone E (146); D, phomapyrone G (148).   
 
 
The chromatograms of cultures in MM displayed three peaks in the polar region (peaks 
A, B, and C) and one peak (peak D) in the non-polar region that did not match UV spectral data 
stored in Dr. Pedras’ HPLC libraries. Metabolites A, B and C were detected in both MM and 
PDB, whereas metabolite D was solely detected in PDB. To elucidate chemical structures of 
metabolites A–D, culture filtrates were extracted and fractionated by flash column 
chromatography (FCC) (Scheme 4.1 and Scheme 4.2). Spectroscopic data (1H and 13C NMR, 
HR-MS, and FT-IR) were used to characterize the chemical structures of these metabolites as 
described below. 
2.1.1.1 α-Acetylorcinol 
 Metabolite A (2.5 mg, tR = 8.4 min, method A) was a yellowish-oily compound. The 
HREI-MS detected a strong peak at m/z 166.0626, establishing the molecular formula of 
metabolite A as C9H10O3 (five degrees of unsaturation). The strong IR band at 1701 cm-1 and 
broad band at 3347 cm-1 indicated a carbonyl group and an alcohol with O-H, respectively. The 
1H NMR spectrum shows three spin systems of eight protons, the ratios of which were 1:2:2:3 
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(Table 5). The proton spectrum in the aromatic region showed mulitplets at δH 6.14 (2H)–6.17 
(1H) that suggested meta coupling. Hence, metabolite A has a trisubstituted benzene ring with 
two hydroxyl groups at 3,5-positions. The other substituent has a carbonyl group, and two 
singlets in the aliphatic region in the 1H NMR spectrum (Table 5). 
The proton-decoupled 13C NMR spectrum of metabolite A showed seven peaks: one 
ketone, two sp3 hybridized carbons and in the aromatic region, three quaternary carbons and two 
sets of protonated carbons indicated a trisubstituted benzene ring. The most deshielded peak at δC 
160.1 represented the carbon atom containing a hydroxyl group.  
In HMBC, methylene protons at δH 3.54 showed correlations with three carbon 
resonances at δC 209.7, δC 138.0 and δC 109.1, suggesting the methylene fragment exists between 
the benzene ring and the acetyl group. In addition, correlations between the carbonyl carbon at δc 
209.7 and the methyl proton at δH 2.12 indicated an acetyl group. Based on spectroscopic data, 
metabolite A was assigned as α-acetylorcinol (210) (Figure 2.3).  
 
Table 5 1H (500 MHz, CD3OD) and 13C (125 MHz, CD3OD) NMR spectroscopic data of α-
acetylorcinol (210).  
C/H # δC δH, multiplicity (3JHH, Hz) 
1 102.4 6.17, 1H, m 
2, 2a 160.1 — 
3, 3a 109.1 6.14, 2H, m 
4 138.0 — 
1’ 51.8 3.54, 2H, s 
2’ 209.7 — 
3’ 29.1 2.12, 3H, s 
 
 
Figure 2.3 HMBC correlations of α-acetylorcinol (210) 
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Synthesis of α-acetylorcinol  
The chemical synthesis of α-acetylorcinol (210) does not appear to have been published. 
To confirm the chemical structure and to obtain sufficient quantity for further experiments, 
synthesis of α-acetylorcinol (210) was carried out. Retrosynthetic analysis of α-acetylorcinol 
(210) suggested 3,5-dimethoxyphenylacetic acid (211) could be a starting material.  Reduction of 
ester 212 to alcohol 213 followed by oxidation to aldehyde 214 and Grignard reaction yielded 1-
(3,5-dimethoxy)propan-2-one (216). Since this synthetic route required more than 5 steps and led 
to a low yield (29%) (Scheme 2.1), another synthetic route was devised.  
 
 
 
 
Scheme 2.1 Synthesis of 1-(3,5-dimethoxy)propan-2-one (216). Reagents and conditions: (i) 
EtOH, H2SO4, reflux, 2 h, quant.; (ii) LAH, THF, ice-water bath à rt, 1.5 h 83%; (iii) PCC, 
CH2Cl2, rt, 1.5 h 42%; (iv) Mg, CH3I, Et2O, NH4Cl, rt 15 min, quant.; (v) PCC, CH2Cl2, rt, 1.5 h, 
82%.  
 
To improve overall yield and to shorten the synthetic route, Weinreb amide (N-methoxy-
N-methylamide) was employed (Wang, Denton et al., 2011). The first two steps yielded 2-(3,5-
dimethoxyphenyl)-N-methoxy-N-methylacetamide (218) under mild conditions (92%) (Scheme 
2.2). In the subsequent step, the Weinreb amide 218 yielded the ketone 216 in 76% yield (De 
Luca, Giacomelli et al., 2001). In the final step, both methoxy groups in 1-(3,5-dimethoxy) 
propan-2-one (216) were deprotected using iodocyclohexane in DMF under reflux (Zuo, Yao et 
O
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al., 2008). Using this synthetic method, α-acetylorcinol (210) was synthesized in four steps with 
36% overall yield. The spectroscopic data were identical with those of naturally occurring α-
acetylorcinol (210) (Pedras and Park, 2015).  
 
 
 
Scheme 2.2 Synthesis of α-acetylorcinol (210). Reagents and conditions: (i) Oxalyl chloride, 
DMF, CH2Cl2, rt, 30 min; (ii) N,O-dimethylhydroxylamine hydrochloride, pyridine, CH2Cl2, rt, 
30 min, 92% overt two steps; (iii) CH3MgI, THF, rt, 30 min, 76%; (iv) Iodocyclohexane, DMF, 
reflux, 52%.  
 
 
2.1.1.2 Tyrosol  
Metabolite B was a white solid (2.5 mg, tR = 9.2 min, method A). HREI-MS detected a 
peak at m/z 138.0682, establishing its molecular formula as C8H10O2 (four degrees of 
unsaturation). The IR spectrum showed intense OH peaks at 3392 cm-1 and 3170 cm-1.  
The 1H NMR spectrum of metabolite B showed two different spin systems: two sets of 
doublets in the aromatic region and two sets of triplets in the aliphatic region. In aromatic region, 
the doublets at δH 7.04 (2H) and δH 6.72 (2H) with J = 8.5 Hz represented protons with ortho 
coupling in a 1,4-disusbstituted benzene ring. In the aliphatic region, one methylene proton at δH 
3.70 and the other methylene proton at δH 2.73 represented a hydroxyethyl moiety (Table 6). 
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The 13C NMR of metabolite B provided six distinct carbon signals: four signals of sp2 
hybridized carbon and, two signals in the aliphatic region. Two quaternary carbons at δC 156.9 
and δC 131.2 and two sp2-hybridized carbons δC 131.0 and δC 116.3 indicated a 1,4-disubstituted 
benzene ring. Furthermore, one sp3-hybrdized carbon at δC 64.8 was deshielded by oxygen and 
the other sp3-hybrized carbon at δC 39.6 was affected by the aromatic ring. The other substituent 
of the benzene ring was assigned as OH based on IR spectrum and an index of hydrogen 
deficiency. Therefore, metabolite B was assigned as tyrosol (219). Spectroscopic data of 
commercially available tyrosol (2-(4-hydroxyphenyl)ethanol) was identical to those of naturally 
occurring tyrosol (219).  
  
 
Table 6 1H (500 MHz, CD3OD) and 13C (125MHz, CD3OD) NMR spectroscopic data of tyrosol 
(219). 
C/H # δC δH, multiplicity (3JHH, Hz) 
1 156.9 - 
2, 2a 116.3 6.72, 2H, d (8.5) 
3, 3a 131.0 7.04, 2H, d (8.5) 
4 131.2 - 
1’ 39.6 2.73, 2H, t (7) 
2’ 64.8 3.70, 2H, t (7) 
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2.1.1.3 Depudecin  
Metabolite C (57 mg, tR = 11.6 min, method A) was a colorless oily compound. HREI-
MS and HPLC-ESI-MS spectra gave neither a molecular nor quasi-molecular ion. The 1H NMR 
spectrum of metabolite C exhibited signals for one methyl group, six methine protons, and five 
olefinic protons, including two terminal olefinic protons. The 13C NMR spectrum detected 11 
signals: one methyl group, six sp3 hybridized carbons containing oxygen, and four sp2 hybridized 
carbons (Table 7). 
In HSQC, one methyl group at δH 1.30 was attached to one methyl carbon at δC 20.1, 
suggesting metabolite C has terminal methyl group (C-1) in the structure. One sp2-hybridized 
carbon at δC 117.2 showed correlations with two olefinic protons at δH 5.39 and at δH 5.26, which 
suggested metabolite C has allyl group (C-11) at the terminal position. In HMBC, intensive 
correlations of δH 1.30 with δC 67.2 and δC 64.4 allowed the assignment of C-2 and C-3, 
respectively. The proton at δH 5.39 (H-11) displayed correlations with δC 71.8 and δC 136.2, 
allowing assignment C-9 and C-10, respectively. Further correlations of the carbon δC 71.8 (C-9) 
with one methine proton δH 3.01 allowed the assignment of H-8. Likewise, the correlation of δC 
64.4 with one methine proton δH 2.90 allowed the assignment of H-3. While δC 55.6 and δC 55.2 
did not display correlations with δH 3.43 and δH 3.38, δC 132.2 and δC 131.7 showed correlations 
with δH 3.43, δH 3.38, and δH 5.66–5.73. Furthermore, δH 5.66–5.73 displayed correlations with 
δC 55.6 and δC 55.2, allowing the complete assignment of C-4, C-5, C-6, and C-7 (Table 7).  
Based on these spectroscopic data and a previous report (Matsumoto, Matsutani et al., 
1992), metabolite C was assigned as depudecin (151). The stereochemistry of depudecin (151) 
isolated in this work was identical to that of depudecin (151) in the literature by comparison of 
optical rotation  ([α]D = −35 (c 0.50, MeOH)), lit. ([α]D = −36 (c 0.52, CHCl3)).  
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Table 7 1H (500 MHz, CDCl3) and 13C (125 MHz, CDCl3) NMR spectroscopic data of 
depudecin (151).  
C/H # δC δH, multiplicity (3JHH, Hz) HMBC 
1 20.1 1.30, 3H, d (6.5) 2-OH 
2 67.2 3.72, 1H, dq (4.5, 6.5) H-1, H-3, 2-OH 
3 64.4 2.90, 1H, dd (4.5, 2) H-1 
4 55.6 3.43–3.38, 1H m  H-5, H-6 
5 132.2 5.69–5.66, 1H, m H-4, H-6 
6 131.7 5.73–5.69, 1H, m H-5,H-7 
7 55.2 3.43–3.42, 1H, m  H-5, H-6 
8 62.7 3.01, 1H, dd (4.5, 2) 9-OH 
9 71.8 4.13–4.11, 1H, m H-8, 9-OH, H-10, H-11 
10 136.2 5.92, 1H, ddd (5.5, 11, 17) H-9, H-11, 9-OH 
11 117.2 5.26, 1H, d (11); 5.39, 1H, d (17) H-9 
OH (C-2) – 2.17–2.16, 1H, m – 
OH (C-9)  – 2.33–2.32, 1H, m – 
 
 
 
2.1.1.4 Dihydrobrassicicolin A  
The purified metabolite D was analyzed by 1H NMR and HPLC-ESI-MS. The HPLC-
ESI-MS detected an ion peak at m/z 703 attributed to a mass shift of 18 from the molecular ion 
peak of brassicicolin A (at m/z 685 [M+H]+). The HRESI-MS established C32H50N2O15Na as 
molecular formula of a sodium adduct ion of metabolite D. The 1H NMR spectrum of metabolite 
D showed high similarity to that of brassicicolin A (1) except for two proton signals at δH 8.30 
and δH 8.26 (Figure 2.4). Those diagnostic proton signals suggested two isocyanide groups in 
brassicicolin A (1) might be hydrolyzed to two formamide groups (-NHCHO). Therefore, 
hydrolyzed brassicicolin A (1) was potentially assigned as a structure of metabolite D.  
H OH
O O OHH
151
15
10
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Hydrolysis of brassicicolin A  
To confirm structure of metabolite D, chemical hydrolysis of brassicicolin A (1) was 
carried out in acidic conditions at room temperature. HPLC analysis showed that the reaction 
mixture contained the hydrolysis product (metabolite D, tR = 23.3 min) as well as unidentified 
products.  Thus, acidic hydrolysis of brassicicolin A (1) was carried out at 4 °C to prevent 
formation of byproducts (Scheme 2.3); the reaction was quenched and analyzed by HPLC-ESI-
MS. A quasi-molecular ion peak at m/z 703 [M-H2O+H]+ was detected by HPLC-ESI-MS 
analysis.  
Comparison of the 1H NMR spectrum of brassicicolin A (1) and that of the reaction 
mixture suggested the presence of formamide groups (-NHCHO) in the reaction mixture (δH 8.30 
and δH 8.26) due to a mixture of three epimers of metabolite D as shown in brassicicolin A (1). 
The 1H NMR spectrum of acid-hydrolyzed brassicicolin A was identical to that of the isolated 
metabolite D obtained from fungal cultures. Thus, metabolite D was assigned as 
dihydrobrassiciolin A (220).  
 
 
 
Figure 2.4 Partial 1H NMR spectra of brassicicolin A (1, A) and metabolite D (220, B). 
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Scheme 2.3 Acidic hydrolysis of brassicicolin A (1).  
 
 
To determine whether dihydrobrassicicolin A (220) is a fungal metabolite or results from 
spontaneous hydrolysis of brassicicolin A (1), brassicicolin A (1) was incubated in PDB at 30 
°C. After 7 days (maximum production of brassicicolin A), PDB was extracted and brassicicolin 
A (1) and dihydrobrassicicolin A (220) were quantified. Brassicicolin A (1, 2.3 mg) was 
hydrolyzed (ca. 50%) spontaneously in PDB media in seven days (1.3 mg), indicating 
dihydrobrassicicolin A (220, 1.7 mg) is a hydrolysis product of brassicicolin A (1) formed 
spontaneously during incubation of A. brassicicola (Pedras and Park, 2015). 
 
 
2.1.2 Modification of culture conditions and quantification of metabolites 
Considering that cultures of A. brassicicola grown in MM produced more complex 
mixtures of metabolites than those grown in PDB (Figure 2.1), it was necessary to deconstruct 
the MM to determine the effects of some components on the biosynthesis of metabolites. 
Specifically, carbon and nitrogen sources are known to affect strongly the production and 
regulation of secondary metabolites of fungi (Tudzynski, 2014) (Table 8). 
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Table 8 Different culture conditions to grow Alternaria brassicicola.  
Entry Modification of standard MM and PDB	a 
1 Standard MM 
2 High glucose (45 g/L, 250 mM) 
3 Low glucose (3 g/L, 17 mM) 
4 Sucrose (15 g/L, 44 mM) substitute for glucose 
5 Fructose (15 g/L, 83 mM) substitute for glucose 
6 Mannitol or sorbitol (15 g/L, 82 mM) substitute for glucose 
7 No asparagine 
8 No thiamine 
9 Low KNO3 (0.31 g/L, 3.1 mM) 
10 NaNO3 (2.5 g/L, 29 mM) substitute for KNO3 
11 Low NaNO3 (0.25 g/L, 2.9 mM) 
12 No nitrate 
13 NH4Cl (0.16 g/L, 3.0 mM) substitute for KNO3 
14 High ferric citrate (54 mg/L, 200 µM) 
15 No ferric citrate 
16 NaClb (10 g/L) 
17 PDBc 
a All cultures were incubated at 23 °C and 30 °C unless stated otherwise. 
b NaCl was added to 60-hour-old cultures of A. brassicicola in standard MM. 
c PDB (potato dextrose broth) was considered a standard medium 
 
 
2.1.2.1 Standard conditions and carbon sources  
A. brassicicola was grown in modified MM (entries 1–16) and PDB (entry 17) at 23 °C 
and 30 °C. After seven days, cultures were filtered and mycelia were weighed. Culture filtrates 
were extracted with EtOAc and each extract was analyzed by HPLC-DAD. Five fungal 
metabolites (1, 151, 25, 210, and 219) were also quantified using calibration curves (Table 18).  
The cultures grown in MM (entry 1) and PDB (entry 17) were considered standard 
culture conditions at low and high temperatures (23 °C and 30 °C). The mycelial weights were 
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similar among standard conditions (entries 1 and 17), while cultures in PDB (entry 17) produced 
significantly larger amounts of extractable metabolites than standard MM (entry 1). In addition, 
high temperature led to increase in extract weights in either PDB or MM (Table 9) (Pedras and 
Park, 2015). 
 
Table 9 Weights of mycelia and extract of culture filtrates of Alternaria brassicicola grown in 
modified MM and PDB. 
Entry Modification of 
standard MM and 
PDBa 
Wet mycelia weight 
(g/100 mL) 
Dry extracts of culture 
filtrates (mg/100mL) 
  23 °C 30 °C 23 °C 30 °C 
1 Standard MM 1.5 ± 0.3g–j 1.6 ± 0.5g–l 3.7 ± 0.7abc 9 ± 3a–f 
2 High glucose  2.0 ± 0.1jkl 2.0 ± 0.1jkl 4.5 ± 0.7abc 11 ± 1a–f 
3 Low glucose  0.4 ± 0.1a 0.4 ± 0.1a 1.0 ± 0.4a 2.8 ± 0.5ab 
4 Sucrose  2.2 ± 0.0l 1.1 ± 0.2b–g 4 ± 3abc 10 ± 2a–f 
5 Fructose  1.6 ± 0.1g–k 1.7 ± 0.1h–l 9.7 ± 0.6a–f 10 ± 4a–f 
6 Mannitol or sorbitol  No growth No growth No growth No growth 
7 No asparagine 1.8 ± 0.1i–l 2.0 ± 0.1jkl 8.7 ± 0.8a–e 9.1 ± 0.7a–f 
8 No thiamine 2.0 ± 0.1jkl 2.1 ± 0.1jkl 6 ± 1a–d 7.9 ± 0.7a–e 
9 Low KNO3  1.4 ± 0.1f–i 0.8 ± 0.0a–f 12 ± 4b-f 19 ± 10e–i 
10 NaNO3  2.1 ± 0.1kl 1.5 ± 0.2g–j 5.1 ± 0.9a–d 12 ± 2a–f 
11 Low NaNO3  1.2 ± 0.1e–h 0.6 ± 0.1a–d 10.4 ± 0.6a–f 27 ± 2hi 
12 No nitrate 0.7 ± 0.1a–e 0.5 ± 0.0a 8.3 ± 0.2a–e 27.0 ± 0.9hi 
13 NH4Cl  1.2 ± 0.1d–h 0.5 ± 0.1abc 15 ± 2c–g 25 ± 2g–i 
14 High ferric citrate  1.8 ± 0.3i–l 1.2 ± 0.3e–h 11 ± 1a–f 16 ± 2d–h 
15 No ferric citrate 0.5 ± 0.2ab 0.3 ± 0.2a 4.0 ± 0.2abc 20 ± 10f–i 
16 NaCl 1.9 ± 0.1i–l 1.4 ± 0.3ghi 6 ± 1a–d 14 ± 3b–g 
17 PDB 1.6 ± 0.1g–k 1.1 ± 0.1c–g 30 ± 10i 51 ± 1j 
a PDB (potato dextrose broth) was considered a standard medium. 
Values are means ± standard deviation of three replicates (n ≥ 3) randomly selected in cases 
where n >3. The means in each treatment were analyzed by one-way ANOVA with Tukey’s test. 
Weights of wet mycelia and extracts of culture filtrates within the same column with the same 
letters are not significantly different at P < 0.05. 
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HPLC analysis of the extracts of culture filtrates obtained from standard conditions 
reveled that the amount of brassicicolin A (1) was approximately 10-fold larger in PDB than that 
in MM, while phomapyrone A (25), α-acetylorcinol (210) and tyrosol (219) were detected in 
relatively much smaller amounts than brassicicolin A (1) in all standard conditions. Furthermore, 
at 30 °C production of brassicicolin A (1) was increased, whereas production of depudecin (151) 
decreased (Table 10).  
The metabolite profiles of cultures containing glucose (entry 1) as the carbon source were 
similar to those of cultures containing sucrose (entry 4), with no statistically significant 
differences. Reducing 5-fold the amount of glucose in the MM (entry 3) clearly affected both the 
mycelial growth and the extract weight, relative to standard cultures (entry 1). By contrast, 
increasing 3-fold the amount of glucose (entry 2) did not affect the mycelial mass or extract 
weight. Cultures grown in sucrose (entry 4) or fructose (entry 5) had similar mycelial weights 
and extract weights relative to control MM. However, A. brassicicola did not grow when sorbitol 
or mannitol were used as carbon sources (entry 6) (Table 9 and Table 10) (Pedras and Park, 
2015). 
	63 
T
ab
le
 1
0 
Q
ua
nt
ifi
ca
tio
n 
by
 H
PL
C
-D
A
D
 o
f 
th
e 
m
aj
or
 m
et
ab
ol
ite
s 
pr
od
uc
ed
 b
y 
Al
te
rn
ar
ia
 b
ra
ss
ic
ic
ol
a 
in
 m
in
im
al
 m
ed
iu
m
 (
M
M
), 
m
od
ifi
ed
 M
M
 a
nd
 p
ot
at
o 
de
xt
ro
se
 b
ro
th
 (P
D
B
). 
 
M
M
 
m
od
ifi
ca
tio
n 
B
ra
ss
ic
ic
ol
in
 A
 (1
) 
(µ
m
ol
/1
00
 m
L)
 
D
ep
ud
ec
in
 (1
51
) 
(µ
m
ol
/1
00
 m
L)
 
Ph
om
ap
yr
on
e 
A
 (2
5)
 
(µ
m
ol
/1
00
 m
L)
 
α-
A
ce
ty
lo
rc
in
ol
 (2
10
) 
(µ
m
ol
/1
00
 m
L)
 
Ty
ro
so
l (
21
9)
 
(µ
m
ol
/1
00
 m
L)
 
23
 °
C
 
30
 °
C
 
23
 °
C
 
30
 °
C
 
23
 °
C
 
 
30
 C
 
23
 C
 
30
 C
 
23
 C
 
30
 C
 
1 
St
an
da
rd
 M
M
 
2±
1a
 
4±
2a
b  
0.
4±
0.
4a
 
0.
04
±0
.0
4a
 
0.
6±
0.
2f
g  
0.
4±
0.
2d
–g
 
0.
03
±0
.0
1a
bc
 
0.
07
±0
.0
5a
–d
 
0.
07
±0
.0
2a
b  
0.
4±
0.
1d
ef
 
2 
H
ig
h 
gl
uc
os
e 
 
0.
6±
0.
3a
 
1.
4±
0.
1a
 
  0
a  
0a
 
0.
24
±0
.0
2b
cd
 
0.
60
±0
.0
2g
 
0.
01
±0
.0
0a
b  
0.
04
±0
.0
1a
–d
 
0.
11
±0
.0
2a
bc
 
0.
6±
0.
2f
 
3 
Lo
w
 g
lu
co
se
  
0a
 
0a
 
0.
03
±0
.0
5a
 
0a
 
0.
18
±0
.0
2a
bc
 
0.
35
±0
.0
9c
–f
 
0a
 
0.
06
±0
.0
2a
–d
 
0a
 
0a
 
4 
Su
cr
os
e 
 
0.
5±
0.
2a
 
3.
7±
0.
9a
b  
0.
2±
0.
2a
 
0.
07
±0
.0
7a
 
0.
30
±0
.0
5b
–e
 
0.
23
±0
.0
4b
cd
 
0.
16
±0
.0
6a
–e
 
0.
38
±0
.0
5a
–f
 
0a
 
0.
29
±0
.0
5b
–e
 
5 
Fr
uc
to
se
 
3.
2±
0.
4a
b  
2±
1a
 
0.
10
±0
.0
4a
 
0.
07
±0
.0
7a
 
0.
23
±0
.0
4b
cd
 
0.
31
±0
.0
7c
de
 
0.
07
±0
.0
2a
–d
 
0.
2±
0.
1a
–e
 
0.
03
±0
.0
1a
 
0.
24
±0
.0
9a
–d
 
6 
So
rb
ito
l o
r 
m
an
ni
to
l 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
N
o 
gr
ow
th
 
7 
N
o 
as
pa
ra
gi
ne
 
4±
2a
bc
 
2.
4±
0.
0a
 
0.
9±
0.
4a
b  
0a
 
0.
29
±0
.0
5b
cd
 
0.
29
±0
.0
5b
cd
 
0.
12
±0
.0
2a
–e
 
0.
05
±0
.0
3a
–d
 
0.
05
±0
.0
1a
 
0.
2±
0.
2a
–d
 
8 
N
o 
th
ia
m
in
e 
2.
6±
0.
7a
 
3.
2±
0.
7a
b  
0.
8±
0.
7a
b  
0a
 
0.
50
±0
.0
4e
fg
 
0.
6±
0.
1g
 
0.
05
±0
.0
2a
–d
 
0.
1±
0.
1a
–e
 
0.
04
±0
.0
0a
 
0.
18
±0
.0
2a
–d
 
9 
Lo
w
 K
N
O
3 
 
2±
2a
 
14
±4
cd
e  
31
±1
0e
 
12
±7
d  
0a
 
0a
 
0.
6±
0.
2c
–g
 
1.
1±
0.
4g
hi
 
0a
 
0.
4±
0.
2d
ef
 
10
 
N
aN
O
3 
 
0.
8±
0.
2a
 
3±
1a
b  
0a
 
0a
 
0.
32
±0
.0
3c
de
 
0.
26
±0
.0
4b
cd
 
0.
01
±0
.0
1a
b  
0.
13
±0
.0
7a
–e
 
0.
06
±0
.0
2a
b  
0.
35
±0
.0
4c
–f
 
11
 
Lo
w
 N
aN
O
3 
2.
8±
0.
6a
 
15
.2
±0
.8
de
 
26
±4
e  
10
±6
cd
 
0a
 
0a
 
0.
53
±0
.0
9b
–f
 
1.
4±
0.
4i
 
0a
 
0a
 
12
 
N
o 
ni
tra
te
 
1.
77
±0
.0
6a
 
16
±3
e  
17
±6
d  
9.
5±
0.
4b
cd
 
0a
 
0a
 
0.
42
±0
.0
6a
–f
 
0.
6±
0.
1e
–h
 
0a
 
0a
 
13
 
N
H
4C
l 
2.
4±
0.
5a
 
9±
1a
–e
 
12
±2
d  
0.
2±
0.
1a
 
0a
 
0a
 
0.
6±
0.
2e
–h
 
1.
1±
0.
3h
i  
0a
 
0a
 
14
 
H
ig
h 
fe
rr
ic
 
ci
tra
te
 
3±
1a
 
6±
2a
–d
 
0.
03
±0
.0
3a
 
0.
04
±0
.0
5a
 
0.
19
±0
.0
5a
bc
 
0.
17
±0
.0
6a
bc
 
0.
02
±0
.0
2a
b  
0.
08
±0
.0
6a
–d
 
0.
01
±0
.0
1a
 
0.
42
±0
.0
6d
ef
 
15
 
N
o 
fe
rr
ic
 c
itr
at
e 
4±
2a
bc
 
13
±9
b–
e  
0a
 
0.
4±
0.
3a
 
0.
35
±0
.0
4c
–f
 
0.
28
±0
.0
5b
cd
 
0a
 
0.
09
±0
.0
2a
–d
 
0a
 
0a
 
16
 
N
aC
l  
2.
3±
0.
3a
 
9±
4a
–e
 
0.
05
±0
.0
4a
 
0.
1±
0.
1a
 
0.
18
±0
.0
1a
bc
 
0.
10
±0
.0
2a
b  
0.
12
±0
.0
5a
–e
 
0.
6±
0.
4d
–g
 
0.
06
±0
.0
1a
b  
0.
5±
0.
1e
f  
17
 
PD
B
 
33
±1
2f
 
33
±1
f  
2.
0±
0.
9a
b  
0.
9±
0.
2a
bc
 
0a
 
0a
 
0.
7±
0.
1f
gh
 
1.
1±
0.
4g
hi
 
0a
 
0a
 
N
ot
e:
 V
al
ue
s 
ar
e 
m
ea
ns
 ±
 s
ta
nd
ar
d 
de
vi
at
io
n 
of
 t
hr
ee
 r
ep
lic
at
es
 (
n 
≥ 
3)
 r
an
do
m
ly
 s
el
ec
te
d 
in
 c
as
es
 w
he
re
 n
 >
 3
. T
he
 m
ea
ns
 i
n 
ea
ch
 t
re
at
m
en
t 
w
er
e 
an
al
yz
ed
 b
y 
on
e-
w
ay
 A
N
O
V
A
 w
ith
 T
uk
ey
’s
 t
es
t. 
V
al
ue
s 
w
ith
 t
he
 s
am
e 
le
tte
rs
 w
ith
in
 e
ac
h 
m
et
ab
ol
ite
 c
ol
um
n 
ar
e 
no
t 
si
gn
ifi
ca
nt
ly
 d
iff
er
en
t 
at
 P
 <
 0
.0
5;
 0
 
µm
ol
/1
00
 m
L 
in
di
ca
te
s 
th
at
 m
et
ab
ol
ite
s 
ar
e 
no
t d
et
ec
te
d 
un
de
r 
re
po
rte
d 
co
nd
iti
on
s;
 m
in
im
um
 d
et
ec
ta
bl
e 
am
ou
nt
s 
at
 2
20
 n
m
: b
ra
ss
ic
ic
ol
in
 A
 (
1)
 =
 1
.2
5 
nm
ol
es
, 
de
pu
de
ci
n 
(1
51
) 
= 
0.
06
3 
nm
ol
es
, 
ph
om
ap
yr
on
e 
A
 
(2
5)
 
= 
0.
02
5 
nm
ol
es
, 
α-
ac
et
yl
or
ci
no
l 
(2
10
) 
= 
0.
00
5 
nm
ol
es
, 
ty
ro
so
l 
(2
19
) 
= 
0.
00
5 
nm
ol
es
.
	 64 
2.1.2.2 Effect of nitrogen sources 
MM has two nitrogen sources: KNO3 (3.1 g/L, 31 mM, inorganic component) and 
asparagine (0.28 g/L, 2.1 mM, organic component). The preliminary results of cultures incubated 
in low concentration of KNO3 (3 mM) showed a substantial increase in depudecin (151) at 23 °C 
and brassicicolin A (1) at 30 °C. These results led to an analysis of effects of nitrogen on 
metabolite profiles of A. brassicicola. A 10-fold decrease in the amount of nitrate (entry 11) or 
its complete removal (entry 12) caused an increase in extract weights, whereas replacing KNO3 
with NaNO3 (entry 10) did not affect extract weights. Similarly, substituting NH4Cl for KNO3 
(entry 13) increased extract weights at 30 °C. High temperature (30 °C) negatively affected 
mycelial growth in nitrogen limitation conditions, while extract weights were significantly 
increased (Table 9) (Pedras and Park, 2015).  
The HPLC chromatograms of culture extracts obtained from low nitrogen (3 mM) 
showed that α-acetylorcinol (210), depudecin (151), and brassicicolin A (1) were detected, 
whereas other metabolites were detected in extremely low amounts (Figure 2.5). Interestingly, a 
low concentration of nitrate (sodium or potassium) or complete removal of nitrate from MM 
increased significantly the production of brassicicolin A (1) at 30 °C, depudecin (151) 23 °C and 
α-acetylorcinol (210) at 30 °C (entries 8, 10 and 11). Similarly, low NH4Cl increased the 
amounts of depudecin (151) at 23 °C and α-acetylorcinol (210) at 23 °C and 30 °C (entry 12). 
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Figure 2.5 HPLC-DAD chromatograms (method A, detection 220 nm) of extracts of the culture 
filtrates of Alternaria brassicicola grown under different nitrogen sources: Arrows indicate α-
acetylorcinol (210, tR = 8.4 min), depudecin (151, tR = 11.6 min), and brassicicolin A (1, tR = 
29.5 min). 
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A. brassicicola grown under low concentration of nitrogen showed darker mycelia at 
either temperature (Figure 2.6). To examine the cause of this darker color, mycelia obtained 
from nitrogen-depleted conditions were extracted in either neutral or acidic condition. However, 
the extraction of dark pigments from mycelia was unsuccessful.  
 
 
Figure 2.6 Alternaria brassicicola (7-d-old) grown under different nitrogen sources. 
 
2.1.2.3 Iron and siderophores 
MM has ferric citrate (0.54 mg/L, 2 µM) as a sole iron source. To determine whether 
ferric citrate affects the metabolite profiles of A. brassicicola, three different concentrations of 
ferric citrate were tested: 0, 2, and 200 µM. A 100-fold increase in ferric citrate (entry 14) 
showed similar mycelial weight, while extract weights were not significantly different compared 
to control (2 µM) cultures. Complete removal of ferric citrate from MM (entry 15) significantly 
inhibited mycelial growth (Table 9) whereas high ferric citrate (entry 14) exhibited similar 
metabolites profiles compared to standard MM (Table 10).  
 
Siderophores 
The production of siderophores in cultures of A. brassicicola in the absence of Fe3+ was 
investigated in more detail. Five-day-old cultures were examined for production of siderophores 
by HPLC-ESI-MS and colorimetric detection at 435 nm (absorption is due to chelation of 
hydroxamic acids with FeCl3) (Jalal, Love et al., 1988; Konetschny-Rapp, Huschka et al., 1988). 
Culture broths grown in MM without ferric citrate showed a stronger reddish color than cultures 
grown in either standard MM (2 µM) or high ferric citrate (200 µM), suggesting a higher 
concentration of siderophores in MM without ferric citrate as previously reported (Oide, Moeder 
et al., 2006) (Figure 2.7).  
KNO3 31 mM 
(CON) 
KNO3 3 mM NaNO3 29 mM NH4Cl 3 mM NaNO3 3 mM 
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Figure 2.7 Culture filtrates of Alternaria brassicicola after addition of FeCl3·6H2O: Top row, 
cultures grown in ferric citrate 0 µM; middle row, ferric citrate 200 µM; bottom row, ferric 
citrate 2 µM. 
 
The extracellular siderophores were partially purified using an amberlite XAD-4 column 
by elution with MeOH. Eluents having red coloration were collected and analyzed by HPLC-
ESI-MS and HR-LC-ESI-MS. The MeOH-fractions contained several peaks that are not detected 
in EtOAc extracts. Removal of ferric citrate significantly increased production of siderophores, 
whereas high ferric citrate and control showed similar metabolite profiles (Figure 2.8). UV and 
high resolution mass spectra (HR-ESIMS) suggest that the structures of the components are 
dimerumic acid (184, tR = 9.0 min, m/z  = 538), unknown (tR = 11.1 min, m/z  = 824), N,N-
dimethyltriornicin (221, tR = 11.3 min, m/z  = 738), coprogen B (222, tR = 11.7 min, m/z  = 780), 
Nα-methylcoprogen B (223, tR = 12.0 min, m/z  = 794), hydroxycoprogen (180, tR = 12.2 min, 
m/z  = 838), N,N-dimethylcoprogen (179, tR = 12.6 min, m/z  = 808) and neocoprogen I (177, tR 
= 12.9 min, m/z  = 752) (Table 11). Furthermore, the presence of peaks of low intensity at m/z 
752 (808-56), 768 (824-56) and 682 (738-56) indicated loss of Fe3+ from the respective quasi-
molecular ions [M-56]+, which is consistent with the structures of these siderophores (Hider and 
Kong, 2010). In addition, their UV spectra were similar to published data (Konetschny-Rapp, 
Huschka et al., 1988). 
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Figure 2.8 HPLC chromatograms (method D, detection 220 nm),  and UV spectra of MeOH 
fractions obtained from culture filtrates-FeCl3 of A. brassicicola grown under different 
concentrations of ferric citrate. tR = 9.0 min, dimerumic acid (184); tR = 11.1 min, unknown; tR = 
11.3 min, N,N-dimethyltriornicin (221); tR = 11.7 min, coprogen B (222); tR = 12.0 min, Nα-
methylcoprogen B (223); tR = 12.2 min,  hydroxycoprogen (180); tR = 12.6 min, N,N-
dimethylcoprogen (179); tR = 12.9 min, neocoprogen I (177).  
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Table 11 High resolution mass spectral data of siderophores produced by Alternaria 
brassicicola. 
tR Siderophores  
Molecular 
formula 
Observed value as 
[M+Fe-2H]+, m/z 
mDa 
error 
9.0 Dimerumic acid (184) C22H34FeN4O8 538.1777 5.64 
11.3 
N,N-Dimethyltriornicin 
(221) C31H50FeN6O11 
738.2955 7.35 
369.6521a 8.77 
11.7 Coprogen B (222) C33H52FeN6O12 
780.3086 9.88 
390.6573a 8.61 
12.0 Nα-methylcoprogen B (223) C34H54FeN6O12 
794.3315 17.14 
397.6651a 8.56 
12.2 Hydroxycoprogen (180) C35H54FeN6O14 838.3163 12.11 
12.6 
N,N-Dimethylcoprogen 
(179) C35H56FeN6O12 
808.3263 -3.7 
404.6704a 3.5 
12.9 Neocoprogen I (177) C31H48FeN6O12 752.2757 8.29 
a Doubly charged ions 
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To examine whether the EtOAc extracts of the second half culture filtrate contain 
siderophores, the extracts were analyzed by HPLC-ESI-MS. Siderophores were detected in 
EtOAc extract of culture filtrates grown in Fe3+ depleted MM and standard MM, albeit in 
relatively lower amount than when using fractionation by XAD-4 column (Pedras and Park, 
2015). 
2.1.2.4 Other conditions 
Removal of asparagine or thiamine from MM did not appear to affect the metabolite 
profiles of A. brassicicola, but decreased the amount of phomapyrone A (25) at 23 °C compared 
to standard MM (entry 1). Since a ten-fold increase in NaCl (entry 16) completely inhibited 
conidia germination, NaCl was added to 60-hour-old cultures. No significant effects of NaCl on 
the mycelial growth or the fungal metabolites were observed. (Table 9 and Table 10) 
 
2.1.3 Epigenetic modifiers 
DNA methyltransferase and HDAC inhibitors are epigenetic modifiers known to induce 
metabolites present in orphan pathways in fungi and bacteria (Scherlach and Hertweck, 2009; 
VanderMolen, Darveaux et al., 2014; Williams, Henrikson et al., 2008). For example, SAHA 
(32) SBHA (33), and 5-Aza (35) triggered modifications of the secondary metabolite profiles of 
various fungal species (Table 1). In this context, two HDAC inhibitors (SAHA 32, and SBHA 
33) and a DNA methyltransferase inhibitor (5-Aza, 35) were tested to determine whether these 
epigenetic modifiers affect A. brassicicola metabolite profiles. 
2.1.3.1 Synthesis of SAHA and SBHA 
Two histone deacetylase inhibitors, SAHA (32) and SBHA (33) were synthesized 
according to published procedures (Mai et al., 2001). Synthesis of SAHA (32) was carried out 
from suberic acid (224) by refluxing with Ac2O. Aniline was added to the cyclic anhydride 225 
to yield acid 226. In the final step, SAHA (32) was obtained upon treatment with hydroxylamine 
solution in overall 22% yield. The synthesis of SBHA (33) was accomplished by adding freshly 
prepared hydroxylamine solution to suberic acid (224) in quantitative yield (Scheme 2.4).  
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Scheme 2.4 Synthesis of suberoylanilide hydroxamic acid (SAHA, 32) and suberoyl bis-
hydroxamic acid (SBHA, 33). Reagents and conditions: (i) Ac2O, reflux 1h; (ii) Aniline, rt, 30 
min, 40% yield over two steps; (iii) ClCO2Me, Et3N in ice-water bath, (iv) NH2OH·HCl, KOH in 
ice-water bath, 55% yield over two step; (v) NH2OH·HCl, Na2CO3 0 °C, quantitative for SBHA 
(33). 
 
2.1.3.2 Administration of epigenetic modifiers 
To investigate effects of histone deacetylase inhibitors on induction of secondary 
metabolism of A. brassicicola, the fungal spores were incubated in presence of SAHA (32) and 
SBHA (33) in standard MM. After seven days, the culture filtrates of A. brassicicola were 
extracted and analyzed by HPLC-DAD. Those culture extracts were compared with control 
culture extracts to examine whether SAHA (32) or SBHA  (33) affects metabolite profiles of A. 
brassicicola.  
The HPLC chromatograms of culture extracts of A. brassicicola grown in MM containing 
SAHA  (32) were similar to those of control cultures in MM, except for an increase in metabolite 
E (tR = 12.9 min, method A) and a decrease in SAHA  (32) (Figure 2.9). On the other hand, the 
HPLC chromatograms of extracts of the culture filtrates containing SBHA (33) were similar to 
those of extracts of the culture filtrates in standard MM. While the extracts of culture filtrates 
containing 5-Aza (35) exhibited similar metabolite profiles compared to standard culture, 5-Aza 
(35) appeared to reduce amounts of metabolites of the A. brassicicola (Figure 2.9) 
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Figure 2.9 HPLC-DAD chromatograms of extracts of the Alternaria brassicicola culture filtrates 
incubated with SAHA  (32, 0.50 mM), SBHA (33, 0.50 mM) or 5-Aza (35, 0.30 mM) (method 
A, detection 220 nm): Metabolite E (227), tR = 12.9 min.   
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N-Phenylacetamide (227) 
The chemical structure of the metabolite E (tR = 12.9 min) was elucidated after 
purification of the culture filtrate extract followed by analyses by 1H NMR and MS 
spectroscopy. The molecular formula obtained by HREI-MS analysis (m/z 135.0688, C8H9NO) 
indicated five degrees of unsaturation. The 1H NMR spectrum displayed spin systems; one spin 
system containing five aromatic protons and another a singlet of three protons at 2.19 ppm. 
Based on these spectroscopic data, the structure of this metabolite was assigned as N-
phenylacetamide (227), and was confirmed by comparison with an authentic sample, prepared by 
standard acetylation of aniline using acetic anhydride. 
 
 
 
 
2.1.3.3 Biotransformation of SAHA 
The time course analysis of SAHA (32) in cultures of A. brassicicola was carried out to 
examine the biotransformation of SAHA (32). Cultures incubated with SAHA (32) and N-
phenylacetamide (227) were monitored for 5 days using HPLC-DAD. The stability of SAHA 
(32) in standard MM was also examined. The concentration of SAHA (32) remained constant for 
the first 24 h and decreased faster at 30 °C than at 23 °C. HPLC analysis of cultures incubated 
with SAHA (32) indicated that A. brassicicola completely transformed SAHA (32) to N-
phenylacetamide (227) at 30 °C in five days, while at 23 °C SAHA (32) was converted much 
slower (Figure 2.10). 
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Figure 2.10 Progress curve of biotransformation of SAHA (32, 0.40 mM) by Alternaria 
brassicicola: ¿ SAHA (32) + A. brassicicola at 23 °C; ¢ SAHA (32) + A. brassicicola at 30 °C; 
 SAHA (32) at 23 °C;p SAHA (32) at 30 °C; ¯ N- phenylacetamide (227), 23 °C; £ N-
phenylacetamide (227) 30 °C.  
 
2.1.3.4 Biotransformation of aniline 
Biotransformation of SAHA (32) suggested that A. brassicicola might enzymatically 
hydrolyze SAHA  (32) followed by enzymatic acetylation of aniline (228). To confirm this 
hypothesis, aniline (228) was added to standard MM and the cultures were monitored by HPLC-
DAD. Aniline (228) was added to two-day-old cultures of A. brassicicola. Cultures were 
collected at different time intervals and then lyophilized immediately. The lyophilized cultures 
were dissolved in water and analyzed by HPLC-DAD. A. brassicicola started to biotransform 
aniline (228) to N-phenylacetamide (227) four hours after addition of aniline (228) (Figure 2.11 
and Figure 2.12) and formation of N-phenylacetamide (227) increased up to 48 h with no further 
changes. Quantification of aniline (228) was not feasible because it formed an adduct with 
glucose (230, tR = 8.7 min, method C). The amount of this adduct did not change in control 
cultures, but decreased as N-phenylacetamide (227) was formed (Figure 2.12). Elucidation of 
the structure of this product follows.  
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Figure 2.11 Progress curve of formation of N-phenylacetamide (227) from aniline (228) in 
cultures of Alternaria brassicicola in MM at 23 °C: ¢ N-phenylacetamide (227).  
 
 
 
Figure 2.12 HPLC-DAD chromatograms (method C, detection 220 nm) of cultures of Alternaria 
brassicicola: CON, standard MM containing 0.20 mM aniline (228); A. brassicicola was 
incubated in MM containing 0.20 mM aniline (228).  
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First, the stability of aniline (228) in H2O was examined. Aniline (228) was dissolved in 
H2O (0.20 mM), and the solution was analyzed by HPLC-DAD. The concentration of aniline 
(228)  remained constant, suggesting it was stable in H2O (Figure 2.13). Next, aniline (228) was 
added to MM without glucose and with glucose, and the solutions were analyzed by HPLC-
DAD. A product was detected only in MM containing glucose and aniline (228), whereas it was 
not detected in MM without glucose (Figure 2.13). 
To characterize the unknown product, aniline (228) and glucose (229)  were stirred in 
H2O at room temperature and the reaction was monitored by HPLC-DAD. The HPLC 
chromatograms showed an increase in the peak area of the unknown component (tR = 8.7 min) 
and a decrease in aniline (228) as the reaction progressed (Figure 2.13). The solution was 
lyophilized and then analyzed by NMR spectroscopy. The 1H NMR and 13C NMR spectra of this 
reaction mixture showed the characteristic anomeric carbon and proton signals of α- and β-D- 
glucopyranoses (δC 92.8 and 96.6 ppm; δH 4.59 and 5.17 ppm), in addition to δ 85.5 ppm and δ 
4.72 ppm (1H, d, 8.8 Hz), respectively. The chemical shifts of the anomeric carbon and proton 
signals of α- and β-D-glucopyranoses were similar to those of published data (Roslund, Tähtinen 
et al., 2008). The additional 1H NMR and 13C NMR spectral data suggested that the unknown 
component was N-β-D-glucopyranosyl aniline (230) (Bridiau, Benmansour et al., 2007) 
(Scheme 2.5). 
Quantification of N-phenylacetamide (227) in the extract of culture filtrates of A. 
brassicicola showed that only ca. 25% of aniline (228) was converted to N-phenylacetamide 
(227) by A. brassicicola in 48 h.  
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Figure 2.13 HPLC-DAD chromatograms (method C, detection 220 nm) of MM (aniline (228) 
with glucose and without glucose) and aniline (228) in H2O. 
 
 
 
Scheme 2.5 Reaction of aniline (228) with glucose.  
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2.1.4 Co-cultivation of A. brassicicola and A. brassicae 
Alternaria black spot disease in most Brassica species is caused by A. brassicae, A. 
brassicicola, and A. raphani. It was hypothesized A. brassicicola might produce potential 
phytotoxin(s) that are not present in standard growth conditions if A. brassicicola was co-
incubated with either A. brassicae or A. raphani. Hence, A. brassicicola and A. brassicae were 
co-cultivated in PDB and MM to examine changes in metabolite production of A. brassicicola.  
Two weeks later, culture broths obtained from each 6-well plate were extracted and then 
analyzed by HPLC-DAD. HPLC analyses of culture extracts of A. brassicae indicated that A. 
brassicae produced destruxin B (123, tR = 29.6 min, Method A) and homodestruxin B (129, tR = 
30.5 min, Method A) in both PDB and MM. Metabolite profiles of co-inoculation were similar to 
those of A. brassicicola in either PDB or MM. However, destruxin B (123) and homodestruxin B 
(129) did not appear to be produced by A. brassicae in co-culture regardless of media. It 
indicates that A. brassicicola might dominate in these growth conditions leading to less growth 
of A. brassicae in co-culture with A. brassicicola.  
 
 
Figure 2.14 HPLC-DAD chromatograms (method A, detection 220 nm) of culture extracts of 
Alternaria brassicae, co-culture, and A. brassicicola.  
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2.1.5 Biological activity - conidia germination 
To determine if any of the metabolites produced by A. brassicicola affects its conidia 
germination and germ tube growth, a microplate reader was used to evaluate conidial 
germination over a period of 36 h. Cultures of A. brassicicola in MM amended with brassicicolin 
A (1), depudecin (151), α-acetylorcinol (210), and tyrosol (219) were incubated in 48-well 
microplates. Comparison of the absorbance of wells containing conidia incubated with the 
various compounds (Figure 2.15) indicated that brassicicolin A (1) caused a slight inhibition of 
spore germination and mycelial growth at early growth stages, but no other effects were 
registered relative to control wells. In addition, similar experiments were carried out with SAHA 
(32), which displayed no effect on conidial germination relative to control cultures.  
 
 
 
Figure 2.15 Growth curve of Alternaria brassicicola in MM containing four fungal metabolites 
(all metabolites at 0.50 mM). 
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2.1.6 Discussion 
A comprehensive investigation of the metabolites produced by A. brassicicola under 
various culture conditions was carried out. Four metabolites—α-acetylorcinol (210), tyrosol (219) 
depudecin (151), dihydrobrassicicolin A (220)—were isolated from the extract of A. brassicicola 
culture filtrates and their structures were elucidated (Pedras and Park, 2015). The synthesis of α-
acetylorcinol (210) was accomplished for the first time (Pedras and Park, 2015). It was reported 
that both tyrosol (219) and α-acetylorcinol (210) were isolated from cultures of fungal plant 
pathogens including A. tagetica (Gamboa-Angulo, García-Sosa et al., 2001), Stagonospora 
apocyni (Venkatasubbaiah, Baudoin et al., 1992) and Ceratocystis species (Ayer, Browne et al., 
1986).  
Production of secondary metabolites of A. brassicicola is strongly affected by culture 
conditions, specifically temperature, nitrogen sources, and ferric ion (Pedras and Park, 2015). 
Production of brassicicolin A (1) was increased in low nitrate conditions at 30 °C, whereas 
depudecin (151) production was increased in media containing low amounts of nitrate at 23 °C, 
compared to control cultures (Table 10 and Figure 2.6) (Pedras and Park, 2015).  
Low concentration of nitrate is likely to activate the pathway(s) that are suppressed (or 
silent) in high concentration of nitrate. For example, A. nidulans grown under nitrogen-starvation 
produced two novel polyketides, sanghaspirodins A and B that are not present in nutrient-rich 
growth conditions (Scherlach, Sarkar et al., 2011). Production of alternariol in cultures of A. 
alternata also was significantly dependent on nitrogen sources. A decrease in the ratio of 
ammonium and nitrate (from 1:2.6 to 1:1) produced ca. 40-fold higher amounts of alternariol 
(Brzonkalik, Herrling et al., 2011). Another study reported that a 2-fold increase in nitrate led to 
a decrease in alternariol and alternariol monomethyl ether in A. alternata cultures (Orvehed, 
Haggblom et al., 1988). Many previously published reports support this concept that nitrogen 
represses certain polyketide-derived secondary metabolites produced by fungal pathogens; 
deoxynivalenol, fusarielin H, and zearalenone produced by Fusarium graminearum, (Giese, 
Sondergaard et al., 2013) and fumonisin produced by Fusarium verticillioides (Kim and 
Woloshuk, 2008).  
Dark mycelia of A. brassicicola grown under low concentration of nitrogen sources could 
be explained by melanin biosynthesis (Figure 2.6). Many Alternaria species have been known to 
produce melanin (Kimura and Tsuge, 1993). Pedras and Yu also reported that under high salt 
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condition, L. maculans/P. Lingam produced 8-hydroxynaphthalene-1-sulfate (30) and bulgarein 
(31a/b), which are related to melanin biosynthesis (Pedras and Yu, 2009b). Cramer et al. 
reported that under nitrogen-starvation condition, A. brassicicola expressed  
“altr015xf07.b1.ab1” gene, which has significant similarity with 1,3,8-trihydroxynaphthalene 
(1,3,8-THN, a precursor of melanin) reductase in A. alternata (Cramer, La Rota et al., 2006). In 
addition, UV irradiation activated the 1,3,8-THN reductase gene in A. alternata (Kihara, 
Moriwaki et al., 2004). Therefore, melanin accumulation is most likely to provide fungal spores 
with resistance to stress conditions such as UV irradiation, high temperature, nutrient scarcity, 
enzymatic lysis, and oxidative stresses. However, further experiments are necessary to establish 
whether nitrogen deprivation induces melanin biosynthesis and sporulation in A. brassicicola.  
Iron is an essential element in almost all microorganisms, plants and animals. They 
utilize iron in many metabolic processes such as respiration and photosynthesis. Many 
microorganisms produce iron-chelating agents (termed siderophores) to transport iron into the 
intercellular space. In addition, siderophores play an important role in detoxifying ROS produced 
by plants. A mutant of A. brassicicola deficient in siderophore production was less virulent on A. 
thaliana than the wild-type isolate. It was proposed that siderophores supply iron to pathogens 
for survival in their hosts, but are not phytotoxic (Oide, Moeder et al., 2006). The results of this 
work are consistent with the data of Oide et al. (2006). 
Genome sequences revealed that biosynthetic gene clusters are not expressed in standard 
fermentation conditions (Gross, 2007). One of the strategies to activate cryptic and/or silent gene 
clusters is to use histone deacetylase inhibitors, leading to discovery of secondary metabolites 
from microorganisms (Table 1). In this work, three epigenetic modifiers (32, 33, and 35) were 
tested to examine whether these compounds affect the metabolite profiles of A. brassicicola. As 
a result, those epigenetic modifiers did not appear to induce novel metabolites; instead, A. 
brassicicola hydrolyzed SAHA (32) to N-phenylacetamide (227) via hydrolysis followed by 
acetylation. 5-Aza (35) down-regulated production of metabolites of A. brassicicola  (Figure 
2.9). According to Sigma-Aldrich product information, the half-life of 5-Aza (35) is short (t1/2 = 
90 min at 50 °C in KPO4 buffer (pH = 7.4). Moreover, Beisler (1978) reported that 5-Aza is 
hydrolyzed into N-(formylamidino)-N'-β-D-ribofuranosylurea (35a), and l--D-ribofuranosyl-3-
guanylurea (35b) (Beisler, 1978). Thus, the degradation products of 5-Aza (35) might down-
regulate production of A. brassicicola metabolites.   
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 SBHA (33) did not induce the production of novel metabolites. A possible explanation is 
that A. brassicicola is likely to have resistance mechanism(s) to exogenous HDAC inhibitors. 
Brosch et al. reported that C. carbonum, a HDAC inhibitor-producing fungus (i.e., HC-toxin 2), 
is resistant to HC-toxin (2) and trichostatin A (a HDAC inhibitor) (Brosch, Dangl et al., 2001). 
Baidyaroy et al. reported that A. brassicicola and Diheterospora chlamydosporia (a HDAC-
inhibitor producing fungus) did not inhibit HDAC (Baidyaroy, Brosch et al., 2002). It was 
established that A. brassicicola hydrolyzed SAHA (32) to aniline (228) followed by acetylation 
to yield N-phenylacetamide (227) (Figure 2.10). It has been reported that A. brassicicola 
hydrolyzed carbamates and dithiocarbamates followed by acetylation of the resulting amines to 
yield the corresponding amide (Pedras, Minic et al., 2012; Pedras, Minic et al., 2009). Therefore, 
A. brassicicola is most likely to have a protection mechanism against hydroxamate HDAC 
inhibitors, which could be biotransformed via hydrolysis-acetylation (Pedras and Park, 2015). 
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2.2 Analyses of metabolites produced on infected leaves 
To understand the chemical-ecological interactions between A. brassicicola and its host 
plants, it is important to know the metabolites produced by A. brassicicola and inducible 
metabolites produced in the host plants. The comparative chemical analyses of the fungal 
metabolites produced on infected leaves of Brassica juncea cv. Cutlass (susceptible), B. napus 
cv. Westar (susceptible) and Sinapis alba cv. Ochre (resistant) are one of the important steps to 
understand the involvement of fungal metabolites in infection processes. In addition, these 
analyses can establish the ecological roles of metabolites involved in plant responses to fungal 
pathogen attack. Toward this end, work described in this section involves phytotoxicity assays, 
and HPLC analyses of infected and control leaves and spore germination fluids (SGFs). 
2.2.1 Phytotoxicity assays  
Whole plant assays 
It was established that A. brassicicola produced brassicicolin A (1) as a host-selective 
toxin. Brassicicolin A (1) caused severe necrosis in B. juncea and B. napus (Pedras, Chumala et 
al., 2009). Depudecin (151) has been known to be produced by A. brassicicola (Matsumoto, 
Matsutani et al., 1992), but its phytotoxicity has not been established. But, Wight et al. recently 
reported that the depudecin-minus mutants of A. brassicicola were less virulent on B. oleracea 
(Wight, Kim et al., 2009). For this reason, it was hypothesized that depudecin (151) might play 
an important role in phytotoxicity in susceptible cultivars. To determine whether depudecin 
(151) shows phytotoxic activity and/or synergistic effects on phytotoxicity, brassicicolin A (1) 
and depudecin (151) were tested using leaves of whole plants of B. juncea (susceptible), and B. 
napus (susceptible). Various concentrations of brassicicolin A (1) and depudecin (151) were 
combined and the mixtures were inoculated onto leaves of whole plants (see Section 4.4.2).  
Brassicicolin A (0.25–5.0 mM) displayed necrotic/chlorotic spots on both B. juncea and 
B. napus, while depudecin (151) did not cause visible necrotic lesions at any concentration 
except for 5.0 mM in B. napus (Figure 2.16). Although a mixture of brassicicolin A (0.25 mM) 
and depudecin (151, 1.0 mM or 0.50 mM) showed slightly larger lesions on B. napus than 
brassicicolin A (1, 0.25 mM) did, no substantial differences among mixtures of both compounds 
(1 and 151) were observed in B. juncea and B. napus (Figure 2.16). In addition, certain 
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combinations did not exhibit concentration-dependent necrotic lesions. For example, a mixture 
of brassicicolin (1) 0.50 mM and depudecin (151) 1.0 mM caused smaller lesions than a mixture 
of brassicicolin (1) 0.50 mM and depudecin (151) 0.50 mM (Figure 2.16). From these 
observations, it is unclear whether brassicicolin A (1) and depudecin (151) have a synergistic 
effect on the phytotoxicity to B. juncea and B. napus.  
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Detached leaf assays 
 
Phytotoxicity of brassicicolin A (1), depudecin (151), α-acetylorcinol (210), tyrosol 
(219), and phomapyrone A (25) was investigated using detached leaves of Brassica species; B. 
juncea cv. Cutlass (susceptible), B. napus cv. Westar (susceptible) and S. alba cv. Ochre 
(resistant). Brassicicolin A (1) caused necrotic/chlorotic lesions around inoculation sites (Figure 
2.17) regardless of the plant species resistance to A. brassicicola. Lesion sizes caused by 
brassicicolin A (0.10–1.0 mM) (1) in the three crucifers were similar in terms of concentration-
dependent necrosis (Table 12). 
Interestingly, detached leaves and leaves whole plants of S. alba showed opposite results; 
whereas no differences between both assays were observed in B. juncea and B. napus (Figure 
2.17). Brassicicolin A (1) caused necrosis in detached leaves of S. alba and did not cause any 
damage at any of the concentrations on leaves of whole plants of S. alba. These results in leveas 
of whole plants are consistent with published data establishing that brassicicolin A (1) did not 
show phytotoxicity in leaves of whole plants of S. alba (Pedras, Chumala et al., 2009). In this 
work, however, a significant difference was observed between leaves of whole plants and 
detached leaves of S. alba responding to brassicicolin A (1)..   
The other fungal metabolites— α-acetylorcinol (210) tyrosol (219), phomapyrone A 
(25)—were tested for phytotoxicity using detached leaves of B. juncea, B. napus, and S. alba. As 
a result, α-acetylorcinol (210) tyrosol (219), depudecin (151), and phomapyrone A (25) did not 
cause any damage at three concentrations (1.0, 0.50 and 0.10 mM) (Table 12). 
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Table 12 Phytotoxicity of fungal metabolites in Brassica juncea cv. Cutlass (brown mustard, 
susceptible), B. napus cv. Westar (canola, susceptible) and Sinapis alba cv. Ochre (white 
mustard, resistant) a.  
 B. juncea cv. Cutlass B. napus cv. Westar S. alba cv. Ochre 
Metabolites (mM) 1.0  0.5  0.1  1.0  0.5  0.1  1.0  0.5  0.1  
Brassicicolin A (1) 3 3 2 3 2 1 3 2 1 
Depudecin (151)  ND ND ND 
Phomapyrone A (25) ND ND ND 
α-Acetylorcinol (210) ND ND ND 
Tyrosol (219)  ND ND ND 
a  Data represent the means of lesion diameters of treated leaves (n = 36). 
Lesion size scale: 0 = 0.0–1.9 mm; 1 = 2.0–2.9 mm; 2 = 3.0–3.9 mm; 3 = 4.0–4.5 mm; 4 = 4.6–
5.5 mm; 5 = 5.6–6.5 mm; 6 = 6.5–7.5 mm. 
b ND = No damage. 
 
 
 
Figure 2.17 Effects of brassicicolin A (1) (1.0 mM and 0.50 mM) on detached leaves of 
Brassica juncea cv. Cutlass (susceptible), B. napus cv. Westar (susceptible) and Sinapis alba cv. 
Ochre (resistant).  
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2.2.2 Analyses and phytotoxicity of spore germination fluids  
Certain phytotoxins are found in spore germination fluids (SGFs) at the early growth 
stage of phytopathogenic fungi in host plants. In addition, host recognition followed by HST 
production by fungal pathogens is one of the important processes during fungal invasion. Thus, 
analyses of SGFs are important to establish roles of fungal metabolites in the early infection 
process on the site of initial contact with the host plants.  
Spore germination fluids (SGFs), initially, were collected from six spots in each leaf of B. 
juncea, B. napus, or S. alba. However, it turned out that amounts of SGFs are too small to 
analyze fungal metabolites. Furthermore, it was difficult to retain moisture in droplets of spore 
suspensions during a period of germination. That is, the droplets of spore suspensions were 
completely dried so that spores stayed on leaves without germination. After several trials to 
optimize conditions by changing spore concentrations (1 × 105 spores/mL, 20µL), the number of 
inoculation spots (40 spots per a leaf), and incubation time  (72 h), reasonable amounts of SGFs 
were collected from detached leaves of the three crucifers (see Experimental section 4.4.3). All 
spore suspensions placed on leaves have dark-yellowish (or brownish) color—initially, spore 
suspensions were transparent—and yellowish necrotic/chlorotic lesions were observed around 
inoculation spots in all species tested (Figure 2.18). Regardless of the resistance to A. 
brassicicola, the three species exhibited macroscopic stress responses such as necrotic/chlorotic, 
water soak lesion, or wilting in infected leaves.  
 
 
 
	 89 
 
 
Figure 2.18 Detached leaves (3-day post inoculation) of Brassica juncea (susceptible), B. napus 
(susceptible), and Sinapis alba (resistant) after inoculation with A. brassicicola spores. Control 
leaves were similarly treated with distilled water.  
 
 
 
SGFs collected from each species were filtered, lyophilized, concentrated and analyzed 
by HPLC-ESI-MS. The MS spectra of SGFs collected from each species revealed that A. 
brassicicola produced several siderophores (see Section 2.1.2.3) as well as phomapyrone A (25). 
These metabolites were not detected in control leaves (H2O-treatment) (Figure 2.19, Figure 2.20, 
and Figure 2.21). Fungal metabolites (siderophores and phomapyrone A (25)) in SGFs collected 
from different crucifers were detected in this work for the first time.  
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Figure 2.19 HPLC-ESI-MS chromatograms (base peak chromatogram (BPC) and extract ion 
chromatograms) of SGF collected from detached leaves of Brassica juncea cv. Cutlass 
(susceptible). EIC: m/z  = 538, dimerumic acid, 184; m/z  = 824, unknown; m/z  = 738, N,N-
Dimethyltriornicin, 220; m/z  = 780, coprogen B, 221; m/z  = 794, Nα-methylcoprogen B, 222; 
m/z  = 838, hydroxycoprogen 180; m/z  = 808, N,N-dimethylcoprogen 179; , m/z  = 752, 
neocoprogen I, 177; m/z  = 235, phomapyrone A (25). 
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Figure 2.20 HPLC-ESI-MS chromatograms (base peak chromatogram (BPC) and extract ion 
chromatograms) of SGF collected from detached leaves of Brassica napus cv. Westar 
(susceptible). EIC: m/z  = 538, dimerumic acid, 184; m/z  = 824, unknown; m/z  = 738, N,N-
Dimethyltriornicin, 220; m/z  = 780, coprogen B, 221; m/z  = 794, Nα-methylcoprogen B, 222; 
m/z  = 838, hydroxycoprogen 180; m/z  = 808, N,N-dimethylcoprogen 179; , m/z  = 752, 
neocoprogen I, 177; m/z  = 235, phomapyrone A (25). 
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Figure 2.21 HPLC-ESI-MS chromatograms (base peak chromatogram (BPC) and extract ion 
chromatograms) of SGF collected from detached leaves of Sinapis alba cv. Ochre (resistant). 
EIC: m/z  = 538, dimerumic acid, 184; m/z  = 824, unknown; m/z  = 738, N,N-Dimethyltriornicin, 
220; m/z  = 780, coprogen B, 221; m/z  = 794, Nα-methylcoprogen B, 222; m/z  = 838, 
hydroxycoprogen 180; m/z  = 808, N,N-dimethylcoprogen 179; , m/z  = 752, neocoprogen I, 177; 
m/z  = 235, phomapyrone A (25) . 
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2.2.3 Analyses of infected leaves of crucifers 
Brassicicolin A (1) is a host-selective phytotoxin of susceptible species B. juncea and B. 
napus (Pedras, Chumala et al., 2009). Although brassicicolin A (1) showed phytotoxicity to 
susceptible Brassica species, experiments to detect brassicicolin A (1) in infected leaves of 
whole plants were not successful (Pedras, Chumala et al., 2009). Detached leaves of three 
crucifer species: B. juncea cv. Cutlass (susceptible), B. napus cv. Westar (susceptible), S. alba 
cv. Ochre (resistant) were infected with A. brassicicola and incubated up to five days. The 
extracts of infected leaves were analyzed by HPLC-DAD. Control leaves were treated with either 
water or autoclaved spores.  
 
2.2.3.1 Brassica juncea cv. Cutlass (brown mustard) 
Two days after inoculation with A. brassicicola spores, detached leaves of B. juncea 
started showing yellowish spots around spore inoculation sites (Figure 2.22). As fungal spores 
germinated in B. juncea, the inoculation sites appeared darker and brownish, but these symptoms 
were absent in controls. Leaves displayed a higher degree of necrotic/chlorotic lesions around 
inoculation sites.  
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HPLC chromatograms of extracts of leaves showed that fungal infection induced the 
production of plant metabolites (Figure 2.23). Plant metabolites were assigned by comparing 
with authentic samples and UV spectral libraries available in Dr. Pedras’ group.   
HPLC-DAD analysis of MeOH-extracts of leaves indicated production of the 
phytoalexins: brassilexin (185), rutalexin (231), and cyclobrassinin (186). Three phytoalexins 
were consistently detected over a five-day inoculation period. Extracts of control leaves did not 
contain phytoalexins. Interestingly, phomapyrone A (25) was detected in 4-d-old and 5-d-old 
infected leaves extracts (Figure 2.24). HPLC-ESI-MS of extracts of infected leaves also detected 
phomapyrone A (25) in B. juncea (Figure 2.29). However, brassicicolin A (1) was not detected 
in extracts of infected leaves of B. juncea.  
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Figure 2.23 HPLC-DAD chromatograms (method C, detection 220 nm) of extracts of control 
leaves (CON-W, H2O; CON-S, autoclaved spores) and infected leaves of Brassica juncea (3-day 
post inoculation) and UV spectra of the corresponding phytoalexins detected in infected leaves. 
The insert in the HPLC chromatogram refers to the expansion of HPLC chromatogram.  
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Figure 2.24 Production of plant and fungal metabolites on infected leaves (n = 3) of Brassica 
juncea cv. Cutlass (susceptible). 
 
2.2.3.2 Brassica napus cv. Westar (canola) 
Leaves of Brassica napus displayed symptoms similar to those of leaves of B. juncea 
(whole plants and detached leaf assays) (Figure 2.17). Three days after inoculation with A. 
brassicicola spores, B. napus started to show necrotic/chlorotic lesions around inoculation sites. 
Five-day-old infected leaves exhibited the most severe damage (dark brown color, and 
necrosis/chlorosis).  
HPLC-DAD analyses of leaf extracts revealed that fungal infection induced the 
production of the phytoalexins, arvelexin (188a), caulilexin (188b) within 24 h (Figure 2.25) 
and phytoanticipins such as glucobrassicin (196), 4-MeO-glucobrassicin (161), and indole-3-
acetonitrile (188) within 48 h. However, neither phytoalexins nor phytoanticipins were detected 
three days after incubation, suggesting production might be below the current detection limits. 
Phomapyrone A (25) was detected in 4-day-old infected leaves of B. napus (Figure 2.26). 
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Figure 2.25 HPLC-DAD chromatograms (method C, detection 220 nm) of extracts of control 
leaves (CON-W, H2O; CON-S, autoclaved spores) and infected leaves of Brassica napus cv. 
Westar (1-day after post inoculation) and UV spectra of the corresponding phytoalexins were 
detected in infected leaves. 
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Figure 2.26 Production of plant and fungal metabolites on infected leaves (n = 3) of Brassica 
napus cv. Westar (susceptible). 
2.2.3.3 Sinapis alba cv. Ochre (white mustard) 
Sinapis alba is resistant to Alternaria species. While B. juncea (susceptible) and B. napus 
(susceptible) exhibited similar necrotic/chlorotic lesions, S. alba responded differently. That is, 
leaves of whole plants did not show necrosis and/or chlorosis, whereas detached leaves showed 
necrosis caused by brassicicolin A (1.0 mM, 0.5 mM, and 0.1 mM, see Section 2.2.1).  
In the detached leaf assay, three days after inoculation with fungal spores, S. alba started 
to show dark brown color, necrosis and/or chlorosis. Although the most severe damage was 
observed in infected leaves, five days post inoculation, the severity of symptoms on S. alba was 
lower than in leaves of B. juncea and B. napus (Figure 2.22). These results were consistent with 
those observed in detached leaves of S. alba after inoculation with brassicicolin A (1) (Figure 
2.17). Detached leaves of S. alba are less resistant to A. brassicicola than leaves of whole plants. 
However, the severity of symptoms appears to be lower than the symptoms observed in leaves of 
B. napus and B. juncea.  
HPLC-DAD analyses of extracts of control leaves and infected leaves of S. alba showed 
that the production of sinalexin (195) and sinalbin A (193) was induced by fungal infection. 4-
Hydroxybenzyl isothiocyante (232) was detected in both control and infected leaf extracts 
(Figure 2.27). Sinalexin (195), a phytoalexin and phomapyrone A (25) were detected in 5-d-old 
infected leaves (Figure 2.28).  
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Figure 2.27 HPLC-DAD chromatograms (method C, detection 220 nm) of extracts of control 
(CON-W, H2O; CON-S, autoclaved spores) and infected leaves of Sinapis alba cv. Ochre (3-day 
after post inoculation) and UV spectra of the corresponding phytoalexins detected in infected 
leaves. 
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Figure 2.28 Production of plant and fungal metabolites on infected leaves (n = 3) of Sinapis alba 
cv. Ochre (resistant). 
 
Figure 2.29 HPLC-ESI-MS chromatograms (base peak chromatogram) of the extracts of 
infected tissues (5-day post inoculation): A, Brassica juncea; B, B. napus; C, Sinapis alba; D, 
mass spectrum of the peak at tR 28 min; red, infected tissue extract; black, control leaf extract. 
The arrow indicates the peak corresponding to phomapyrone A (25) in infected tissue extracts. 
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2.2.3.4 Arabidopsis thaliana Col-0, pen2-1 and pad3-1 
Arabidopsis thaliana is a well-known model in the plant field. Since the genome 
sequencing of A. thaliana has been completed (TheArabidopsisInitiative, 2000), numerous 
studies have been carried out using A. thaliana wild types and mutants. Investigation of 
secondary metabolites of A. brassicicola in infected A. thaliana and its mutants could help to 
understand the importance of metabolites in plant-pathogen interactions. It was hypothesized that 
A. brassicicola might produce larger amounts of fungal metabolites in susceptible mutants pen2-
1 and pad3-1 than in the resistant ecotype Col-0. To test this hypothesis, A. thaliana Col-0, pad3-
1, and pen2-1 seedlings were grown in hydroponic kits. Plants (4–5-week-old) were inoculated 
with fungal spore suspensions and incubated for two days. No substantial differences around 
inoculation sites in Col-0, pad3-1, and pen2-1 were observed (Figure 2.30).  
To examine the fungal metabolites produced during infection, SGFs were collected and 
analyzed by HPLC-ESI-MS. While the known plant metabolites, glucobrassicin (196), 4-MeO-
glucobrassicin (161), and camalexin (209) were detected, none of the fungal metabolites 
including siderophores and phomapyrone A (25) was observed in SGFs collected from Col-0, 
pad3-1, or pen2-1. The infected leaves and control leaves were extracted and the extracts were 
analyzed by HPLC-DAD. HPLC chromatograms of leaf extracts of infected Col-0 and pen2-1 
showed induction of camalexin (209) and unknown metabolites (tR 11–13 min); but no fungal 
metabolites were detected in Col-0, pen2-1 and pad3-1. In addition, pad3-1 did not produce 
camalexin (209) in infected leaves, whereas unknown metabolites (tR 11–13 min) appeared to 
accumulate (Figure 2.31). In the MS spectrum of the unknown metabolites, one metabolite (tR 
12.2 min) showed a quasimolecular ion peak [M+1]+ at m/z 247. Considering the molecular 
weight and UV spectrum of the peak at tR 12.2 min in pad3-1, presumably, the peak might be 
(S)-dihydrocamalexic acid (208), a precursor of camalexin (209) (Schuhegger, Nafisi et al., 
2006). However, further experiments are needed to characterize the peak at tR 12.2 min.  
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Figure 2.30 Leaves  of Arabidopsis thaliana ecotype (Col-0) and mutants (pad3-1 and pen2-1) 
infected with spores of  A. brassiciola (2-day post inoculation). 
 
Figure 2.31 HPLC-DAD chromatograms (method C, detection 220 nm) of extracts of 
Arabidopsis thaliana Col-0 and mutants (pad3-1 and pen2-1) (2-day post inoculation). Arrows 
indicate plant metabolites induced by Alternaria brassicicola. UV spectra of the unknown 
metabolite (tR = 12.2 min) and camalexin (209). 
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Quantification of plant metabolites produced in Col-0, pen2-1, and pad3-1 was carried 
out using calibration curves built with authentic compounds. Although quantification of 
glucobrassicin (196) and 4-MeO-glucobrassicin (161) in polar region (tR = 5–8min in Figure 
2.31) was not successful due to poor resolution, those metabolites appeared to increase in 
infected leaves in all of the A. thaliana lines. Camalexin (209) was induced by fungal infection in 
Col-0 and pen2-1, whereas it was not detected in pad3-1 (Figure 2.32).  
 
 
 
 
Figure 2.32 Production of camalexin (209) in infected leaves of Arabidopsis thaliana Col-0 and 
mutants (pad3-1 and pen2-1) (2-day post inoculation). Asterisk indicates that camalexin was not 
detected.  
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2.2.4 Discussion 
The comparative chemical analyses of the fungal metabolites produced on infected and 
control leaves of B. juncea cv. Cutlass (susceptible), B. napus cv. Westar (susceptible) and S. 
alba cv. Ochre (resistant) were carried out to understand the involvement of fungal metabolites 
during fungal invasion. In this work, depudecin (151) exhibited phytotoxicity only at 5.0 mM in 
leaves of whole plants of B. napus. Considering phytotoxic activity of other metabolites (e.g., 
brassicicolin A – 0.1 mM), depudecin (151) does not seem to have phytotoxic activity in the 
tested crucifers. Further experiments are needed to establish if depudecin (151) might have 
synergistic effects on phytotoxicity in susceptible plants.  
Depudecin (151) has been known as a HDAC inhibitor (Kwon, Owa et al., 1998). 
However, other biological activities of depudecin (151) are unknown, except for low virulence of 
the depudecin minus mutants of A. brassicicola (Wight, Kim et al., 2009). Considering that HC-
toxin (2), a HDAC inhibitor produced by C. carbonum, exhibited severe phytotoxicity in 
susceptible maize cultivars (Walton, 2006), depudecin (151) might have an important role in A. 
brassicicola–crucifers pathosystems. To establish biological activity, further experiments are 
necessary.  
None of the metabolites (except for brassicicolin A (1)) did exhibit phytotoxicity in the 
three crucifers in whole plant assays. Previously published results showed that tyrosol (219) was 
phytotoxic to leaves of marigold (Tagetes erecta L.) (Gamboa-Angulo, García-Sosa et al., 2001), 
prickly sida (Sida spinosa L.) and lamb's quarters (Chenopodium album L.), whereas α-
acetylorcinol (210) displayed relatively lower phytotoxicity to prickly sida and lamb's quarters 
(Venkatasubbaiah, Baudoin et al., 1992). Furthermore, tyrosol (219) inhibited seed germination 
of lettuce (Kimura and Tamura, 1973), while 219 promoted germination of spores of the fungus,  
C. albicans (Chen, Fujita et al., 2004).  
Pedras et al. established that brassicicolin A (1) exhibited phytotoxic activity in leaves of 
whole plants of B. juncea, and B. napus, but not on S. alba showed necrosis caused by 
brassicicolin A (1) (Pedras, Chumala et al., 2009). In this work, a significant difference was 
observed in between leaves of whole plants and detached leaves of S. alba responding to 
brassicicolin A (1) (Figure 2.17). S. alba might lose resistance to A. brassicicola in excised 
leaves. Furthermore, loss of resistance is likely to allow A. brassicicola to infect S. alba (Figure 
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2.22). On the other hand, the lower severity of disease symptoms on S. alba is probably due to 
other defense mechanisms regardless of physical stress (i.e., excision of leaves).  
Spore germination fluids (SGFs) produced by Alternaria species during germination 
contain various phytotoxic metabolites, resulting in visible necrosis and/or chlorosis in 
susceptible plants (Oka, Akamatsu et al., 2005; Otani, Kohnobe et al., 1998; Parada, Sakuno et 
al., 2008; Quayyum, Gijzen et al., 2003). SGF is one of the useful tools for the investigation of 
plant-pathogen interactions because SGF is involved in host recognition and HST production on 
the sites of initial contact at the early stage of infection. SGFs collected from B. juncea, B. napus, 
and S. alba were analyzed by HPLC-ESI-MS to determine whether SGFs contain potentially 
toxic metabolites rather than known protein toxins (i.e., AB-toxin) (Oka, Akamatsu et al., 2005). 
Eight siderophores plus phomapyrone A (25) were detected in SGFs collected from the three 
crucifers for the first time (Figure 2.19–Figure 2.21). Production of siderophores is considered 
one of the essential processes to utilize iron from the plants and to have resistance to localized 
reactive oxygen species (ROS) produced by plants (Haas, Eisendle et al., 2008; Oide, Moeder et 
al., 2006).  
Considering antifungal activity of phytoalexins and hydrolyzed products of indole 
glucosinolates, the pen2 mutant is more vulnerable to fungal pathogens than the eco type 
(Bednarek, Pislewska-Bednarek et al., 2009). It was expected that A. brassicicola might be able 
to infect the pen2 mutant. However, no germination was observed in the pen2 mutants. None of 
the fungal metabolites were detected in either HPLC-DAD or HPLC-ESI-MS. Presumably, 
improper incubation conditions (e.g., short incubation time or spore concentration) might prevent 
germination and further fungal invasion.  
Camalexin has shown strong antifungal activity against A. brassicicola (Pedras and 
Abdoli, 2013). PAD3 (phytoalexin deficient 3) is a key enzyme associated with camalexin (209) 
biosynthesis (Schuhegger, Nafisi et al., 2006). The Arabidopsis pad3 exhibited more 
susceptibility than in wild-type against A. brassicicola (Thomma, Nelissen et al., 1999). After 
infection with A. brassicicola, the enhanced peak (tR = 12.9 min, m/z 247) was detected in 
extracts of the pad3 (Figure 2.31). It can be deduced from UV and MS spectra that the peak is 
most likely to be (S)-dihydrocamalexic acid (208) (Schuhegger, Nafisi et al., 2006). None of the 
fugal metabolites were detected in SGFs and extracts of infected pad3. Further experiments are 
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needed to establish roles of fungal metabolites in the chemical-ecological interactions between A. 
brassicicola and A. thaliana.  
2.3 Biosynthesis of brassicicolin A  
The structure of brassicicolin A (1) was first elucidated by Gloer et al. and confirmed 
through chemical degradation studies (Gloer, Poch et al., 1988). Brassicicolin A (1) 
(C32H48N2O14) has a D-mannitol unit (233) to which two isocyanoisovaleryl (C-9/C-9’–C-14/C-
14’), two 2-hydroxy-3-methylbutanoyl (C-4/C-4’–C8/C-8’), and two acetyl (C15/C15’–C-16/C-
16’) units are connected through ester linkages. The chemical structure of brassicicolin A (1) has 
an axis of symmetry (C2) and two epimerizable centers at the α-carbons of isocyanoisovaleryl 
units. Theoretically, four diastereomers are possible (Figure 2.33); however, since two (1c and 
1d) of the potential four isomers are identical (a meso-compound), three diastereomers would be 
observed. Furthermore, these stereoisomers are in equilibrium due to labile protons at α to the 
isocyanogroups, which makes these isomers interconvertible in solution. As shown in Figure 
2.34 and Figure 2.35, a total of 16 carbon resonances are detected in the 13C NMR spectrum 
with each carbon displaying three signals in the 13C due to a mixture of three stereoisomers. 
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Figure 2.33 Brassicicolin A (1) as a mixture of three diastereomers.  
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Figure 2.35 Expansions of the 13C NMR (125 MHz, CDCl3) spectrum of natural abundance 
brassicicolin A (1). Numbers on peaks refer to carbon numbers of brassicicolin A (1).  
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Based on previous reports on the structure of brassicicolin A (1) (Gloer, Poch et al., 
1988; Pedras, Chumala et al., 2009), all carbon resonances were assigned as shown in Table 13. 
 
Table 13 1H (500 MHz, CDCl3) and 13C (125MHz, CDCl3) NMR spectroscopic data of 
brassicicolin A (1) 
 
Carbon number δCa δHb 
1/1’ 67.13, 66.99, 66.96 5.57–5.47, m, 2H 
2/3’ 70.36, 70.32, 70.18, 70.07 5.13–5.04, m, 2H 
3/3’ 62.03, 61.83, 61.69, 61.66 4.27–4.15, m, 2H 
4/4’ 174.52, 174.48, 174.42 — 
5/5’ 75.46, 75.41, 75.36 4.09–4.03, m, 2H 
6/6’ 32.10, 32.07, 32.05 2.10–2.05, m, 2H 
7/7’† 16.82, 16.55, 16.50 0.90–0.87, m, 6H 
8/8’† 16.37, 16.32 1.04–1.02, m, 6H 
9/9’ 165.84, 165.72, 165.68 — 
10/10’ 63.04 4.53–4.39, m, 4H 
11/11’ 161.27, 161.17, 161.04 — 
12/12’ 31.36, 31.31, 30.78, 30.71 2.39–2.31, m, 2H 
13/13’§ 19.66, 19.54, 19.51 1.16–1.13, m, 6H 
14/14’§ 18.97 1.02–0.99, m, 6H 
15/15’ 169.91, 169.83, 169.79 — 
16/16’ 20.76, 20.74, 20.70, 20.69 2.16–2.13, m, 6H 
OH (5/5’) — 2.71–2.63, m, 2H 
a,b Chemical shifts of carbons and protons were consistent with those 
previously reported (Gloer, Poch et al., 1988; Pedras, Chumala et al., 2009) 
† C-7/C-7’ and C-8/C-8’ are interchangeable.  
§ C-13/C-13’ and C-14/C-14’ are interchangeable.  
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2.3.1 Incorporation of D-[U-13C6]glucose into brassicicolin A 
Retrobiosynthetic analysis of brassicicolin A (1) suggested that the main skeleton (C-1/C-
1’–C-3/C-3’) could derive from mannitol (233) and the isocyanoisovaleryl (C-9/C-9’–C-14/C-
14’), and 2-hydroxy-3-methylbutanoyl (C-4/C-4’–C-8/C-8’) groups could derive from valine. 
Two acetyl groups (C-15/C-15’–C-16/C-16’) could derive from acetyl-CoA. The origin of the 
carbons C-11 and C-11’ of the isocyanide groups, however, is unclear.  
In the previous section (See Section 2.1.2), carbon, nitrogen, and temperature affected 
production of brassicicolin A (1) in modified MM. Briefly, high temperature (30 °C) increased 
the amount of brassicicolin A (1), while it was not produced in media containing 5-fold lower 
amounts of glucose. A. brassicicola did not grow in MM containing mannitol (233) instead of 
glucose. The amount of brassicicolin A (1) in PDB was significantly larger (ca. 16-fold) than in 
standard MM (Table 10). Although production of brassicicolin A (1) increased in PDB, PDB 
was excluded in this biosynthetic study of brassicicolin A (1) due to its carbohydrate content 
(potato starch 4 g/L; glucose 20 g/L), which would dilute isotopically labeled glucose, 
potentially, leading to lower incorporation. Standard MM at 30 °C was employed in feeding 
experiments because of lager production (ca. 2.5-fold) of brassicicolin A (1) compared to 
standard MM at 23 °C. Furthermore, since brassicicolin A (1) appeared to be produced at later 
growth stage, isotopically labeled glucose were administered twice: the earlier (2–3d-old culture) 
and later (4–5d-old culture) growth stages.  
Cultures of A. brassicicola in standard MM were grown at 30 °C. D-[U-13C6]glucose was 
administered to 72-h-old culture (100 mg in 100 mL of MM), and 120-h-old culture (100 mg in 
100 mL of MM). After 8 days, cultures were extracted and brassicicolin A (1) was isolated from 
the crude extracts by FCC (see Scheme 4.6). After obtaining brassicicolin A (1) (2.7 mg from 
300 mL of MM), the resultant brassicicolin A (1) was analyzed by NMR (1H, 13C, and 2D 
INADEQUATE) and HPLC-ESI-MS.  
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13C NMR analysis 
As shown in Figure 2.36 (entire spectrum) and Figure 2.37 (expanded spectrum), the 13C 
NMR spectrum of 13C-enriched brassicicolin A (1) obtained from incubation of cultures with D-
[U-13C6]glucose was complex. This is due to the presence of an inseparable mixture of 
diastereomers and one-bond couplings (1J13C-13C) of 13C-labeled carbons. For instance, the 
carbonyl carbon of the acetyl group (C-15/C-15’) in brassicicolin A (δC 169.8 ppm) showed the 
expected three resonances with each resonance showing coupling with adjacent 13C-labeled 
carbons. All carbon signals showed couplings except for the isocyanide carbon at C-11/C-11’ (δC 
161.1 ppm) as expected, since there is no 13C-labeled carbon adjacent to C-11/C-11’.  
To determine whether isocyanide carbons (C-11/C-11’) in brassicicolin A (1) are labeled, 
natural abundance brassicicolin A (1) (2.7 mg in CDCl3) was analyzed by 13C NMR using the 
identical parameters as those used for 13C-enriched brassicicolin A (1) (2.7 mg in CDCl3). After 
the peaks were aligned, the 13C NMR spectra were compared. For example, resonances of C-4/C-
4’ show doublets due to adjacent 13Cs (C-5/C-5’) plus singlets in the center due to the natural 
abundance of 13C. A significant enhancement was observed at isocyanide carbons at C-11/C-11’ 
(δC 161.1 ppm), suggesting isocyanide carbons derived from D-[U-13C6]glucose.  
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Incorporation of [U-13C6]glucose into brassicicolin A (1) was established using NMR 
spectroscopy. INADEQUATE spectrum showed intense correlations between δC 174.5 (C-4/C-
4’) and 75.4 (C-5/C-5’), δC 32.1 (C-6/C-6’) and 16.3 (C-7/C-7’) or 16.7 (C-8/C-8’), δC 165.7 (C-
9/C-9’) and 63.1 (C-10/C-10’), and δC 31.2 (C-12/C-12’) and 18.9 (C-14/C-14’) or 19.7 (C-
13/C13’) (Figure 2.38). In the mannitol (233) unit, correlations between δC 67.0 (C-1/C-1’) and 
70.2 (C-2/C-2’) and δC 70.2 (C-2/C-2’) and 61.7 (C-3/C-3’) were observed. Because C-1 and C-1’ 
show the same chemical shift, a correlation cannot be established. A strong correlation between 
δC 169.8 (C-15/C-15’) and 20.7 (C-16/C-16’) indicated incorporation of D-[U-13C6]glucose into 
acetyl groups of brassicicolin A (1) (Figure 2.38). Based on those observations in the 
INADEQUATE spectrum, the labeling pattern of the 13C-enriched brassicicolin A (1e) was 
established (Figure 2.39).  
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Figure 2.38 INADEQUATE spectrum of 13C-enriched brassicicolin A (1e) obtained from 
incubation of cultures with D-[U-13C6]glucose (A). B and C represent expanded INADEQUATE 
spectra. Dashed red lines indicate couplings (1J13C-13C) between the adjacent carbons. Numbers 
indicate carbon numbers of brassicicolin A (1). 
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Figure 2.39 Labeling patterns in 13C-enriched brassicicolin A (1e) obtained from incubation of 
cultures with D-[U-13C6]glucose. Bold lines indicate correlations detected in the 2D 
INADEQUATE spectrum.  
 
 
ESI-MS analysis 
According to IUPAC, an isotopologue is “a molecular entity that differs only in isotopic 
composition”; whereas, isotopomers have “the same number of each isotopic atom but differing 
in their position” (IUPAC, 1997). For example, [1,2,3,4,5,6-13C6]glucose (229a), and [1,2-
13C2]glucose (229b) are isotopologues; whereas, [1,2-13C2]glucose (229c) and [1,3-13C2]glucose 
(229d) are isotopomers (Figure 2.40).  
 
 
 
Figure 2.40 Examples of isotopologues and isotopomers of glucose. Red squares refer to 13C 
atoms.  
 
HPLC-ESI-MS analysis confirmed incorporation of D-[U-13C6]glucose (229a) into 
brassicicolin A (1). Natural abundance brassicicolin A (1) (molecular weight 684) displayed 
three quasimolecular ion peaks at m/z 685 [M+1]+, 703 [M+H2O+1]+, 707 [M+Na]+ in HPLC-
ESI-MS spectrum (Figure 2.41). Although 13C-enriched brassicicolin A (1e) displayed a 
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natural abundance brassicicolin A (1) (Figure 2.41), indicating all carbons in 13C-enriched 
brassicicolin A (1) are labeled.  
Detection of various quasi-molecular ions (686, 687, 688, etc.) indicates a mixture of 
isotopologues and isotopomers of the 13C-enriched brassicicolin A (1). D-[U-13C6]Glucose is 
metabolized by A. brassicicola providing various labeled precursors of brassicicolin A (1). For 
example, D-[U-13C6]glucose is converted to doubly labeled [1,2-13C2]acetyl-CoA thorough 
glycolysis. The doubly labeled acetyl-CoA could be incorporated into C-15/C-15’ and C-16/C-
16’ in brassicicolin A (1) leading to detection of a peak at m/z 688 [M+2+H]+. However, 
detection of a peak at m/z 688 does not necessarily mean that one of two acetyl groups (C-15/C-
15’ and C-16/C-16’) of brassicicolin A (1) is labeled with 13C. In other words, another 
isotopomer that has two 13Cs in any two positions in brassicicolin A (1) could give a peak at m/z 
688 [M+2+H]+. Similarly, detection of a peak at m/z 689 [M+3+H]+ indicates three carbons are 
labeled in brassicicolin A (1), but it is not feasible to determine the exact positions of labeled 
carbons in brassicicolin A (1).  
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Figure 2.41 HPLC-ESI-MS spectra of natural abundance (A) and 13C-enriched (B) brassicicolin 
A (1e) obtained from incubation of cultures with D-[U-13C6]glucose (229a) 
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2.3.2 Incorporation of L-[2H8]valine and L-[15N]valine into brassicicolin A 
Brassicicolin A (1) has isocyanoisovaleryl (C-9/9’–C-14/14’) and 2-hydroxy-3-
methylbutanoate (C-4/4’–C-8/8’) groups connected to mannitol (233) through ester linkages. 
Since valine is likely a precursor of brassicicolin A (1), preliminary experiments using unlabeled 
valine were carried out to examine whether addition of valine to MM affects production of 
brassicicolin A (1). As a preliminary experiment, unlabeled valine was added to 48-h-old 
cultures (50 mg) and 96-h-old cultures (50 mg). After eight days, culture filtrates were extracted 
and brassicicolin A (1) was quantified. The amount of brassicicolin A (1) in standard MM at 30 
°C increased by ca. 150 % in standard MM amended with valine at 30 °C.  
A. brassicicola cultures were grown in standard MM at 30 °C. L-[2H8]Valine was 
administered to 48-h-old culture (50 mg in 100 mL MM) and 96-h-old culture (50 mg in 100 mL 
MM), where total amount of L-[2H8]valine was 100 mg in a 100 mL of standard MM. After 8 
days, culture filtrates were extracted and the crude extracts were subjected to FCC. Purified 
brassicicolin A (1) (19.5 mg, see Scheme 4.7) obtained from incubation of cultures with L-
[2H8]valine was analyzed by 1H NMR and HRESI-MS.  
The 1H NMR of brassicicolin A (1) obtained from incubation of cultures with L-
[2H8]valine was compared to that of natural abundance brassicicolin A (1) (Figure 2.42). 
Integration of the 1H NMR spectrum revealed that the protons in isocyanoisovaleryl and 2-
hydroxy-3-methylbutanoyl groups were replaced by deuteria. The reduced integration of 1H 
NMR signals (H-6/6’–8/8’ and H-12/12’–14/14’) of 2H-enriched brassicicolin A (1) suggest that 
L-[2H8]valine is incorporated into brassicicolin A (1) at H-6/6’–H-8/8’ and H-12/12’–H-14/14’.  
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Figure 2.42 1H NMR spectra of 2H-enriched brassicicolin A (1j) resulting from incubation of 
cultures with L-[2H8]valine and natural abundance brassicicolin A (1) (B). Arrows indicate the 
partial replacement of protons by deuteria. 
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The HRESI-MS spectrum confirmed incorporation of L-[2H8]valine into brassicicolin A 
(1) (Figure 2.43). Four quasimolecular ion peaks were detected in 2H-enriched brassicicolin A 
(1) resulting from incubation of cultures with L-[2H8]valine. For example, a quasimolecular ion 
[M+H]+ at m/z 692.3633 showed 7 mass units higher than natural abundance brassicicolin A (1) 
[M+H]+ at 685.3224, suggesting the protons in either isocyanoisovaleryl or 2-hydroxy-3-
methylbutanoate groups are replaced by deuteria (Figure 2.44). Similarly, a quasimolecular ion 
[M+H]+ at m/z 713.4941 showed 28 mass units higher than natural abundance brassicicolin A 
(1), suggesting that the protons of two isocyanoisovaleryl and two 2-hydroxy-3-methylbutanoate 
moieties are replaced by deuteria. HRESI-MS suggests that the 2H-enriched brassicicolin A (1) is 
present as a mixture of isotopologues (e.g., 1f and 1j are isotopologues) and isotopomers (e.g., 1f 
and 1g are isotopomers). Each quasi-molecular ion peak and the corresponding molecular 
formula are shown in Table 14. 
 
 
 
Figure 2.43 HR-MS spectrum of 2H-enriched brassicicolin A (1j) obtained from administration 
of L-[2H8]valine. 
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Table 14 Quasi-molecular ions of 2H-enriched brassicicolin A. 
 
m/z Molecular formula 
685.3224 [M+H]+, C32H49N2O14 
692.3633 [M+H+7]+, C32H422H7N2O14 
699.4055 [M+H+14]+, C32H352H14N2O14 
706.4478 [M+H+21]+, C32H282H21N2O14 
713.4941 [M+H+28]+, C32H212H28N2O14 
 
 
Figure 2.44 Examples of isotopologues and isotopomers of 2H-enriched brassicicolin A. 
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incubated with L-[15N]valine were extracted and the crude extracts were subjected to FCC to 
isolate brassicicolin A. Brassicicolin A (13.3 mg Scheme 4.7) was obtained and the15N-enriched 
brassicicolin A (1m) was analyzed by 1H, 13C, 15N NMR and HRESI-MS. 
The spin systems and chemicals shifts in the 1H NMR spectrum of the 15N-enriched 
brassicicolin A (1) were identical with those of natural abundance brassicicolin A (1) (Figure 
2.45). The 13C NMR spectrum of the 15N-enriched brassicicolin A (1) was also identical with that 
of natural abundance of brassicicolin A (1) except for isocyanide carbon (C-11). More complex 
couplings at C-11 were detected in 15N-enriched brassicicolin A (1) compared to the natural 
abundance molecules (Figure 2.46).  
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Figure 2.45 1H NMR spectra of 15N-enriched brassicicolin A (1m) (upper) obtained from 
incubation of cultures with L-[15N]valine and natural abundance brassicicolin A (1) (lower). 
B 
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Figure 2.46 13C NMR spectrum of 15N-enriched brassicicolin A (1) obtained from incubation of 
cultures with L-[15N]valine. The insert shows C-11/C-11’ resonance of 15N-enriched brassicicolin 
A (red) and natural abundance brassicicolin A (1) (blue).  
 
For 15N NMR analysis, the 15N resonances were externally referenced to the signal of 
liquid CH3NO2 (379.6 ppm relative to external liquid NH3 as a zero-point standard) containing 
CDCl3 (Wishart, Bigam et al., 1995). The 15N NMR of the 15N-enriched brassicicolin A (1m) 
resulting from incubation of cultures with L-[15N]valine showed three resonances (Figure 2.47). 
Brassicicolin A (1) is an equilibrium mixture of diastereomers; thus, three resonances in the 15N 
NMR are indicative of three different diastereomers. The HRESI-MS spectrum of 15N-enriched 
brassicicolin A (1m) revealed molecular ions [M+H+1]+ at m/z 686.3174 and [M+H+2]+ at m/z 
687.3165, besides the natural abundance at m/z 685.3211 (Figure 2.48). Considering that 
brassicicolin A (1) has two nitrogens (next to C-11, and C-11’), detection of a peak at m/z 
686.3174 indicates one nitrogen in two isocyanide groups is replaced with 15N. That is, a mixture 
of two isotopomers (1k and 1l) yielded detection of a peak at m/z 686.3174. In addition, 
detection of two peaks at m/z 686.3174 and 687.3165 in 15N-enriched brassicicolin A indicates 
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the15N-enriched brassicicolin A (1m) is a mixture of isotopologues of nitrogen (e.g., 1k and 1m) 
(Figure 2.49). Each quasi-molecular ion of 15N-enriched brassicicolin A and the corresponding 
molecular formula are shown in Table 15. 
 
 
 
Figure 2.47 15N NMR (50.7 MHz, CDCl3) of brassicicolin A (1) obtained from incubation of 
cultures with L-[15N]valine. 
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Figure 2.48 HRESI-MS spectrum of 15N-enriched brassicicolin A (1) obtained from incubation 
of cultures with L-[15N]valine. 
 
 
 
Figure 2.49 Isotopologues and isotopomers of 15N-enriched brassicicolin A. Red circles refer to 
15N atoms.  
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Table 15 Quasi-molecular ions of 15N-enriched brassicicolin A. 
m/z Molecular formula 
685.3211 [M+H]+, C32H49NO14 
686.3174 [M+H+1]+, C32H4915NNO14 
687.3165 [M+H+2]+, C32H4915N2O14 
 
2.3.3 Discussion 
Alternaria brassicicola produces various secondary metabolites. Ciegler and Lindenfelser 
(1969) first reported that the extracts of Alternaria brassicicola exhibited antibiotic activities 
(Ciegler and Lindenfelser, 1969). Gloer et al. elucidated the structure of the main component of 
antibiotic complex (named brassicicolin A) using NMR and MS spectrometry (Gloer, Poch et al., 
1988). More recently, Pedras et al. established that brassicicolin A (1) is a host-selective 
phytotoxin in Brassica juncea cv. Cutlass using a whole plant assay (Pedras, Chumala et al., 
2009). There are no reports regarding the biosynthetic studies on brassicicolin A (1). 
All spectroscopic data of 13C, 2H, or 15N-enriched brassicicolin A showed successful 
incorporation of labeled precursors into brassicicolin A (1), suggesting that brassicicolin A (1) is 
originated from those biosynthetic precursors (i.e., valine and glucose). To determine whether 
isocyanide carbons (C-11/C-11’) in brassicicolin A (1) are labeled, natural abundance 
brassicicolin A  (1) was analyzed by 13C NMR using the identical parameters as those used for 
13C-enriched brassicicolin A (1e). A significant enhancement of C-11/C-11’ carbon signals in 
13C-enriched brassicicolin A (1e) indicates the isocyanide carbons are labeled (Figure 2.37). A 
biosynthetic precursor of marine isocyanide compounds is most likely inorganic cyanide (Garson 
and Simpson, 2004), while the origin of the carbon in isocyalexin (166), a unique plant-derived 
isocyanide, is (S)-tryptophan (155) (Pedras and Yaya, 2013). In addition, it was reported that the 
isocyanide carbon of indole vinylisocyanide (158) was derived from ribulose-5-phosphate in the 
recombinant E. coli (Brady and Clardy, 2005b). Considering that brassicicolin A (1) is a 
terrestrial microbe-derived isocyanide, it is likely that the isocyanide carbon of brassicicolin A 
(1) is derived from glucose via ribulose-5-phophate (156a). Further experiments are needed to 
further establish the biosynthetic origin of the isocyanide carbons of brassicicolin A (1) using 
more advanced precursors (e.g., [2-13C]ribose) than [U-13C6]glucose.   
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3 Conclusions and future work 
A comprehensive investigation of secondary metabolites produced by A. brassicicola was 
carried out for a better understanding of the chemical interactions between A. brassicicola and its 
host plants. Previously, as described in the introduction, several metabolites including 
brassicicolin A (1), diterpenoides (Figure 1.18), polyketides (Figure 1.19) and siderophores 
(176, 179, 184) were reported. In this work, four metabolites—α-acetylorcinol (210), tyrosol 
(219), depudecin (151), and dihydrobrassicicolin A (220)—were isolated from the extracts of 
culture filtrates of A. brassicicola grown in MM or PDB under standard conditions. The 
chemical synthesis of α-acetylorcinol (210) was accomplished for the first time with an overall 
yield of 36% (Pedras and Park, 2015).  
Secondary metabolic pathways of A. brassicicola are strongly dependent on culture 
conditions, specifically nitrogen sources, ferric ion and temperature. An increase in the 
incubation temperature (from 23 °C to 30 °C) of cultures increased the production of 
brassicicolin A (1), whereas the production of depudecin (151) was decreased at the higher 
temperature (30 °C). Nitrates appeared to down-regulate biosynthetic pathways of brassicicolin 
A (1), depudecin (151) and α-acetylorcinol (210). In the Fe3+-deficient condition, A. brassicicola 
produced larger amounts of siderophores than in control cultures (ferric citrate 2 µM) or in high 
concentration of ferric citrate (200 µM). A. brassicicola hydrolyzed SAHA (32) to N-
phenylacetamide (227) via hydrolysis of SAHA (32) followed by acetylation. Neither SBHA 
(33) nor 5-Aza (35) affected metabolite profiles of A. brassicicola in MM. These results suggest 
that A. brassicicola might be resistant to exogenous epigenetic modifiers (Pedras and Park, 
2015).  
Detached leaf assays were employed to determine the phytotoxicity of secondary 
metabolites of A. brassicicola. Neither α-acetylorcinol (210), tyrosol (219) nor phomapyrone A 
(25) showed necrosis on detached leaves of B. juncea, B. napus, and S. alba (Pedras and Park, 
2015). However, a significant difference was observed between leaves of whole plants (no 
necrosis) and detached leaves (necrosis) of S. alba responding to brassicicolin A (1). 
Furthermore, detached leaves of S. alba infected with A. brassicicola exhibited disease 
symptoms, suggesting physical stresses (e.g. excision of leaves) might affect plant resistance. On 
the other hand, lower severity of disease symptoms in detached leaves of S. alba infected with A. 
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brassicicola suggested that other resistance mechanisms might be present in detached leaves of 
S. alba.  
HPLC-ESI-MS analyses of SGFs collected from detached leaves of B. juncea, B. napus, 
or S. alba showed that all SGFs contained siderophores and phomapyrone A (25). It suggests that 
A. brassicicola might produce siderophores to obtain iron from host plants. However, further 
experiments are necessary to establish roles of phomapyrone A (25) in the chemical interactions 
of A. brassicicola and its host plants.  
Incorporation of D-[U-13C6]glucose, L-[15N]valine, or L-[2H8]valine into brassicicolin A 
was determined using 1H , 13C NMR, 15N NMR spectroscopy, HRMS-ESI and HPLC-ESI-MS 
spectrometry. The 13C NMR and INADEQUATE spectra of 13C-enriched brassicicolin A (1e) 
showed 13C-13C coupling attributed to adjacent 13C carbons. In addition, enhancement of the 
carbon resonances of isocyanide carbon of brassicicolin A (1) suggested that isocyanide carbons 
of brassicicolin A are labeled. Spectroscopic data including 1H NMR, 15N NMR, HRMS-ESI and 
HPLC-ESI-MS of brassicicolin A (1) indicated that both 2-hydroxyisopentanoyl and 2-
isocyanoisopentanoyl residues are derived from valine. 
Currently, it is unclear whether brassicicolin A (1) is a virulence factor or pathogenicity 
factor of Alternaria black spot disease in crucifers. One of the ways to prove the involvement of 
brassicicolin A (1) in disease is to establish pathogenicity or virulence using mutants that would 
not produce brassicicolin A (1). If the mutant deficient in brassicicolin A are less virulent to host 
plants than the wild type, brassicicolin A might be considered a key determinant of the disease. 
On this basis, the biosynthetic pathway of brassicicolin A could be a plausible target to control A. 
brassicicola. Design of selective inhibitors of enzymes involved in biosynthesis of brassicicolin 
A (1) would contribute to development of eco-friendly biocontrol agents (Cools and Hammond-
Kosack, 2013; Pedras and Park, 2015). 
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4 Experimental 
4.1 General 
Chemicals were purchased from Alfa-Aesar (Ward Hill, MA, USA), Fisher Scientific 
Canada (Ottawa, ON), Sigma-Aldrich Canada (Oakville, ON) and TCI America (Portland, OR, 
USA). D-[U-13C6]Glucose (99%), L-[2H8]valine (98%), and L-[15N]valine (98%) were purchased 
from Cambridge Isotope Laboratories (Tewksbury, MA, USA). All solvents were HPLC grade. 
Organic extracts were dried over Na2SO4 and solvents were evaporated under reduced pressure 
in a rotary evaporator.  
Flash column chromatography (FCC) was carried out using silica gel grade 60 (mesh size 
230–400 Å). 
Analytical thin layer chromatography (TLC) was carried out on alumina sheets pre-
coated with TLC silica gel 60 F254 (Merck, Germany). Bands on TLC plates were visualized 
under UV light and by dipping in a solution of 5% aqueous (w/v) phosphomolybdic acid 
containing 1% (w/v) ceric sulfate and 4% (v/v) H2SO4 followed by heating. 
HPLC analyses were carried out with Agilent high performance liquid chromatographs 
equipped with quaternary pumps, automatic injector, and diode array detector (DAD, wavelength 
range 190–600 nm), and degasser. The HPLC methods (A, B, and C) are summarized in Table 
16.  
 HPLC-ESI-MS analysis was carried out with an Agilent 1100 series HPLC system 
equipped with an autosampler, binary pump, degasser and diode array detector connected 
directly to a mass detector (Agilent G2440A MSD-Trap-XCT ion trap mass spectrometer) with 
an ESI source. Chromatographic separation was carried out at room temperature. The interface 
and mass parameters were as follows: nebulizer pressure, 70.0 psi (N2); dry gas, N2 (12.0 L/min); 
dry gas temperature, 350 °C; spray capillary voltage 3500 V; skimmer voltage, 40.0 V; ion 
transfer capillary exit, 100 V; scan range, m/z 100–2000. Ultrahigh purity He was used as the 
collision gas. The HPLC-ESI-MS method (method D) is summarized in Table 16. 
Nuclear magnetic resonance (NMR) spectra (1H, 500 MHz; 13C, 125.8 MHz; 15N, 50.7 
MHz; COSY-correlation spectroscopy; HSQC-Heteronuclear Single Quantum Coherence; 
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HMBC-Heteronuclear Multiple Bond Coherence; INADEQUATE-Incredible Natural 
Abundance DoublE QUAntum Transfer) were recorded on Bruker Avance 500 spectrometers at 
room temperature, unless otherwise stated. The 15N resonances were externally referenced to the 
signal of liquid CH3NO2 containing CDCl3 (379.6 ppm relative to external liquid NH3 as a zero-
point standard) (Wishart, Bigam et al., 1995). Data processing was carried out using TopSpin™ 
3.2 software. 
High resolution electron impact mass (HREI-MS) spectra were obtained from a VG70 SE 
mass spectrometer employing a solid probe. High resolution field desorption mass (HRFD-MS) 
spectra were obtained from JEOL AccuTOF GCv 4G by direct insertion. High resolution 
electrospray ionization mass (HRESI-MS) spectra were obtained from a QSTAR XL Mass 
Spectrometer (Hybrid Quadrupole-TOF LC/MS/MS) with turbo spray ESI source. 
Specific rotations ([α]D) were determined at room temperature on a polarimeter using a 1 
mL, 10 cm length cell; the units are 10-1 deg cm2 g-1 and the concentration was g/100 mL.  
Fourier transform infrared (FT-IR) spectral data were obtained from a Bio-Rad FTS-40 
spectrometer and spectra were measured by the diffuse reflectance method on samples dispersed 
in KBr.  
Statistical analysis was conducted by one-way ANOVA with Tukey’s test at significance 
level P < 0.05 using SPSS version 22.0 (SPSS, Inc. Chicago, IL, USA).  
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Table 16 HPLC methods used for analysis of metabolites of Alternaria brassicicola and 
Brassica species§. 
 Time MeOH H2O Flow rate 
Method Aa 0 10 90 0.4 mL/min 
10 30 70 
35 100 0 
Method Ba 0 30 70 0.4 mL/min 
35 100 0 
 Time MeCN H2O  
Method Cb 0 0 100 1.0 mL/min 
25 50 50 
35 75 25 
40 100 0 
 Time MeCN 
(0.2% HCOOH) 
H2O 
(0.2 % HCOOH) 
 
Method Db 0 25 75 1.0 mL/min 
35 75 25  
40 100 0  
§ All signals in HPLC analyses were detected at 210, 220, and 254 nm.  
a Eclipse XDB C-18 column (3.5 µm particle size silica, 3.0 i.d. × 100 mm) 
b Eclipse XDB C-18 column (5.0 µm particle size silica, 4.6 i.d. × 150 mm) 
 
 
Cultures of A. brassicicola  
Alternaria brassicicola isolate UAMH 7474 was obtained from the University of Alberta 
Microfungus Collection and Herbarium (UAMH). A. brassicicola isolate UAMH7474 was 
subcultured in potato dextrose agar (PDA) plates under constant light at 23 ± 1 °C for 14 days. 
The spores were collected by adding sterilized H2O (10 mL) to each agar plate and by scraping 
off the agar surface followed by filtration and centrifugation (3,000 rpm for 30 min) of the spore 
suspension. The resulting pellets were suspended with sterile H2O. The spores were counted 
under a microscope using a hemocytometer and stored at −20 °C. 
Alternaria brassicicola UAMH 7474 was grown in a Erlenmeyer flask (250 mL) 
containing minimal medium (MM, 100 mL) inoculated with fungal spores (2 × 106 spores / 100 
mL) and incubated on a shaker at 110 rpm, at 23 ± 1 °C and 30 ± 1 °C for 7 days, unless 
otherwise stated. 
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Composition of standard MM:  
Solution 1: KNO3 (3.1 g/L, 31 mM), K2HPO4 (0.75 g/L, 4.3 mM), KH2PO4 (0.75 g/L, 5.5 mM), 
NaCl (0.10 g/L, 1.7 mM), asparagine (0.28 g/L, 2.1 mM);  
Solution 2: CaCl2·2H2O (0.10 g/L, 0.68 mM), MgSO4·7H2O (0.50 g/L, 2.0 mM);  
Solution 3: ZnSO4·7H2O (0.40 mg/L, 1.4 µM), CuSO4·5H2O (0.079 mg/L, 0.32 µM), 
MnSO4·4H2O (0.041 mg/L, 0.18 µM), MoO3 (85%, 0.018 mg/L, 0.12 µM), ferric citrate (0.54 
mg/L, 2.0 µM), Na2B4O7·10H2O (0.038 mg/L, 0.10 µM);  
Solution 4: thiamine (0.10 mg/L, 0.38 µM);  
Glucose: (15 g/L, 83 mM). 
Solutions 1, 3 and glucose were combined and the pH of the mixed solution was adjusted 
to 6.5, autoclaved, allowed to cool and combined with solutions 2 and 4, which were previously 
sterilized by autoclaving and filtering using a 0.2 µm membrane filter, respectively.  
 Potato dextrose broth (PDB) was prepared by suspending PDB powder (VWR, Canada) 
in distilled water (24 g/L) followed by sterilization. A. brassicicola UAMH 7474 (2 × 106 
spores/100 mL) was incubated in a Erlenmeyer flask (250 mL) containing PDB (100 mL) on a 
shaker at 110 rpm, at 23 ± 1 °C and 30 ± 1 °C for 7 days, unless otherwise stated.  
4.2  Isolation and structure elucidation of fungal metabolites 
4.2.1 Metabolites produced in MM  
A. brassicicola cultures (12 L at 23 °C and 10.6 L at 30 °C) grown in standard MM (7-
day-old) were filtered followed by lyophilization (Scheme 4.1). Lyophilized culture filtrates 
were diluted with distilled water and extracted with EtOAc.  
The extracts (1.1 g, 30°C) of culture filtrates were fractionated by flash column 
chromatography (FCC) using silica gel.  The crude extracts of fungal culture filtrates were eluted 
with CH2Cl2:MeOH (100:0 to 80:20 (v/v), gradient) followed by CH2Cl2:MeOH (99:1 (v/v), 
isocratic) to obtain α-acetylorcinol (210, 2.5 mg) and tyrosol (219, 2.5 mg). Fractions 2–3 (93 
mg) were combined and further purified by hexane:Et2O (40:60 to 0:100, gradient) to obtain 
brassicicolin A (1, 77.3 mg) and phomapyrone A (25, 1.3 mg) (Scheme 4.1).  
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The crude extracts (1.1 g) of culture filtrates of A. brassicicola grown at 23°C were 
eluted with CH2Cl2:MeOH (100:0 to 80:20, gradient) followed by hexane:EtOAc (15:85 to 5:95 
(v/v), isocratic) to obtain  depudecin (151 57 mg) and hexane:EtOAc (95:5, isocratic) to yield 
phomapyrone A (25, 2.1 mg) (Scheme 4.2).  
Phomapyrones E (146) and G (148) were isolated from combined crude extracts (1.3 g) 
of A. brassicicola culture filtrates. The combined crude extracts (1.3 g) were eluted with 
CH2Cl2:MeOH (99:1 to 80:20, gradient) followed by Et2O:CH2Cl2 (50:50, isocratic) and 
Hexane:EtOAc (95:5, isocratic) to obtain phomapyrone G (148, 1.5 mg). Fraction 9 obtained 
from the first purification step was eluted with CH2Cl2:MeOH (97:3, isocratic) followed by 
Et2O:CMeOH (97:3, isocratic) and Et2O:Hx:MeOH (70:30:2, isocratic) to obtain phomapyrone E 
(146, 2.1 mg) (Scheme 4.3). 
 
 
 
 
 
Scheme 4.1 Flow chart for isolation of metabolites of Alternaria brassicicola grown in standard 
MM at 30 °C. 
 
EtOAc extracts of culture filtrates (30 °C, 10.6 L, 1.1 g)
FCC
CH2Cl2-MeOH (99:1 → 80:20)
F5 F7-8
F2-3
Tyrosol (219) 
(2.5 mg)
α-Acetylorcinol (210) 
 (2.5 mg)
F5-10
FCC
CH2Cl2-EtOAc(40:60)
FCC
CH2Cl2-MeOH(99:1)
Phomapyrone A (25)
(1.3 mg)
FCC
Hexane-Et2O
(40:60 → 0:100)
FCC
CH2Cl2-MeOH (98:2 → 90:10)
Brassicicolin A (1)
(77.3 mg)
F4-5 F10-11 F47-69F25-42
(190 mg)
(93 mg)
(246 mg)
(7mg)
F2-3
(8 mg)
F4
(94 mg)
F6
(67 mg)
F9
(175 mg)
F10
(118 mg)
F16
(150mg)
F4-6
(31 mg)
F7
(24 mg)
F8-11
(11 mg)
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Scheme 4.2 Flow chart for isolation of metabolites of Alternaria brassicicola grown in standard 
MM at 23 °C. 
 
EtOAc extracts of culture filtrates (23 °C, 12 L, 1.1 g)
FCC
CH2Cl2-MeOH 
(97:3 →80:20)
F2-3
F4-5
FCC
CH2Cl2-EtOAC
(100:0 →90:10)
FCC
CH2Cl2-MeOH 
(98:2 → 90:10)
F9-20
FCC
CH2Cl2-MeOH 
(99:1)
Phomapyrone A (25) 
(2.1 mg)
Brassicicolin A (1)
 (38.7 mg)
F10-45
FCC
Hexane-EtOAC
(90:10)
F4-12
(160 mg)
(100 mg)
(50 mg)
F6-9
(8 mg)
F1 F4-6
(166 mg)
F9
(145 mg)
F7-8
(107mg)
F8-18
FCC
Hexane-EtOAC
(15:85 →5:95)
α-Acetylorcinol (210)
 (0.8 mg)
Tyrosol (219)
(0.6 mg)
FCC
CH2Cl2-MeOH(98:2)
F11
F6-11 F13-17
(280 mg)
FCC
CH2Cl2-MeOH (95:5)
(260 mg)
F2
(3 mg)
F2-3
(5 mg)
F6
(18 mg)
F7-10
(15 mg)
F12-13
(10 mg)
F7-8
(2.5 mg)
F21-25
(35 mg)
 (13 mg)
F1-2
(3 mg)
F3-5
(8 mg)
F7-8
(21 mg) (40mg)
F19
F3
(15 mg) Depudecin (151)
(57mg)
F4-6
(55mg)
F8-10
F6-23
(6 mg)
F24-30
(2 mg)
FCC
Hexane-EtOAC
(95:5)
(2.3 mg)
F16-32
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Scheme 4.3 Flow chart for isolation of metabolites of Alternaria brassicicola grown in standard 
MM at 23 °C and 30 °C. 
 
 
 
 
 
EtOAc extracts from MM obtained from various culture conditions
 (c.a. 1.3 g; 12.9 L)
CH2Cl2-MeOH
(99:1 → 80:20)
F1 F2 F5 F9 F10–F11
CH2Cl2-MeOH
(99:1 → 80:20)
F1 F2 F7 F9
(5.2 mg) (4.8 mg)
CH2Cl2-MeOH 
(97:3)
F33-38 F39-51F1–27 F52-71
(41 mg)
F1–21 F23-43 F44-61
Et2O-MeOH 
(97:3)
(7.8 mg)
Et2O-Hx-MeOH 
(70:30:2)
F1-30 F34-60
(2.1 mg)
(41.8 mg) (99.1 mg)(53.3 mg) (43.2mg)
F1-36
Et2O:CH2Cl2
(50:50)
F37-51 F52
Et2O-Hx
(95:5)
(9.5 mg)
F1-20 F40F21-38
(4 mg)
(1.5 mg)
(1.6 mg)Phomapyrone G (148)
Phomapyrone E (146)
(57.6 mg)(19 mg) 68 mg)(4.4 mg)(7.6 mg)
F10–F11
(8.2 mg) (10.5 mg)
F61
(1 mg) (2 mg)
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4.2.1.1 α-Acetylorcinol (210) 
HPLC tR = 8.4 min, Method A. 
1H NMR (500 MHz, CD3OD), 13C NMR (125 MHz, CD3OD) see Table 5. 
HREI-MS: m/z 166.0626, C9H10O3, calcd. 166.0629; m/z 166.0626 (100%), 123.0450 
(65%).  
FTIR (KBr): 3347, 1701, 1603, 1452, 1346, 1159, 1006, 842 cm-1.  
4.2.1.2 Tyrosol (219) 
HPLC tR = 9.2 min, Method A. 
1H NMR (500 MHz, CD3CD), 13C NMR (125 MHz, CD3OD) see Table 6. 
HREI-MS: m/z 138.0682, C8H10O2, calcd. 138.0680; m/z 138.0682 (27%), 107.0497 
(100%).  
FTIR (KBr): 3392, 3170, 2953, 2958, 1514, 1360, 1345, 1238, 1051, 818cm-1. 
4.2.1.3 Depudecin (151) 
HPLC tR = 11.6 min, Method A. 
1H NMR (500 MHz, CDCl3), 13C NMR (125 MHz, CDCl3) see Table 7. 
FT-IR (KBr): 3388, 3083, 2976, 2144, 1743, 1666, 1379, 1223 cm-1 
[α]D = -35 (c 0.50, MeOH). 
Spectral data were consistent with those previously reported (Matsumoto, Matsutani et 
al., 1992).  
4.2.1.4 Phomapyrone A (25) 
HPLC tR = 24.7 min, Method B.  
1H NMR (500 MHz, CDCl3): δ7.01(s, 1H), 6.16 (s, 1H), 5.66–5.62 (m, 1H), 3.92 (s, 3H), 
2.04 (s, 3H), 1.95 (s, 3H), 1.83 (s, 3H), 1.76 (d, 3H, J = 7 Hz). 
HRFD-MS: m/z 234.1264 calcd. C14H18O3, 234.1256. 
Spectral data were consistent with those previously reported (Pedras, Morales et al., 
1994). 
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4.2.1.5 Phomapyrone E (146) 
HPLC tR = 20.1 min, Method A. 
1H NMR (500 MHz, CDCl3) diagnostic peaks of doublet at δH1.21 (3H, 6 Hz). 
4.2.1.6 Phomapyrone G (148) 
HPLC tR = 24.1 min, Method A. 
1H NMR (500 MHz, CDCl3) diagnostic peaks of quartet at δH3.47 (1H, 6 Hz). 
HREI-MS: m/z 250.1207 calcd. C14H18O3, 250.1205 
4.2.2 Metabolites produced in PDB  
The EtOAc extract (1.1g) of PDB culture filtrates was eluted with CH2Cl2:MeOH 
gradient to give 17 fractions. The resulting F7–10 (787 mg) was refractionated with 
hexane:EtOAc followed by CH2Cl2:MeOH to yield brassicicolin A (1, 208 mg) (Scheme 4.4). In 
addition, dihydrobrassicicolin A (220, 3.5 mg) was obtained from combined PDB extracts using 
reverse phase FCC  (Scheme 4.5).  
 
 
Scheme 4.4 Flow chart for isolation of metabolites of Alternaria brassicicola grown in PDB. 
EtOAc extracts of culture filtrates (PDB, 1.1g 2L, 30 °C)
FCC
CH2Cl2-MeOH (99:1 → 85:15)
F1-6 F11-12
Brassicicolin A (1)
F7-10 F13-15 F16-17
(17 mg) (787 mg) (128 mg) (87 mg) (123 mg)
F5-6 F14-17F12-13
(80 mg) (22 mg) (470 mg)
FCC
EtOAc-Hexane
50:50
F7-11
(166 mg)
F11-14
(62 mg) F6-11
(142 mg)
F16-18
(18mg)
Brassicicolin A (1) α-acetylorcinol (210)
FCC
CH2Cl2-MeOH(98:2)
FCC
CH2Cl2-MeOH(98:2)
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Scheme 4.5 Flow chart for isolation of dihydrobrassicicolin A (220) of Alternaria brassicicola 
grown in PDB. 
 
4.2.2.1 Dihydrobrassicicolin A (220) 
HPLC tR = 23.3 min, Method B. 
1H NMR (500 MHz, CDCl3) Doublets of the formamide group at δ 8.30 (d, J = 5 Hz) and 
8.26 (d, J = 5 Hz). 
HRESI-MS: m/z [M-H2O+Na]+ 725.3187, C32H50N2O15Na, calcd. 725.3103. 
 
4.2.2.2 Brassicicolin A (1) 
HPLC tR = 25.5 min, Method B; tR = 29.5 min, Method A 
1H NMR 13C NMR (125 MHz, CDCl3) see Table 13.  
 HRESI-MS: m/z [M+H]+ 685.3190, C32H49N2O11, calcd. 685.3183. 
Spectral data were consistent with those previously reported (Gloer, Poch et al., 1988; 
Pedras, Chumala et al., 2009) 
 
 
 
 EtOAc extracts of culture filtrates
(PDB, combined extract-282 mg)
FCC
CH2Cl2-MeOH 
(100:0 →80:20)
F10
RP-FCC
CH3CN-H2O 
(50:50 → 100:0  )
Dihydrobrassiciolin A
(220, 3.5 mg)
F4
(49 mg)
	 144 
Table 17 Production of fungal metabolites in standard MM and PDB. 
 
Media α-Acetylorcinol 
(210) (mg) 
Tyrosol 
(219) (mg) 
Depudecin 
(151) (mg) 
Phomapyrone A 
(25) (mg) 
Brassicicolin 
A (1) (mg) 
MM-23 °C 
(12L, 1.1 g) 
0.8 2.1 57 2.4 39 
MM-30 °C 
(10.6L, 1.1 g) 
2.5 2.5 - 1.3 77 
PDB-30 °C 
(2L, 1.1 g) 
18  - - - 204 
 
 
 
 
 
 
4.2.3 Synthesis of α-acetylorcinol  
4.2.3.1 Synthesis of 2-(3,5-dimethoxyphenyl)-N-methoxy-N-methylacetamide (218) 
3,5-Dimethoxyphenylacetic acid (211, 50 mg, 0.26 mmol) in anhydrous CH2Cl2 (1 mL) 
was added to an oven-dried flask. N,N-dimethylformamide (DMF) (one drop) as a catalyst and 
oxalyl chloride (49 mg, 0.39 mmol) were added to the flask. The resulting mixture was stirred 
for 30 min at room temperature. The reaction mixture was concentrated to dryness in vacuo to 
remove excess of oxalyl chloride. N,O-dimethylhydroxylamine hydrochloride (38 mg, 0.39 
mmol) in pyridine (100 µL) was added to the reaction mixture in anhydrous CH2Cl2 (1 mL). The 
resulting mixture was stirred for 30 min at room temperature. Diluted hydrochloric acid (2 M, 2 
mL) solution was added to the reaction mixture. The reaction mixture was extracted with diethyl 
ether (4 mL × 3). The organic layer was dried over Na2SO4 and filtered using a cotton plug. 
Solvents in the filtrate were evaporated using a rotary evaporator. The crude residue gave 2-(3,5-
dimethoxyphenyl)-N-methoxy-N-methylacetamide (218, 54 mg, 0.23 mmol, yield 92%) without 
purification. 
 
	 145 
2-(3,5-Dimethoxyphenyl)-N-methoxy-N-methylacetamide (218) 
HPLC tR = 21.6 min, Method A.  
1H NMR (500 MHz, CDCl3): δ 6.47 (d, J = 2 Hz, 2H), 6.36 (t, J = 2 Hz, 1H), 3.78 (s, 
6H), 3.71 (s, 2H), 3.62 (s, 3H), 3.20 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 172.3, 161.0, 137.3, 107.5, 99.2, 61.5, 55.7, 39.8, 32.4.  
HREI-MS: m/z 239.1166, C12H17NO4, calcd. 239.1158; m/z 239.1166 (33%), 178.0623 
(29%), 151.0756 (100%). 
FTIR (KBr): 2937, 1661, 1594, 1460, 1380, 1205, 1151, 1064, 1007 cm-1. 
Spectral data were consistent with those previously reported (Wang, Denton et al., 2011).  
 
 
4.2.3.2 Synthesis of 1-(3,5-dimethoxyphenyl)propan-2-one (216) 
A freshly prepared CH3MgI in anhydrous Et2O (1 mL) was added to 2-(3,5-
dimethoxyphenyl)-N-methoxy-N-methylacetamide (216, 60 mg, 0.25 mmol) in anhydrous Et2O 
(1 mL). The reaction mixture was stirred for 30 min at room temperature. Ammonium chloride 
(80 mg, 1.5 mmol) in water (2 mL) was poured into the reaction mixture. The reaction mixture 
was extracted with Et2O (4 mL × 3) and the extract was dried over Na2SO4. The extract was 
concentrated to dryness in vacuo. The crude residue gave 1-(3,5-dimethoxyphenyl)propan-2-one 
(2, 37 mg, 0.19 mmol, yield 76%) after purification by FCC using silica gel (hexane:EtOAc = 
60:40 (v/v)). Preparation of CH3MgI: Mg (30mg, 1.25 mmol) and CH3I (78 µL, 1.25 mmol) were 
stirred in anhydrous Et2O (1mL) until Mg was completely consumed.  
 
1-(3,5-Dimethoxyphenyl)propan-2-one (216) 
HPLC tR = 20.7 min, Method A. 
1H NMR (500 MHz, CDCl3): δ 6.38 (t, J = 2 Hz, 1H), 6.36 (d, J = 2 Hz, 2H), 3.79 (s, 
6H), 3.62 (s, 2H), 2.16 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 206.5, 161.2, 136.6, 107.6, 99.2, 55.5, 51.5, 29.3. 
HREI-MS: m/z 194.0944 C11H14O3, calcd. 194.0943; m/z 194.0944 (95%), 151.0762 
(100%), 69.0257 (30%). 
FT-IR (KBr): 2941, 2839, 1710, 1595, 1462, 1431, 1349, 1205, 1155, 1066, 835 cm-1. 
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4.2.3.3 Synthesis of α-acetylorcinol (210) 
Iodocyclohexane (326 µL, 2.5 mmol) was added to 1-(3,5-dimethoxyphenyl)propan-2-
one (216, 40 mg, 0.21 mmol) in dry DMF (1 mL). The resulting mixture was refluxed for 4 h, 
cooled, and poured into water (20 mL). The reaction mixture was extracted with EtOAc (20 mL 
× 3). The organic phase was washed with NaHSO3 (5 mL) and brine, and dried over Na2SO4. 
Solvents in the organic layer were evaporated in a rotary evaporator. The crude residue was 
purified by FCC (Et2O:hexane, 60:40 (v/v), isocratic) to afford α-acetylorcinol (210, 18mg, 0.11 
mmol, 52% yield).  
 
α-Acetylorcinol (210) 
HPLC: tR = 8.4 min, Method A.  
1HNMR (500 MHz, CD3OD): δ 6.16–6.14 (m, 3H), 3.52 (s, 2H), 2.09 (s, 3H).  
HREI-MS: m/z 166.0633, C9H10O3, calcd. 166.0632; m/z 166.0633 (100%), 123.0445 
(69%).  
Spectral data were consistent with those of α-acetylorcinol (210) previously isolated from 
the extracts of fungal culture filtrates.  
  
 
4.2.4 Hydrolysis of brassicicolin A  
Brassicicolin A (1) (23 mg, 0.034 mmol) in MeOH (2 mL) was dissolved in HCl (0.10 
mM, 2 mL) and kept at 4 °C for 2 h. The reaction was quenched with Na2CO3 (1 M, 4 mL), and 
extracted with EtOAc to yield dihydrobrassicicolin A (220). The extract was concentrated and 
the residue was analyzed by 1H NMR, HPLC-ESI-MS, and HRESI-MS.  
To examine hydrolysis of brassicicolin A (1) to dihydrobrassicicolin A (220) in media in 
the absence of A. brassicicola spores, brassicicolin A (1) (0.3 mM) in PDB was incubated at 30 
°C. Seven days later, PDB media (20 mL) was withdrawn and extracted with EtOAc (20 mL × 
2). After evaporation of solvents, the residue was dissolved in MeOH (1mL). Brassicicolin A (1) 
and dihydrobrassicicolin A (220) were quantified using calibration curves (Table 18).  
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Dihydrobrassicicolin A (220) 
HPLC tR = 28.5, Method A; tR = 23.3 min, Method B.  
HRESI-MS: m/z [M-H2O+Na]+, 725.3187, C32H50N2O15Na, calcd., 725.3103.  
1H NMR (500 MHz, CDCl3): δ 8.30 (d, J = 5 Hz), 8.26 (d, J = 5 Hz) at formamide group.  
Spectral data were consistent with those of the metabolite previously isolated from the 
fungal culture extracts.  
 
 
 
Table 18 Parameters used in HPLC-DAD quantification of fungal metabolites and synthetic 
compounds.  
Metabolite or compound Method (detection at 220 
nm) - tR (min) 
R2 (calibration curve 
equation) 
α-Acetylorcinol (210) A - 8.4 0.9995 (y = 8704x)  
Tyrosol (219) A - 9.2 0.9999 (y = 5010x)  
Depudecin (151) A - 11.6 0.9924 (y = 3680x)  
Dihydrobrassicicolin (220) B - 23.3 0.9995 (y = 196x)  
Phomapyrone A (25) B - 24.7 0.9997 (y = 2571x)  
C - 31.2 0.9993 (y = 2382x)  
Brassicicolin A (1) B - 25.5 0.9977 (y = 251x)  
SAHA (32) C - 16.3 0.9992 (y = 2023x)  
N-Phenylacetamide (227) A - 12.9 — 
 C - 13.5 0.9981 (y = 1896x) 
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4.3 Modification of minimal media 
Various culture conditions are summarized in Table 8. A. brassicicola spores (2 × 106 
spores/100 mL) were incubated in modified MM or standard MM on a shaker at 110 rpm at 23 
°C ± 1 and 30 °C ± 1 for 7 days. Cultures grown under various conditions (Table 8) were filtered 
to remove mycelia from culture broths, mycelia were weighted and the culture filtrates were 
extracted with EtOAc (150 mL × 1). After evaporation of solvents using a rotary evaporator, 
residues were dissolved in MeOH (500 µL) and analyzed by HPLC-DAD and HPLC-ESI-MS. 
4.3.1 Carbon sources and other components 
MM containing high glucose (entry 2, 45 g/L, 250 mM) or low glucose (entry 3, 5 g/L, 
17 mM) was prepared. Sucrose (entry 4, 15 g/L, 44 mM), fructose (entry 5, 15 g/L, 83 mM); 
mannitol (entry 6, 15 g/L, 82 mM), or sorbitol (entry 6, 15 g/L, 82 mM) was substituted for 
glucose in standard MM.  
Asparagine (entry 7) or thiamine (entry 8) was excluded from standard MM. For NaCl 
(entry 16), cultures were grown under standard MM, and then NaCl (10 g/100 mL) was added to 
60-h-old cultures of A. brassicicola.  
4.3.2 Nitrogen sources 
MM containing low KNO3 (entry 9, 0.31g /L, 3.1 mM), NaNO3 (entry 10, 2.5 g/L, 29 
mM), low NaNO3 (entry 11, 0.25 g/L, 2.9 mM), no nitrate (entry 12, complete removal of 
KNO3) or NH4Cl (entry 13, 0.16 g/L, 3.1 mM) was prepared.  
4.3.3 Iron source and siderophores 
Ferric citrate (0.54 mg/L, 2 µM) was used as a sole iron source in standard MM. A. 
brassicicola was incubated in MM containing high ferric citrate (entry 14, 54 mg/L, 200 µM) or 
no ferric citrate (entry 15).  
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4.3.3.1 Purification of siderophores 
MM was prepared with three different concentrations of ferric citrate (0, 2, and 200 µM). 
A. brassicicola spores (2 × 106 spore/100mL) were inoculated to MM. All cultures were 
incubated on a shaker at 110 rpm at 23 °C ± 1. The experiment was carried out in five replicates. 
After five days, cultures were filtered to separate fungal mycelia from culture broths. Each 
culture filtrate (100 mL) was divided into two 50 mL-portions.  
One portion (50 mL) of culture filtrates was used to fractionate iron-binding compounds 
(reddish fractions) with the revised method based upon Oide et al (2006). Ferric chloride 
hexahydrate (FeCl3·6H2O, 33 mg, 2.4 mM in 50 mL culture) was added to the culture filtrates. 
To fractionate siderophores, amberlite XAD-4 (5 g per 50 mL of culture-FeCl3) preequlibrated 
with 50 mM KPO4 buffer (pH = 7.5) was used. Culture filtrates containing FeCl3 were loaded 
onto preequlibrated XAD-4 and then washed out with four column volumes of 50 mM KPO4. 
Four column volumes of MeOH were used to elute iron-binding compounds (reddish fractions) 
from the XAD-4. Freshly prepared XAD-4 column was used for each separation. After 
evaporation of MeOH in a rotary evaporator, the residue was dissolved with a mixture of 
solvents (H2O:MeOH, 90:10 (v/v), 500 µL) and analyzed by HPLC-ESI-MS and HRESI-MS.  
The other portion (50 mL) of culture filtrates was used for extraction with EtOAc (50 mL 
× 2). After evaporation of solvents using a rotary evaporator, each extract was dissolved in 
MeOH (500 µL) and analyzed by HPLC-DAD.  
4.3.4 Epigenetic modifiers 
SAHA (32) and SBHA (33) were synthesized as described below and 5-Aza (35) was 
purchased from Alfa Aesar (Ward Hill, MA, USA). A. brassicicola was grown in standard MM 
containing suberoylanilide hydroxamic acid (SAHA, 32), suberoyl bis-hydroxamic acid (SBHA, 
33), or 5-azacytidine (5-Aza, 35). The experimental details were described below. 
4.3.4.1 Synthesis of suberoylanilide hydroxamic acid (SAHA, 32) 
A solution of suberic acid (224, 1.25 g, 7.2 mmol) in acetic anhydride (5 mL) was 
refluxed for 1 h. After cooling down, the reaction mixture was concentrated to dryness in vacuo. 
Aniline (228, 830 µL, 8.9 mmol) was added to the resulting mixture in THF. The mixture was 
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stirred for 1 h at room temperature. The mixture was poured into 1 M NaHCO3 (100 mL) and 
extracted with EtOAc (100 mL × 2). The aqueous layer was acidified by adding concentrated 
HCl, and extracted with EtOAc (100 mL × 2). The extract was concentrated to dryness in vacuo 
to yield 7-(phenylcarbamoyl)heptanoic acid (738 mg, 2.9 mmol) (226) as white solid  in 40% 
yield.  
Methyl chloroformate (70 µL, 0.9 mmol) and Et3N (167 µL, 1.2 mmol) were added to a 
solution of suberanilic acid (224, 150 mg, 0.6 mmol) in anhydrous THF (5 mL) in an ice-water 
bath and the reaction mixture was stirred for 20 min. The solid was filtered using a cotton plug 
and the filtrate was added to a freshly prepared hydroxylamine solution—hydroxylamine 
hydrochloride (168 mg, 2.4 mmol) in MeOH (3 mL) was added to a solution of KOH (138 mg, 
2.4 mmol) in MeOH (3 mL)— and the mixture was stirred for 15 min in an ice-water bath. The 
mixture was filtered using a cotton plug and the filtrate was stirred for 15 min at room 
temperature. After evaporation of the solvents, the residue was recrystallized from MeCN to 
yield N-hydroxy-N’-phenyloctanediamide (32, suberoylanilide hydroxamic acid, SAHA) (88 mg, 
0.33 mmol, yield 55%).  
 
 
SAHA (suberoylanilide hydroxamic acid, 32) 
HPLC tR = 16.3 min, Method C. 
1H NMR (500 MHz, CD3OD): δ 7.53 (d, J = 7.0 Hz, 2H), 7.29 (t, J = 7.5 Hz, 2H), 7.08 (t, 
J = 7.5 Hz, 2H), 2.36 (t, J = 7.5 Hz, 2H), 2.09 (t, J = 7.0 Hz, 2H), 1.70 (t, J = 7.0 Hz, 2H), 
1.63 (t, J = 7.0 Hz, 2H), 1.45–1.35 (m, 4H).  
13C NMR (125 MHz, CD3OD): δ 174.8, 173.1, 140.0, 129.9, 125.3, 121.4, 38.0, 33.8, 
30.1, 30.0, 29.7, 26.9, 26,7. 
HRESI-MS: m/z [M+H]+ 265.1550, C14H21N2O3, calcd. 265.1546. 
FTIR (KBr): 3284, 2936, 2845, 1661, 1602, 1544, 1444, 1317, 975, 755, 691 cm-1.  
m.p.: 153–155 °C. 
Spectral data were consistent with those previously reported (Mai, Esposito et al., 2001).  
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4.3.4.2 Synthesis of suberoyl bis-hydroxamic acid (SBHA, 33)  
Et3N (197 µL, 1.4 mmol) and methyl chloroformate (291 µL, 3.7 mmol) were 
successively added to a solution of suberic acid (224, 81 mg, 0.47 mmol) in anhydrous THF 
(4mL). The reaction mixture was stirred for 1.5 h in an ice-water bath. The reaction mixture was 
filtered and the solvent in the filtrate was evaporated in vacuo. Freshly prepared 
hydroxylamine—hydroxylamine hydrochloride (82 mg, 1.2 mmol) in MeOH (3 mL) was added 
to a solution of Na2CO3 (62 mg, 0.6 mmol) in water (0.3 mL)—was added to a solution of the 
reaction mixture in anhydrous THF (0.5 mL). The resulting mixture was stirred for 1 h at room 
temperature. The reaction mixture was filtered, and the filtrate was dried over Na2SO4, and 
concentrated to dryness in vacuo to yield suberoyl bis-hydroxamic acid (33) (98 mg, 0.47 mmol) 
as a white powder quantitatively.  
 
 
SBHA (suberoyl bis-hydroxamic acid, 33) 
1H NMR (500 MHz, CD3OD): δ 2.09 (t, J = 7.5 Hz, 4H), 1.65–1.56 (m, 4H), 1.39–1.31 
(m, 4H).  
13C NMR (125 MHz, CD3OD): δ 173.2, 33.8, 29.8, 26.7 
HRESI-MS: m/z [M-H]- 203.1038, C8H15N2O4, calcd. 203.1037,  
FTIR (KBr): 3257, 3059, 2943, 2845, 1781, 1665, 1465, 1426, 1075, 978 cm-1  
m.p.: 149–151 °C. 
 
4.3.4.3 Preparation of fungal cultures with epigenetic modifiers 
SAHA (32)  
SAHA (32, 93 mg) was dissolved in MeOH (3.5 mL) and then added to standard MM to 
a final concentration of 0.50 mM. As control, MeOH (500 µL) was added to standard MM (100 
mL). 
SBHA (33)   
SBHA (33, 61 mg) was dissolved in DMSO (3 mL) and then added to standard MM to a 
final concentration of 0.50 mM. As control, DMSO (500 µL) was added to standard MM (100 
mL).  
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5-Aza (35)   
5-Aza (35, 73mg) was dissolved in standard MM (50 mL) and sterilized using a 0.2 µm 
membrane filter. The resulting 5-Aza (35, 50 mL) was combined with standard MM (950 mL) to 
a final concentration of 0.30 mM.  
A. brassicicola was grown in standard MM containing each epigenetic modifier on a 
shaker at 110 rpm at 23°C ± 1 or 30 °C ± 1 for 7 days. Cultures were filtered, mycelia were 
weighted and the culture filtrates were extracted with EtOAc. The residues were dissolved in 
MeOH (500 µL) and analyzed by HPLC-DAD. All experiments were carried out in triplicate. 
 
4.3.4.4 Isolation of N-phenylacetamide (227) 
To purify the peak at tR = 12.9 min (Method A), a major metabolite of A. brassicicola 
grown in standard MM containing SAHA (32), the extracts of the culture filtrates were 
fractionated by silica gel flash column chromatography (Et2O:hexane,  60:40 to 100:0 (v/v), 
gradient).  
 
 
N-phenylacetamide (227) 
HPLC tR = 12.9 min, method A; tR = 13.2 min, method C.  
1H NMR (500 MHz, CDCl3): δ 7.50 (d, J = 8, 2H), 7.33 (t, J = 8, 2H), 7.11 (t, J = 8, 1H), 
2.19 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 168.5, 138.1, 129.2, 124.5, 120.1, 24.8.  
HREI-MS: m/z 135.0688, C8H9NO, calcd. 135.0684; m/z 135.0688 (45%), 93.0577 
(100%) 
Spectral data were consistent with those of the authentic compound.   
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4.3.4.5 Biotransformation of SAHA (32) 
A. brassicicola (2 × 106 spores/100 mL) was grown in MM containing SAHA (32, 0.40 
mM) at 23 °C and 30 °C. A 10 mL of cultures was withdrawn and extracted with EtOAc (10 mL 
× 3) every 24 hours for 5 days. Culture extracts were dissolved with MeOH (500 µL) and were 
analyzed by HPLC-DAD. To examine stability of SAHA (32) in MM, MM containing SAHA 
(32) (0.40 mM) was incubated without the fungal spores and a 10 mL of MM was extracted with 
EtOAc (10 mL × 3). All experiments were carried out in triplicate.  
4.3.4.6 Biotransformation of aniline (228) to N-β-D-glucopyranosyl amine(230) 
A. brassicicola (2 × 106 spores/100 mL) was grown in standard MM. The cultures were 
shaken at 110 rpm at 23 °C ± 1. After 48 h, aniline (228) was added to A. brassicicola culture to 
a final concentration of 0.20 mM. Cultures (10 mL) at different time intervals (0h, 4h, 8h, 12h, 
24h, 18h, 24h, 48h, and 72h) were collected and lyophilized. Lyophilized cultures were dissolved 
with distilled water for HPLC analysis. Due to low solubility with distilled water, 48-h-old-
cultures and 72-h-old-cultures were extracted with EtOAc (10 mL × 3). The EtOAc extracts were 
concentrated to dryness using a rotary evaporator, and the residue was dissolved with MeOH for 
HPLC analysis. Control cultures were shaken in the presence of aniline (228) with no fungal 
spores. All experiments were carried out in triplicate. 
To test stability of aniline (228) in standard MM, aniline (228, 13 mg, 0.14 mmol) was 
dissolved in MeOH (1.4 mL), and then a 40 µL of 100 mM aniline was added to following 
solutions to a final concentration of 0.02 mM: a) standard MM (20 mL) b) MM (20 mL) with no 
glucose or c) H2O (20 mL). All solutions were incubated at room temperature for 3 days. The 48-
-h or 72-h-old solutions were analyzed by HPLC-DAD (method C). All experiments were carried 
out in triplicate.  
To confirm formation of N-β-D-glucopyranosyl amine (230) (HPLC tR = 8.7 min, Method 
C) in standard MM, two reaction mixtures were prepared: five (90 mg, 0.5 mmol) or ten (180 
mg, 1.0 mmol) equivalents of glucose (229) were prepared in distilled water (1 mL) (pH = 6 
adjusted by 1 M HCl). Aniline (228, 10 µL, 0.11 mmol) was added to each glucose solution. 
Each reaction mixture was stirred at room temperature for 3 days. After lyophilization, both 
residues  were analyzed by 1H and 13C NMR.. The 1H and 13C NMR spectroscopic data of both 
residues indicated the presence of mixtures of α- and β-D-glucopyranose and N-β-D-
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glucopyranosyl aniline (230), consistent with the previously reported data (Bridiau, Benmansour 
et al., 2007; Roslund, Tähtinen et al., 2008). 
4.3.5 Co-cultivation of A. brassicicola with A. brassicae 
4.3.5.1 Collection of A. brassicae spores 
Alternaria brassicae UAMH4936 was obtained from the University of Alberta 
Microfungus Collection and Herbarium. A. brassicae UAMH4936 was subcultured in freshly 
prepared V8 agar in the dark  at 23 ± 1 °C for 10 days. The spores were collected by adding 
sterilized H2O (10 mL) to each agar plate and by scrapping off agar surface followed by filtration 
and centrifugation of suspension. The resulting pellets were rinsed with sterile H2O. The spores 
were counted under a microscope using a hemocytometer and stored at −4 °C.  
Preparation of V8 agar plate: V8 juice 100mL, CaCO3 0.37g, and agar 7.5g were added 
to H2O 400 mL. A 500 µL of rose bengal (40 mg/mL) was added to the autoclaved V8 juice 
mixture (500 mL).  
4.3.5.2 Co-cultivation of A. brassicicola with A. brassicae 
A. brassicae (1 × 104 spores), A. brassicicola (1 × 104 spores) and co-culture were 
incubated in 6-well plates (in triplicate), where each well contains 6 mL of either PDB or MM. 
The plates were placed on a shelf at 23 °C under constant light for two weeks. The cultures were 
extracted with EtOAc (10 mL × 2). After evaporation of solvent, the residues were dissolved in 
MeOH (200 µL) and then analyzed by HPLC-DAD.  
4.3.6 Evaluation of biological activity of metabolites: conidia germination inhibition 
A microplate reader (xMark Microplate Spectrophotometer, Bio-Rad Laboratories, Inc.) 
was used to assess the conidia germination of A. brassicicola in standard MM containing the 
fungal metabolites brassicicolin A (1), depudecin (151), α-acetylorcinol (210), and tyrosol (219). 
The assay was carried out in sterile, Nunclon 48 well plates, each well containing standard MM 
(400 µL) (Pedras et al. 2014). Each fungal metabolite was dissolved in DMSO then added to 
wells containing 1 × 105 spores/mL in standard MM to give final concentrations of 0.50 mM. 
Eight replicate wells were set up per treatment per experiment. The plates were sealed and 
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incubated at 25 ± 0.5 °C, shaken at medium speed and were read in kinetic mode at 595 nm; 
absorbance readings were automatically recorded every hour over the course of 36 h. The 
absorbance was measured using the Microplate Manager 6 Software (Bio-Rad). After processing 
the raw data, the absorbance was plotted against time using the Microsoft Office Excel Software 
(Version 2003, USA).  
 
 
4.4 Analyses of metabolites produced on infected leaves 
4.4.1 Whole plant assay to determine phytotoxicity 
Brassica juncea cv. Cutlass (brown mustard, susceptible) and B. napus cv. Westar 
(canola, susceptible) were grown in a growth chamber at 20 ± 2 °C with an 18-h photoperiod 
(fluorescent and incandescent 410–450 µmol s-1m-2) and ambient humidity (ca. 50%) for two 
weeks. Six leaves were employed, where each leaf was gently scratched with a needle at six 
spots. Various concentrations (0.25, 0.50, 1.0, 2.5 and 5.0 mM) of purified compounds were 
prepared in MeOH-H2O (1:1, v/v). A 10 µL droplet of each concentration was placed on the six 
spots per leaf. In addition, various mixtures of two compounds were prepared as follows: 
brassicicolin A (1) 1.0 mM + depudecin (151) 10 mM, 5.0 mM, 2.0 mM, 1.0 mM or 0.50 mM; 
brassicicolin A (1) 0.50 mM + depudecin (151) 10 mM, 5.0 mM, 2.0 mM, 1.0 mM or 0.50 mM; 
depudecin (151) 2.0 mM + brassicicolin A (1) 10 mM, 5.0 mM, 2.0 mM, 1.0 mM or 0.50 mM; 
depudecin (151) 1.0 mM + brassicicolin A (1) 10 mM, 5.0 mM, 2.0 mM, 1.0 mM or 0.50 mM. A 
10 µL droplet of the mixtures was placed on the six spots per leaf. Control leaves were treated 
similarly with MeOH-H2O (10 µL, 1:1, v/v). Whole plants were incubated in the growth chamber 
for one week. The visible necrotic areas were measured using a stencil having circles with 
different diameters and damage index was recorded by converting diameters to damage index 
scale. Lesion size scale is as follows: 0 = 0.0–1.9 mm; 1 = 2.0–2.9 mm; 2 = 3.0–3.9 mm; 3 = 
4.0–4.5 mm; 4 = 4.6–5.5 mm; 5 = 5.6–6.5 mm; 6 = 6.5–7.5 mm (Pedras, Chumala et al., 2009). 
Sinapis alba cv. Westar (white mustard, resistant) was grown under the same conditions 
described above. Six leaves were employed, where each leaf was gently scratched with a needle 
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at six spots. A 10 µL droplet of brassicicolin A (1) (1.0, 0.50, and 1.0 mM) in MeOH-H2O (1:1, 
v/v) was placed on the six spots. Control leaves were treated similarly with MeOH-H2O (10 µL, 
1:1, v/v). Whole plants of S. alba were incubated in the growth chamber for one week under the 
same conditions as described above.  
 
4.4.2 Detached leaf assay to determine phytotoxicity 
Brassica juncea cv. Cutlass, B. napus cv. Westar and Sinapis alba cv. Ochre were grown 
as described above. The six second or third leaves were excised at the base of the petiole, where 
each leaf was gently scratched with a needle at six spots. Three concentrations (0.1, 0.5 and 1.0 
mM) of purified metabolites (α-acetylorcinol (210), tyrosol (219), depudecin (151), 
phomapyrone A (25), and brassicicolin A (1)) were prepared in MeOH-H2O (1:1, v/v). A 10 µL 
droplet of each concentration was placed on the six spots. Control leaves were treated similarly 
with MeOH-H2O (10 µL, 1:1, v/v). Each detached leaf was placed in a Falcon tube containing 
water for one week in an incubator at 23 ± 2 °C with an 18-h photoperiod. Visible necrotic areas 
were measured using a stencil having circles with different diameters and damage index was 
recorded by converting diameters to damage index scale, as described above (Pedras, Chumala et 
al., 2009).  
 
4.4.3 Analysis of spore germination fluids  
Brassica juncea, B. napus, and Sinapis alba 
Brassica juncea cv. Cutlass, B. napus cv. Westar, and Sinapis alba cv. Ochre were grown 
as described above. To prepare spore germination fluids (SGFs), A. brassicicola spores in water 
(1 × 105 spores/mL, 20 µL) were placed at 40 spots in each leaf of three species. Leaves (6 
leaves per species) were prepared as follows: A leaf was excised at the base of petiole from B. 
juncea, B. napus and S. alba. The lower (or back) side of the excised leaf was gently scratched 
using a pipet tip. After inoculation of spores, each leaf was placed on a filter paper in a petri dish. 
Petiole of each leaf was covered with a moistened cotton plug. Petri dishes were covered with 
lids and then sealed with parafilm. Leaves in petri dishes were incubated for 72 hours in an 
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incubator under dark conditions at 23 ± 2 °C. The control leaves were treated similarly using 
distilled water. The germinated spore suspension droplets at inoculated sites were collected and 
filtered using a 0.2 µm-membrane filter to remove remaining spores and mycelia in SGFs. The 
filtrates of control and SGFs were lyophilized, dissolved with H2O (500 µL), and analyzed by 
HPLC-DAD and HPLC-ESI-MS.  
 
 
Arabidopsis thaliana and its mutants 
Seeds of Arabidopsis thaliana Columbia ecotypes (Col-0), and two mutants (pad3-1 and 
pen2-1) were purchased from The Arabidopsis Information Resource (TAIR). Additional seeds 
of mutants (pad3-1 and pen2-1) were provided by Dr. Wei in Department of Biology, University 
of Saskatchewan, SK, Canada. Seeds of Col-0, pen2-1 and pad3-1 were grown according to the 
modified method using hydroponic kits (Tocquin, Corbesier et al., 2003). Briefly, seeds were 
grown on the surface of seed-holders containing solidified 0.70% agar. Those seeds holders were 
placed onto hydroponic kits containing 2000-times diluted nutrient solutions (Tocquin, Corbesier 
et al., 2003). To keep moisture of agar in each seed holder, a hydroponic kit was covered with a 
plastic bag. The resulting hydroponic kits were placed into an incubator at 23 ± 2 °C under a 
period of 18-h-light for 4–5 weeks. 
The fungal spore suspension (1 × 106 spores/mL, 20 µL) was placed on to leaves of A. 
thaliana (4–5 spots per a seedling). Hydroponic kits were covered with plastic bags to keep 
moisture. All infected plants were incubated in an incubator at 23 ± 2 °C under a period of 18-h-
light for 48 h. After collection of SGF, infected leaves of Col-0, pen2-1 and pad3-1 were 
extracted with MeOH. Each extract was dissolved in MeCN-MeOH (300 µL, 1:1, v/v) and 
analyzed by HPLC-DAD. 
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4.4.4 Time course analysis of metabolites in infected leaves 
Brassica juncea cv. Cutlass, B. napus cv. Westar, and Sinapis alba cv. Ochre were grown 
as described above. Each detached leaf was placed in a falcon tube containing a mixture of 
diluted nutrient solutions (see above). Each detached leaf was gently scratched using a needle at 
20 spots. The A. brassicicola spore suspension (1 × 106 spores/mL, 20 µL) was placed onto each 
spot. The falcon tubes were placed in a tray covered with a plastic bag to keep moisture. Distilled 
water (20 µL), or autoclaved spores (1 × 106 spores/mL, 20 µL) were placed onto spots and 
considered control treatments. Infected and control leaves were weighted every 24 h for five 
days. The leaves were frozen with liquid N2, and extracted with MeOH (10 mL) for 1 h. After 
concentration, each residue was dissolved with MeCN-MeOH (300 µL, 1:1, v/v) and analyzed by 
HPLC-DAD and HPLC-ESI-MS. Plant and fungal metabolites were quantified using calibration 
curves built with authentic compounds (Table 19). 
 
 
Table 19 Parameters used in HPLC-DAD quantification of plant metabolites. 
 
Metabolite or compound Method (detection at 220 
nm) - tR (min) 
R2 (calibration curve equation) 
Glucobrassicin (196)a C - 4.6 min 0.9999 (y = 26649x)  
4-MeO-glucobrassicin (161)a C - 6.1 min  0.9982 (y = 24293x)  
Tryptophan (155)b C - 9.4 min 0.9978 (y = 52535x)  
Indole-3-acetonitrile (188)b C - 22.4 min 0.9970 (y = 41528x)  
Brassilexin (185)a C - 22.7 min 0.9995 (y = 64611x)  
Camalexin (209)a C - 24.7 min 0.9992 (y = 16000x)  
Rutalexin (231)a C - 25.0 min 0.9969 (y = 21924x)  
Sinalexin (195)a C - 29.6 min 0.9979 (y = 29112x)  
Cyclobrassinin (186)a C - 32.8 min 0.9996 (y = 44889x)  
a Compounds were provided by EE, VK, and AA 
b Compounds are commercially available.  
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4.5 Biosynthesis of brassicicolin A 
4.5.1 Administration of D-[U-13C6]glucose 
Alternaria brassicicola (5 × 106 spores/100 mL) was incubated in MM (3 × 100 mL MM 
in a 250 mL Erlenmeyer flask) on a shaker at 110 rpm at 30 °C for 8 days. D-[U-13C6]glucose 
was administered to 72-h-old cultures (100 mg in 100 mL MM), and 120-h-old-cultures (100 mg 
in 100 mL). The cultures were combined, and filtered to remove mycelial debris. The culture 
filtrate was extracted with EtOAc, and the solvent was evaporated in a rotary evaporator. The 
residue was loaded onto silica gel FCC to isolate brassicicolin A (1e) (2.7 mg) (Scheme 4.6). 
 
 
Scheme 4.6 Flow chart for isolation of 13C-enriched brassicicolin A (1e) after incubation of 
cultures with D-[U-13C6]glucose. 
 
Additionally, 13C-enriched (2.7 mg) and natural abundance (2.7 mg) brassicicolin A (1) 
were analyzed by 13C NMR (125.8 MHz, CDCl3) under conditions as follows: Pulse sequence, 
the power-gated decoupling sequence (zgpg30, Bruker library); 13C excitation pulse, 7.0 µs; dead 
time 6.0 µs; acquisition time, 1.1 s; relaxation delay, 2.0 s; number of scan, 17500, room 
temperature. 
Brassicicolin A (1e)
EtOAc extracts of culture filtrates (30 °C, 47.5 mg, 300 mL)
FCC
EtOAc-CH2Cl2
(60:40 →80:20)
F2–3
F4
(12.2 mg)
(1 mg)
F4–5
(4.8 mg)
F6–11
(18.7 mg)
RP-FCC
MeCN:H2O (50:50→60:40)
F2
(1.5 mg)
F5
(trace)
F6
(trace)
F7–8
(2.7 mg)
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4.5.2 Administration of L-[2H8]valine and L-[15N]valine 
Alternaria brassicicola (2 × 106 spores/100 mL) was incubated in MM (3 × 100 mL MM 
in a 250 mL Erlenmeyer flask) on a shaker at 110 rpm at 30 °C for 8 days. L-[2H8]valine was 
added to the cultures at 48-h (50 mg in 100 mL MM), and 96-h (50 mg in 100 mL MM). 
Similarly, L-[15N]valine was administered twice to 48-h-old culture (50 mg in 100 mL MM) and 
96-h-old culture (50 mg in 100 mL MM). After 8 days, cultures were filtered and the resultant 
culture filtrates were extracted with EtOAc. The crude extracts were fractionated using silica gel 
FCC to purify brassicicolin A (1). Purified brassicicolin A obtained from L-[2H8]valine or L-
[15N]valine was 19.5 mg or 13.3 mg, respectively (Scheme 4.7).  
 
 
 
 
 
Scheme 4.7 Flow charts for isolation of 2H-enriched brassicicolin A (1j) and 15N-enriched 
brassicicolin A (1m) obtained from incubation of cultures with L-[2H8]valine and L-[15N]valine, 
respectively.  
 
EtOAc extracts 
of culture filtrates 
(30 °C, 99.3 mg, 300 mL)
FCC
EtOAc-CH2Cl2
(0:100 50:50)
F7–8
F12
(1.4 mg)
(13.3 mg)
F9–10
(1.4 mg)
F11
(15 mg)
FCC
CH2Cl2:MeOH (100:095:5)
F1-11
(trace)
F13-15
(trace)
F12–14
(5.7 mg)
F15–16
(29.6 mg)
EtOAc extracts
of culture filtrates
 (30 °C, 120 mg, 300 mL)
F7–8
F13
(19.5 mg)
F11–12
(24.7 mg)
F13–14
(5.8 mg)
F1-12
(trace)
F14-15
(trace)
F15
(1.8 mg)
F16–17
(33.7 mg)
FCC
EtOAc-CH2Cl2
(0:100 50:50)
FCC
CH2Cl2:MeOH (100:095:5)
Brassicicolin A (1j) Brassicicolin A (1m)
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